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Abstract
Invasive infections due to group A Streptococcus (GAS) advance rapidly causing tissue
degradation and unregulated inflammation. Neutrophils are the primary immune cells that
respond to GAS infection, where it is known that the degree of the neutrophil inflammatory
response can influence the outcome of infection. The response of human neutrophils to GAS has
not been described in depth. This thesis aimed to characterise the neutrophil response to GAS
using in vitro and in vivo models of invasive infection, to further understand the contribution of
neutrophils to invasive GAS disease. The current project optimised methodology to investigate
the presence of intracellular neutrophil proteins via immunoblot, including caspases, where
increased proteases and phosphatase inhibitors decreased protein degradation in neutrophil
lysates. Methods of immunoblot normalisation were assessed and revealed total protein is the
most appropriate method when undertaking densitometric quantification of neutrophil proteins.
Previous research identified a lytic form of neutrophil death in response to emm98.1 GAS isolate
NS88.2 (isolated from invasive infection, covS mutant), however the neutrophil phenotype was
largely uncharacterised. Taking into account recent developments in the understanding of cell
death, the neutrophil response to GAS was further characterised in vitro using emm98.1 GAS
strain NS88.2 and avirulent variant NS88.2rep. Co-incubation of neutrophils with NS88.2 resulted
in GAS proliferation and reduced the production of reactive oxygen species when compared with
NS88.2rep. In the presence of NS88.2, neutrophil death was delayed compared with NS88.2rep.
Infection with either GAS strain induced expression of inflammatory caspases-1 and -4 in
neutrophils, with increased detection of activated inflammatory caspases in response to
NS88.2rep compared with NS88.2. NS88.2 infection caused differential expression of cell-surface
CD66b, CD16 and CD31, when compared to NS88.2rep.
A predominant burden of invasive GAS disease can be attributed to emm1 GAS isolates, which has
made emm1 strains a key research focus. It is largely unknown if the host neutrophil response to
GAS is emm-type-specific or displays common characteristics for multiple strains isolated from
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invasive disease. This project aimed to determine if the neutrophil response to GAS isolates of
different emm-type, share similarities. Hence, the neutrophil response to GAS was further
characterised in response to two emm1 isolates; 5448 (isolated form invasive infection) and
animal passaged variant 5448AP (covS mutant) in vitro. Similar to NS88.2, co-incubation of
neutrophils with 5448AP resulted in proliferation of GAS and lowered the production of reactive
oxygen species when compared with 5448. Infection with both strains invoked neutrophil death,
however apoptosis was reduced in response to 5448AP. Both strains induced neutrophil caspase1 and caspase-4 expression, with inflammatory caspase activation detected. 5448AP invoked
differential expression of CD16 and CD31, when compared to 5448. The neutrophil response to
5448 and 5448AP was further characterised using an in vivo 24 h intradermal mouse model of
invasive infection. Neutrophils are the predominant responding immune cells to GAS infection
during the early stage of infection (≤24 h), though inflammatory monocytes (iMOs) were also
detected. Both neutrophils and iMOs die rapidly in response to GAS infection (≤24 h) and activate
inflammatory caspases at the site of infection. Increased cytokine release was observed due to
5448AP, including the release of IL-1β. Collectively, NS88.2 (emm98.1) and 5448AP (emm1)
promote an inflammatory neutrophil phenotype, where increased inflammation and ineffective
bacterial eradication is observed. This neutrophil profile does not aid the resolution of
inflammation and may be a contributing factor to the severity of invasive GAS infections.

UOW

iii

Characterising the neutrophil response to Group A Streptococcus

Acknowledgements
I am grateful to have been supported by many amazing people during the completion of this thesis
at UOW, many of which fall into multiple categories as mentors, colleagues and friends and have
made my experience ever so pleasant. You have all contributed to many different aspects of my
life and hence directly or indirectly to this project. I value every single one of these contributions
that has led to the end of this degree, even if you still don’t share my love for neutrophils. Through
these words I will try and express my gratitude to those who have gone above and beyond to help
me achieve this document before you.
Firstly, I would like to thank my supervisor Martina Sanderson-Smith. I have continually felt
supported under your mentorship and my opinion highly valued. I greatly appreciate the
countless knowledge, guidance and encouragement you have provided me. You are an amazing
role model that I will continue to look up to and you have further nurtured the inquisitive scientist
within me. Though it is a happy achievement to reach completion, it is also sad to be reaching the
end of my time in your amazing lab group.
I thank my co-supervisor Ron Sluyter. Your wisdom and rationality have had a great impact upon
my development as a scientist. You too have been a constant source of guidance and
encouragement for me. I aspire to one day share the same amount passion and investment you
have in the development of those around you, and for that I thank you.
Next, I would in fact like to thank my wonderful partner Hillary and my family, Dad, Mum and
Thomas. You have all supported me in many through a rainbow of emotions during my PhD.
Without this support, my journey would have been far more difficult. Thank you and I love you
all.
I thank Diane Ly, Jody Gorman and Nicholas Geraghty, who have always been there for support,
scientific advice and friendship. Throughout my PhD you have all gone above and beyond to assist
me, even if that may be at a moment’s notice, and for that I am forever grateful. I also thank James
Tsatsaronis, Mark Wilson and Heath Ecroyd for contributions during the project’s conception.
There have been many contributors to our lab group over the years and I thank you all!
Particularly though, I would like to mention Emma, Anuk, Dave, Heema, Jason and Luke.
Additionally, I would like to thank my office co-workers for insightful chats over the years. To my
fellow peers and other colleagues, thank you for making UOW such a wonderful place to work
and encouraging collaborative science. I thank those that also facilitate a scientific debrief over a
few cold ones at the bar on regular occasions.
A thank you is due to our numerous blood donors, who not only let me stab them with a needle
but also make primary human research like this possible. Additionally, I would also like to thank
the technical and operations staff of IHMRI, the Science Teaching Facility, the Animal Research
Facility and Molecular Horizons, who have provided training, support and countless hours of help
during my time here at UOW.
To my friends, those that understand the hardships of a PhD and those that don’t. Thank you for
your compassion, care and patience, particularly those who have been my housemates and I have
grown closer to during the difficult year of 2020.

J.G.W

iv

Certification

Certification

I, Jonathan Graeme Williams, declare that this thesis submitted in fulfillment of the requirements
for the conferral of the degree Doctor of Philosophy, from the University of Wollongong, is wholly
my own work unless otherwise referenced or acknowledged. This document has not been
submitted for qualifications at any other academic institution.

Jonathan Graeme Williams
26th of February, 2021

UOW

v

Characterising the neutrophil response to Group A Streptococcus

Table of contents
Abstract ..................................................................................................................................................... ii
Acknowledgements .............................................................................................................................. iv
Certification .............................................................................................................................................. v
Publications included in thesis .......................................................................................................... x
Other contributions to publications ...............................................................................................xi
Conference proceedings .................................................................................................................... xii
List of figures ........................................................................................................................................ xiii
List of tables ............................................................................................................................................xv
Abbreviations ....................................................................................................................................... xvi
1

Review of the literature ............................................................................................................ 19
1.1

Overview .................................................................................................................................. 19

1.2

Group A Streptococcus.......................................................................................................... 20

1.2.1

1.3
1.3.1
1.3.2
1.3.3
1.3.4
1.3.5
1.3.6

1.4

M- and emm-typing........................................................................................................................................... 21

GAS spectrum of disease pathology and epidemiology .............................................. 22
Superficial GAS infections .............................................................................................................................. 22
Immune sequelae resulting after GAS infection ..................................................................................... 23
Invasive GAS infections ................................................................................................................................... 24
Global Epidemiology of GAS disease........................................................................................................... 25
Oceanic epidemiology...................................................................................................................................... 28
Current clinical practices for the treatment of invasive GAS infection ........................................... 29

The innate immune response to bacterial infection ................................................... 30

1.4.1 Pathogen recognition....................................................................................................................................... 30
1.4.2 Inflammation ...................................................................................................................................................... 33
1.4.3 Phagocytes and the complement system .................................................................................................. 35
1.4.4 Neutrophil bactericidal defence ................................................................................................................... 37
1.4.5 Anti-inflammatory programmed cell death ............................................................................................. 38
1.4.5.1
Apoptosis ................................................................................................................................................... 39
1.4.5.2
Efferocytosis ............................................................................................................................................. 40
1.4.5.3
Autophagy ................................................................................................................................................. 41
1.4.6 Pro-inflammatory programmed cell death .............................................................................................. 43
1.4.6.1
Pyroptosis.................................................................................................................................................. 43
1.4.6.2
NETosis ...................................................................................................................................................... 45
1.4.6.3
Necroptosis ............................................................................................................................................... 47

1.5

Development of invasive GAS infection........................................................................... 48

1.5.1 Genetic vulnerability to invasive infection ............................................................................................... 49
1.5.2 Subversion of neutrophil mediated defence ............................................................................................ 49
1.5.2.1
Hyaluronic acid capsule ........................................................................................................................ 50
1.5.2.2
Streptolysins............................................................................................................................................. 52

J.G.W

vi

Certification
1.5.2.3
Streptococcal pyogenic exotoxins ..................................................................................................... 52
1.5.2.4
Other enzymatic activity ...................................................................................................................... 53
1.5.3 CovRS and M1T1 propensity to cause invasive infection.................................................................... 54
1.5.4 GAS modulation of neutrophil function..................................................................................................... 56

2

1.6

Bacterial disruption to the homeostatic balance of cell death ................................. 57

1.7

Project aims ............................................................................................................................ 59

General materials and methods ............................................................................................ 60
2.1

Plasticware.............................................................................................................................. 60

2.2

Bacterial strains and culture conditions ........................................................................ 60

2.3

Flow cytometry ...................................................................................................................... 61

2.4

Green fluorescent protein GAS .......................................................................................... 61

2.4.1
2.4.2
2.4.3

2.5

Construction of green fluorescent protein vector pLZ12Km2-P23R-TA:GFP for GAS .............. 61
Wizard Plus SV Mini-prep DNA purification ............................................................................................ 64
Transformation of GAS using electroporation ........................................................................................ 65

Isolation of human neutrophils from venous blood .................................................... 65

2.5.1
2.5.2

2.6

Ethics statement ................................................................................................................................................ 65
Isolation of human neutrophils .................................................................................................................... 66

Neutrophil immunoblotting ............................................................................................... 67

2.6.1
2.6.2
2.6.3
2.6.4
2.6.5

2.7

Lysate preparation ........................................................................................................................................... 67
Quantification of protein concentration using the DC protein assay .............................................. 68
Tris-Glycine Polyacrylamide gel electrophoresis................................................................................... 68
Western transfer ............................................................................................................................................... 68
Immunoblotting and antibodies .................................................................................................................. 69

In vitro infection of neutrophils with GAS ...................................................................... 70

2.7.1
2.7.2
2.7.3
2.7.4
2.7.5
2.7.6
2.7.7
2.7.8
2.7.9
2.7.10

GAS survival and proliferation ..................................................................................................................... 70
GAS internalisation (gentamicin protection assay)............................................................................... 71
GAS phagocytosis .............................................................................................................................................. 71
Reactive oxygen species production........................................................................................................... 71
Immunoblotting................................................................................................................................................. 72
Annexin-V/viability staining ......................................................................................................................... 72
FAM-FLICA inflammatory caspase activation ......................................................................................... 72
Cytometric cytokine bead assay................................................................................................................... 73
Cluster of differentiation expression.......................................................................................................... 74
Data visualisation and statistical methods .......................................................................................... 74

3 Optimisation of methods for isolation of intracellular proteins in human
neutrophils ............................................................................................................................................. 76
3.1

Introduction............................................................................................................................ 76

3.2

Materials and methods ........................................................................................................ 79

3.2.1
3.2.2
3.2.3
3.2.4
3.2.5

UOW

Neutrophil lysis and cell wash buffer recipes ......................................................................................... 79
Physical lysis of neutrophils .......................................................................................................................... 79
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis......................................................... 79
Flow cytometry .................................................................................................................................................. 80
Statistical analyses............................................................................................................................................ 81

vii

Characterising the neutrophil response to Group A Streptococcus
3.3
3.3.1
3.3.2
3.3.3
3.3.4
3.3.5
3.3.6
3.3.7

3.4

4

Polymorphprep allows high purity neutrophil isolation..................................................................... 82
Neutrophil lysis may degrade intracellular proteins ............................................................................ 82
Selection of lysis buffer ................................................................................................................................... 83
Optimisation of RIPA buffer conditions for neutrophil lysis .............................................................. 85
Increased protein preservation through early inhibitor exposure .................................................. 87
The use of optimised lysis conditions allows for improved caspase-1 detection ....................... 88
Selection of appropriate normalisation method for neutrophil lysate immunoblot.................. 89

Discussion ............................................................................................................................... 92

Characterisation of the neutrophil response to emm98.1 Group A Streptococcus
95
4.1

Introduction............................................................................................................................ 95

4.2

Materials and methods ........................................................................................................ 97

4.2.1
4.2.2
4.2.3

4.3
4.3.1
4.3.2
4.3.3
4.3.4
4.3.5
4.3.6

4.4

5

Results ...................................................................................................................................... 82

Bacterial culture, neutrophil isolation and in vitro infection ............................................................. 97
Flow cytometry .................................................................................................................................................. 97
Statistical analysis............................................................................................................................................. 97

Results ...................................................................................................................................... 98
GAS persistence occurs during a dampened neutrophil phagocytic response ............................ 98
Neutrophil death is delayed in response to NS88.2 ............................................................................ 100
Caspase-1 and caspase-4 are upregulated in neutrophils in response to emm98.1 GAS ....... 101
Neutrophils activate inflammatory caspases in response to GAS .................................................. 102
Neutrophils release IL-1b, TNF-a and IL-8 during infection with GAS ........................................ 104
Avirulent GAS invokes greater changes to neutrophil cell-surface CD expression .................. 106

Discussion ............................................................................................................................. 108

Characterisation of the neutrophil response to emm1 Group A Streptococcus112
5.1

Introduction.......................................................................................................................... 112

5.2

Materials and methods ...................................................................................................... 114

5.2.1
5.2.2
5.2.3

5.3

Bacterial culture, neutrophil isolation and in vitro infection ........................................................... 114
Flow cytometry ................................................................................................................................................ 114
Statistical analysis........................................................................................................................................... 114

Results .................................................................................................................................... 115

5.3.1 GAS persistence and proliferation occurs during a dampened neutrophil reactive oxygen
species response ............................................................................................................................................................. 115
5.3.2 Neutrophil death is delayed during infection with 5448AP ............................................................. 116
5.3.3 GAS infection upregulates caspase-1 and caspase-4 in neutrophils .............................................. 117
5.3.4 Neutrophils activate inflammatory caspases in response to GAS infection ................................ 118
5.3.5 Proinflammatory cytokines IL-1β and TNF-α are released by neutrophils in response to GAS
121
5.3.6 GAS infection alters the neutrophil phenotype..................................................................................... 123

5.4

Discussion ............................................................................................................................. 126

6 Characterising the response of neutrophils to Group A Streptococcus in an
intradermal murine model of invasive infection ................................................................. 130
6.1

Introduction.......................................................................................................................... 130

J.G.W

viii

Certification
6.2

Materials and methods ...................................................................................................... 133

6.2.1
6.2.2
6.2.3
6.2.4
6.2.5
6.2.6
6.2.7
6.2.8
6.2.9
6.2.10

6.3
6.3.1
6.3.2
6.3.3
6.3.4
6.3.5
6.3.6
6.3.7
6.3.8
6.3.9

6.4

Ethics statement .............................................................................................................................................. 133
Animals ............................................................................................................................................................... 133
Murine intradermal GAS infection ............................................................................................................ 133
Euthanasia and tissue collection................................................................................................................ 134
Blood processing ............................................................................................................................................. 134
Bacterial enumeration................................................................................................................................... 135
Flow cytometry ................................................................................................................................................ 135
Flow cytometric analysis of murine immune cells .............................................................................. 135
Murine serum cytokine determination.................................................................................................... 136
Statistical analysis...................................................................................................................................... 137

Results .................................................................................................................................... 138
Intradermal GAS infection causes invasive infection in C57BL/6J mice ...................................... 138
Characterisation of murine immune cells using flow cytometry .................................................... 138
Neutrophils respond to GAS infection and activate inflammatory caspases .............................. 141
Characterisation of neutrophil CD11b, CD16 and CD31 expression ............................................. 141
Monocytes respond to GAS infection and activate inflammatory caspases ................................ 143
Characterisation of monocyte CD11b, CD16 and CD31 expression ............................................... 144
GAS infection does not invoke a strong response from murine macrophages within 24 h ... 145
Characterisation of macrophage CD11b, CD16 and CD31 expression .......................................... 146
Increased inflammatory cytokines are released in response to 5448AP..................................... 148

Discussion ............................................................................................................................. 151

7

Concluding remarks and future direction ...................................................................... 157

8

References ................................................................................................................................... 164

9

Appendices .................................................................................................................................. 198
9.1

Appendix A: Buffers and solution ................................................................................... 198

9.2

Appendix B: Bacterial concentrations at mid-log phase .......................................... 200

9.3
Appendix C: Calculation of protein concentrations of neutrophil lysates using the
DC Protein Assay .............................................................................................................................. 201
9.4

Appendix D: Calculation of cytokine concentrations ................................................ 202

9.5

Appendix E: Screening for the release of inflammatory cytokines ....................... 203

9.6

Appendix F: Anti-human antibody titration ................................................................ 204

9.7
Appendix G: Counts of murine immune cells following flow cytometric
characterisation ............................................................................................................................... 205

UOW

ix

Characterising the neutrophil response to Group A Streptococcus

Publications included in thesis
This thesis includes chapters that have been published in the following journal:
Williams, J. G., Ly, D., Geraghty, N. J., McArthur, J. D., Vyas, H. K. N., Gorman, J., Tsatsaronis, J. A.,
Sluyter, R. & Sanderson-Smith, M. L. 2021. Streptococcus pyogenes M1T1 Variants Induce an
Inflammatory Neutrophil Phenotype Including Activation of Inflammatory Caspases. Frontiers in
Cellular and Infection Microbiology, 10. Incorporated as Chapter 5.
Author
J. G. Williams

Contribution
GAS survival and phagocytosis (100%)
ROS production (100%)
Annexin-V/Viability (95%)
Immunoblotting (100%)
FLICA caspase activation (100%)
Cytokine release (95%)
CD expression (95%)
Intradermal mouse infection (50%) *
Generation of GFP GAS (10%)
Wrote the paper (100%)
D. Ly
Intradermal mouse infection (50%) *
N. J. Geraghty
Annexin-V/Viability (5%)
Cytokine release (5%)
CD expression (5%)
J. D. McArthur
Generation of GFP GAS (45%)
H. K. N. Vyas
Generation of GFP GAS (45%)
J. Gorman
Directed and supervised (5%)
J. A. Tsatsaronis
Directed and supervised (5%)
R. Sluyter
Directed and supervised (30%)
Edited (40%)
M. L. Sanderson-Smith
Directed and supervised (60%)
Edited (60%)
* Mouse studies presented in Chapter 6.

All authors provided feedback and edited the final version of the manuscript prior to
submission to Frontiers in Cellular and Infection Microbiology, however substantial contribution
was made by other authors prior to this stage and is represented.
As primary supervisor, I, Associate Professor Martina Sanderson-Smith, declare that the greater
part of this work is attributed to the candidate, Jonathan Graeme Williams. Jonathan contributed
to study design, primary performed data collection, data analysis and interpretation as described
above. The first draft was written by Jonathan and he was responsible for addressing feedback
from his co-authors.

Associate Professor Martina Sanderson-Smith
26th of February, 2021

J.G.W

x

Other contributions to publications

Other contributions to publications
Turner R.J., Geraghty N.J., Williams J.G., Ly D., Carolan M.G., Brungs D., Guy T.V., Watson D., de
Leon J.F., Sluyter R. Comparison of peripheral blood mononuclear cell isolation techniques
and the impact of cryopreservation on lymphocytes expressing CD39 and CD73. Purinergic
Signalling (2020)
Lambert, K., Bird, L., Borst, A., Fuller, A., Wang, Y., Rogers, G.B., Stanford, J., Sanderson-Smith,
M.L., Williams, J.G., McWhinney, B.C., Neale, E.P., Probst, Y., Lonergan, M., (2020). Safety and
Efficacy of Using Nuts to Improve Bowel Health in Hemodialysis Patients. Journal of Renal
Nutrition
Leong, W., Lutz, C., Williams, J., Poh, Y.H., Yeo, B.K.Y., Chua, C., Rice, S.A., Givskov, M.,
Sanderson-Smith, M. and McDougald, D., 2020. Pseudomonas aeruginosa isolates co-incubated
with Acanthamoeba castellanii exhibit phenotypes similar to chronic cystic fibrosis
isolates. Under review (2020) Preprint: http://doi.org/10.1101/2020.02.25.964320

UOW

xi

Characterising the neutrophil response to Group A Streptococcus

Conference proceedings
Williams, J. G., Geraghty, N. J., Tsatsaronis, J. A., Gorman, J., Sluyter, R., Sanderson-Smith, M. L.
Streptococcus pyogenes causes a proinflammatory phenotype in human neutrophils. BacPath
15, Swan Valley, Perth, Australia, 30th of September – 3rd of October, 2019. Oral Presentation.
Williams, J. G., Ly, D., Geraghty, N. J., Tsatsaronis, J. A., Gorman, J., Sluyter, R., Sanderson-Smith,
M. L. Mutations in the covRS of M1T1 Group A Streptococcus promotes polymorphonuclear
leukocyte dysfunction, inflammation and bacterial dissemination. Molecular Horizons
Symposium, Wollongong, NSW, Australia, 26th of July, 2019. Poster Presentation.
Williams, J. G., Gorman, J., Sluyter, R., Sanderson-Smith, M. L. Highly virulent Streptococcus
pyogenes proliferates in the presence of polymorphonuclear leukocytes and causes immune
dysfunction. Bugs by the beach 2, Newcastle, NSW, Australia, 15th-16th of November, 2018.
Poster Presentation.
Williams, J. G., Gorman, J., Tsatsaronis, J. A., Sluyter, R., Sanderson-Smith, M. L. GAS induce
multiple regulated cell death pathways in human polymorphonuclear leukocytes. Sydney
Micro, Sydney, NSW, Australia, 1st of February, 2018. Oral Presentation.
Williams, J. G., Tsatsaronis, J. A., Sluyter, R., Sanderson-Smith, M. L. Alteration of
polymorphonuclear leukocyte regulated cell death by Group A Streptococcus contributes to
inflammation. XX Lancefield International Symposium on Streptococci and Streptococcal
Diseases, Denarau Island, Fiji, 12th-16th of October, 2017. Poster Presentation.
Williams, J. G., Gorman, J., Tsatsaronis, J. A., Sluyter, R., Sanderson-Smith, M. L. What’s the
swelling interest around regulated PMN cell death? Bugs by the Beach, Wollongong, NSW,
Australia, 11th-12th of May, 2017. Poster Presentation
The presenting author is underlined.

J.G.W

xii

List of figures

List of figures
Figure 1.1: Number of publications by year on GAS that quote emm-type...............................................27
Figure 1.2: Toll-like receptor and NOD-like receptor interactions with GAS. .........................................33
Figure 1.3: Anti-inflammatory mechanisms of cell death. .................................................................................42
Figure 1.4: Inflammatory mechanisms of neutrophil cell death. ...................................................................46
Figure 1.5: Mutations to the control of virulence regulator system influence the regulation of
multiple genes in GAS. ..........................................................................................................................................................56
Figure 1.6: Theoretical model outlining how neutrophil inflammatory and anti-inflammatory
death pathways work in homeostasis to control bacterial infection. ..........................................................58
Figure 2.1: Construction of stable GFP expression by GAS using a toxin-antitoxin system.............63
Figure 3.1: Neutrophil isolation with polymorphprep yields high purity of cells positive for
CD66b............................................................................................................................................................................................82
Figure 3.2: Sample degradation occurs during the preparation of neutrophil cell lysates. .............84
Figure 3.3: Comparison of neutrophil lysis using detergent-based buffers and sonication by SDSPAGE. .............................................................................................................................................................................................86
Figure 3.4: Optimisation of RIPA buffer lysis using sheer stress, increased protease and
phosphatase inhibitors and increased SDS. ..............................................................................................................87
Figure 3.5: Exposure to protease and phosphatase inhibitors during cell washing preserves
protein in neutrophil lysates.............................................................................................................................................89
Figure 3.6: Caspase-1 detection in neutrophils by immunoblot following optimisation. .................90
Figure 3.7: Normalisation methods for neutrophil immunoblot using total protein, β-actin and
GAPDH. .........................................................................................................................................................................................91
Figure 4.1: NS88.2 resists neutrophil killing and proliferates in the presence of active
neutrophils. ................................................................................................................................................................................98
Figure 4.2: NS88.2 is less readily phagocytosed by human neutrophils....................................................99
Figure 4.3: GAS infection induces neutrophil death. ......................................................................................... 101
Figure 4.4: NS88.2 infection increases abundance of inflammatory caspases and decreases
abundance of apoptotic caspases in neutrophils. ............................................................................................... 103
Figure 4.5: GAS infection activates inflammatory caspases in human neutrophils. ......................... 104
Figure 4.6: Avirulent and virulent GAS invoke differential cytokine release from neutrophils. 105
Figure 4.7: Infection with GAS changes neutrophil CD expression............................................................ 107
Figure 5.1: GAS proliferates in the presence of human neutrophils. ........................................................ 115
UOW

xiii

Characterising the neutrophil response to Group A Streptococcus
Figure 5.2: Reduced phagocytosis of GAS by neutrophils occurs during a dampened reactive
oxygen species response. ................................................................................................................................................. 117
Figure 5.3: GAS infection induced neutrophil death.......................................................................................... 119
Figure 5.4: Neutrophil death following GAS infection involves multiple caspases. .......................... 120
Figure 5.5: GAS infection activates inflammatory caspases in human neutrophils. ......................... 121
Figure 5.6: Neutrophils differentially release inflammatory cytokines during infection with GAS.
....................................................................................................................................................................................................... 123
Figure 5.7: GAS infection changes neutrophil functionality. ......................................................................... 125
Figure 6.1: Mice infected with emm1 GAS display signs of invasive disease 24 h post-infection.
....................................................................................................................................................................................................... 139
Figure 6.2: Flow cytometric sequential gating strategy for the identification of murine
neutrophils, inflammatory monocytes and macrophages. ............................................................................. 140
Figure 6.3: Infection with GAS in vivo activates inflammatory caspases in murine neutrophils.
....................................................................................................................................................................................................... 142
Figure 6.4: Neutrophil function during in vivo GAS infection can be tracked by cell-surface CD
expression................................................................................................................................................................................ 143
Figure 6.5: Infection with GAS in vivo activates inflammatory caspases in murine inflammatory
monocytes. ............................................................................................................................................................................... 144
Figure 6.6: Inflammatory monocyte function during in vivo GAS infection can be tracked by cellsurface CD expression. ...................................................................................................................................................... 146
Figure 6.7: GAS infection in vivo does not involve a strong macrophage response.......................... 147
Figure 6.8: Macrophage function during in vivo GAS infection can be tracked by cell-surface CD
expression................................................................................................................................................................................ 148
Figure 6.9: In vivo infection with 5448AP invokes greater release of inflammatory cytokines
than 5448 infection. ............................................................................................................................................................ 150
Figure 7.1: Theoretical model of how infection with GAS promotes an inflammatory neutrophil
phenotype and contributes to the severity of disease. ..................................................................................... 158
Figure 9.1: Colony forming units (CFU) per mL of Group A Streptococcus at mid-logarithmic
phase........................................................................................................................................................................................... 200

J.G.W

xiv

List of tables

List of tables
Table 1.1: Virulence factors of GAS bestowing resistance to host innate immunity and causing
inflammation. ............................................................................................................................................................................51
Table 2.1: Plasticware used in this thesis...................................................................................................................60
Table 2.2: Bacterial strains and plasmids utilised in this study. ....................................................................62
Table 2.3: Antibodies and blocking buffers used for immunoblot analysis of neutrophil lysates.
..........................................................................................................................................................................................................70
Table 2.4: Fluorochrome conjugated antibodies and fluorescent dyes used for human in vitro
experiments in this thesis...................................................................................................................................................74
Table 3.1: Neutrophil lysis buffers and cell wash recipes. ................................................................................80
Table 3.2: Protein concentration of neutrophil lysates separated via SDS-PAGE. ................................85
Table 6.1: Fluorochrome conjugated antibodies and fluorescent dyes used in for in vivo
experiments in this thesis................................................................................................................................................ 136
Table 9.1: Comparison of bovine serum albumin (BSA) standard curve models for the
determination of protein concentration in neutrophil lysates. ................................................................... 201
Table 9.2: Standard curve construction for the determination of cytokine concentrations using
the LEGENDplex™ (BioLegend) bead-based flow cytometric assay.......................................................... 202
Table 9.3: Standard curve for the calculation of cytokine (IL-1β) concentration using the
LEGENDplex™ (BioLegend) bead-based flow cytometric assay and the LEGENDplex™ software
V8.0.............................................................................................................................................................................................. 202
Table 9.4: The release of cytokines from human neutrophils during GAS infection was measured
using the LEGENDplex™ human inflammation cytometric bead assay and flow cytometry over
360 min. .................................................................................................................................................................................... 203
Table 9.5: Titration of antibodies used during flow cytometry of human neutrophils. .................. 204
Table 9.6: Event counts of immune cells characterised by flow cytometry. ......................................... 205

UOW

xv

Characterising the neutrophil response to Group A Streptococcus

Abbreviations
°C
µg
µL
µM
A
AEC
AMP
APC
APSGN
ARF
AV
BSA
BV
CD
CovR/covR
CovRS/covRS
CovS/covS
Cy
DAMP
DC
DMSO
DNA
DNase
DOC
EDTA
em
ex

FBS
FITC
FSC-A
FSC-H
g
g
G
GAPDH
GAS
GFP
GM-CSF
GSDMD
h
HA
HBSS
HRP
IFN
Ig
IL

J.G.W

Degrees Celsius
Micrograms
Microlitres
Micromolar
Absorbance
Animal Ethics Committee
Antimicrobial peptide
Allophycocyanin
Acute poststreptococcal glomerulonephritis
Acute rheumatic fever
Annexin-V
Bovine serum albumin
Brilliant violet
Cluster of differentiation
Control of virulence regulator
Control of virulence regulatory system
Control of virulence sensor
Cyanine
Danger-associated molecular pattern
Dendritic cell
Dimethyl sulfoxide
Deoxyribose nucleic acid
Deoxyribonuclease
Sodium deoxycholate
Ethylenediaminetetraacetic acid
Emission
Excitation
Foetal bovine serum
Fluorescein isothiocyanate
Forward scatter-area
Forward scatter-height
Gram
Gravitation force
Gauge
Glyceraldehyde 3- phosphate dehydrogenase
Group A Streptococcus, Group A Streptococci, Streptococcus pyogenes
Green fluorescent protein
Granulocyte-macrophage colony-stimulating factor
Gasdermin D
Hour
Hyaluronic acid
Hanks balanced salt solution
Horseradish peroxidase
Type I interferon
Immunoglobulins
Interleukin

xvi

Abbreviations

iMO
kDA
LB
M
MCP
min
mL
MLKL
mM
mm
MOI
ND
NET
NF
NK
NLR
nM
nm
NOD
NP-40
OD
PAGE
PAMP
PANDAS
PBS
PBSI
PE
PerCP
PMN
PMSF
PRR
PS
PVDF
RBS
RFU
RHD
RIPA
RIPK
RNA
ROS
rpm
RPMI
RT
SD
Sda
SDS
sec
SLO

UOW

Inflammatory monocyte
Kilodaltons
Lysogeny broth
Molar
Monocyte chemoattractant
Minutes
Millilitre
Mixed-linage kinase domain-like protein
Millimolar
Millimetre
Multiplicity of infection
Not determined
Neutrophil extracellular trap
Necrotising fasciitis
Natural killer
Nucleotide-binding and oligomerisation domain-like receptor
Nanomolar
Nanometres
Nucleotide-binding and oligomerisation domain
Nonidet P-40
Optical density
Polyacrylamide gel electrophoresis
Pathogen-associated molecular pattern
Paediatric autoimmune neuropsychiatric disorders associated with
streptococcal infection
Phosphate buffered saline
Phosphate buffered saline with inhibitors
R-phycoerythrin
Peridinin chlorophyll protein
Polymorphonuclear leukocyte, neutrophil
Phenylmethylsulphonyl fluoride
Pattern recognition receptor
Phosphatidylserine
Polyvinylidene fluoride
Ribosomal binding site
Relative fluorescence units
Rheumatic heat disease
Radioimmunoprecipitation assay
Receptor interacting protein kinase
Ribose nucleic acid
Reactive oxygen species
Revolutions per minute
Roswell Park Memorial Institute
Room temperature
Standard deviation
Streptodornase
Sodium dodecyl sulphate
Seconds
Streptolysin O

xvii

Characterising the neutrophil response to Group A Streptococcus

SLS
SMP
SON
Spe
SpyA
SpyCEP
SS
SSC-A
STSS
TA
TBST
TGX
THY
TLR
TNF
UOW
V
v/v
w/v
Z

J.G.W

Streptolysin S
Skim milk powder
Sonication
Streptococcal pyogenic exotoxin
Streptococcus ADP-ribosyl transferase
Streptococcus pyogenes cell envelope protease
Sheer stress
Side scatter-area
Streptococcal toxic shock syndrome
Toxin-antitoxin
Tris buffered saline containing 0.1% tween 20
Tris-glycine eXtended
Yeast supplemented Todd-Hewitt broth
Toll-like receptor
Tumour necrosis factor
University of Wollongong
Volts
Volume/volume
Weight/volume
Zombie membrane viability

xviii

Review of the literature

1 Review of the literature
1.1 Overview
Streptococcus pyogenes (Group A Streptococcus, Group A Streptococci, GAS) is a cause of
superficial epithelial infection and life threatening disease in humans (Walker et al., 2014).
Invasive infections caused by GAS are characterised by unregulated inflammation and tissue
destruction, though further complications can arise during invasive infections, such as the
development of sepsis or streptococcal toxic shock syndrome (STSS). GAS that cause disease often
have increased resistance to the human innate immune system, in particular against mechanisms
of defence provided by neutrophils (polymorphonuclear leukocytes, PMNs). Multiple virulence
factors increase bacterial resistance to neutrophil killing (Bisno et al., 2003, Courtney et al., 2002,
DiPersio et al., 1996, Hynes, 2004, Tsatsaronis et al., 2014). Research has typically focused on
neutrophil killing and virulence factors that provide immune resistance, with limited research
exploring the effects of GAS isolated from invasive disease upon other aspects of neutrophil
function. Neutrophils use their stored granules and reactive oxygen species (ROS) to degrade
phagocytosed bacteria, and hence neutrophil function can significantly influence the resolution
of infection (Mortaz et al., 2018). Though they are essential for bacterial defence, neutrophils can
be a double-edged sword, where an uncontrolled inflammatory response can negatively
contribute to disease progression. The induction of lytic forms of neutrophil death in response to
GAS has previously been reported (Kobayashi et al., 2003a, Tsatsaronis et al., 2015), however
details of the cell death pathways involved are not well characterised. The modulation of immune
cells by GAS promotes bacterial survival, yet can lead to increased disease severity (NorrbyTeglund and Johansson, 2013). Here, the literature has been reviewed to outline current evidence
around the influence of GAS upon neutrophil function and death that may contribute to the
development of invasive disease.
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1.2 Group A Streptococcus
The genus Streptococcus arguably accounts for between 50-90 known species and subspecies of
gram-positive bacteria (Facklam, 2002, Krzyściak et al., 2013, Tagg et al., 2011). These facultative
anaerobes are coccus (spherical) shaped as the name suggests and exist in arrangements varying
from single cells, to long chains. Species can be genetically characterised into six major groups;
pyogenic, anginosus, mitis, salivaris, bovis and mutans, (Tagg et al., 2011) but are also classified
by their haemolytic potential (Facklam, 2002). Streptococci are predominantly found in mammal
hosts, residing on mucosal surfaces and generally quite adapted to their particular niche (Tagg et
al., 2011). Though some Streptococci may commensally colonise the host, where some constitute
the natural microbiota of the human oral cavity and nasopharynx, many are also responsible for
significant disease. S. pneumoniae, S. pyogenes, S. agalactiae and S. mutans are four Streptococci
that contribute to significant human morbidity and mortality (Krzyściak et al., 2013). In 2019 the
Centers for Disease Control and Prevention (CDC) named S. pneumoniae a serious threat and S.
pyogenes and S. agalactiae as concerning threats, due to increased rates of antibiotic resistance
in the United States of America (Centers for Disease Control and Prevention, 2019). S. pneumoniae
is a leading cause of bacterial pneumonia and meningitis and similarly S. agalactiae can also cause
pneumonia and meningitis as well as skin infections (Centers for Disease Control and Prevention,
2019). These threats outline the importance that the Streptococcus genus has upon human health.
Of the numerous species collected under the Streptococcus genus, GAS is one of the most
prevalent in terms of human infection (Elliott et al., 1971). GAS are distinguished by the group A
carbohydrate in the bacterial cell wall (Lancefield, 1933). The term GAS is used synonymously
with S. pyogenes, however reactivity of S. dysgalactiae equisimilis and S. anginosus to the group A
carbohydrate has been reported in isolated cases (Elliott et al., 1971). Nonetheless, GAS is a term
that refers specifically to S. pyogenes in this text. GAS is non-motile and causes characteristic βhaemolysis of red blood cells (Ekelund et al., 2005, Österlund and Engstrand, 1997). Infections
arising from this human-specific pathogen include; superficial skin and throat infections,
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induction of auto-immune disease due to recurrent infection and severe invasive infections
(Cunningham, 2000, Ralph and Carapetis, 2013, Walker et al., 2014), although asymptomatic
carriage on epithelial surfaces such as the skin and throat is common and can go undetected
(Ekelund et al., 2005). Transmission is predominantly understood to occur through person-toperson contact (skin-to-skin, respiratory droplets or saliva) which can be increased in crowded
living spaces that may also provide limited access to hygiene facilities (Kaplan et al., 1971,
Kreikemeyer et al., 2004, Österlund and Engstrand, 1997, Walker et al., 2014). Nosocomial
transmission has been reported for GAS (Daneman et al., 2005), but it is not notorious as a
pathogen that resides in hospitals.

1.2.1 M- and emm-typing
The M protein is the most abundant cell-surface GAS protein (Severin et al., 2007) expressed by
almost every strain and extends from the cell-wall as an α-helical coiled-coil (Fischetti, 1989,
Metzgar and Zampolli, 2011). The role and importance of M protein in GAS virulence and
pathogenesis is thoroughly reviewed elsewhere (Cunningham, 2000, Ghosh, 2011, Oehmcke et
al., 2010, Okada, 1996, Ploplis and Castellino, 2020, Robinson and Kehoe, 1992, Walker et al.,
2014). The M-protein has conserved, variable and hypervariable regions, which collectively can
invoke an antibody response. Due to antigenic differences between M proteins, serological M
typing has historically been used to serotype GAS (Lancefield, 1928), distinguishing >80 M types
(Cunningham, 2000). In addition to their relevance as a typing scheme, M type-specific antibodies
provide immunological protection within a serotype. Historically, in situations where M typing
has proven ineffective additional serotyping was performed in response to the T-antigen,
encoded by the tee gene (Jones et al., 1991), this has since been superseded by more thorough
genetic based techniques.
The M protein is encoded by the emm gene and with the emergence of polymerase chain reaction
more accurate typing methods have been developed by sequencing approximately 180 bases of
the 5’ end of the emm gene, encoding the hypervariable N-terminus region of the M-protein (Beall
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et al., 1996). New emm-types are characterised as having <92% homology to existing types, where
methods of typing are standardised and available in detail from the Centers for Disease Control
and Prevention (CDC, https://www.cdc.gov/streplab/groupa-strep/emm-background.html).
There is a strong correlation between M type and emm-type (Facklam et al., 1999), though the
GAS emm-typing method now defines >240 types and subtypes (Bessen et al., 2018, Smeesters et
al., 2010). Correlation of GAS disease with M type has allowed epidemiologists to describe
prevalence of carriage in different demographics and even tissue type (Bessen et al., 1996, Steer
et al., 2009b). More recently a system has been proposed classifying 175 emm serotypes into 48
emm clusters. Phylogenetic analysis of M protein sequence similarities allowed clustering, with
each cluster representing functionally distinct groups (Sanderson-Smith et al., 2014). Full
genomic sequencing is becoming a standard for bacterial characterisation due to the high levels
of information to be gained from whole genome sequencing. A standardised method of typing
from genomic data has been developed (CDC, https://www.cdc.gov/streplab/groupastrep/emm-background.html) and utilised in a recent global investigation of GAS diversity
(Davies et al., 2019).

1.3 GAS spectrum of disease pathology and epidemiology
1.3.1 Superficial GAS infections
Superficial or non-invasive GAS infection of the throat epithelia (pharyngitis) affects 616 million
people annually (Carapetis et al., 2005, World Health Organisation, 2005). GAS is the most
common cause of bacterial pharyngitis, occasionally resulting in the more serious scarlet fever
(Bisno, 2001). GAS are not thought to be normal throat flora and although asymptomatic carriage
can occur, disease generally presents as a sore red throat, fever and swollen lymph nodes with
tonsillar exudates (Choby, 2009). Scarlet fever can occasionally occur as a result of GAS infection,
where a scarlet (deep red) coloured rash and ‘strawberry tongue’ often develops on the patient
during feverish, exudative pharyngitis (Walker et al., 2014). Scarlet fever is thought to be a toxinmediated disease, in which pyrogenic exotoxins such as streptococcal pyogenic exotoxin (Spe)A
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and SpeC play an important role in disease development (Cunningham, 2000, Ferretti et al.,
2016). Although a generally rare disease that troubled humanity in the 19th and early 20th
centuries, recent outbreaks globally (Tse et al., 2012, Turner et al., 2016, Walker et al., 2019, You
et al., 2018) have brought scarlet fever back to immediate attention.
Impetigo is the most common pyodermic bacterial skin infection and is highly contagious, where
infection among children is very common (Cole and Gazewood, 2007). The World Health
Organisation estimates that in 2005 there were 111 million prevalent skin epithelia infections
due to impetigo/pyoderma (Carapetis et al., 2005, World Health Organisation, 2005). GAS is a
common cause of impetigo, where infection often occurs in conjunction with Staphylococcus
aureus (Bowen et al., 2014, Feingold, 1993). Though a higher global burden of impetigo can be
attributed to S. aureus (Bisno and Stevens, 1996), the disease burden in tropical climates is
predominantly due to GAS (Carapetis et al., 2005, Mahe and Hay, 2005). Skin barriers that are
disrupted by minor trauma allow the entry of GAS where vesicles form and then may erupt,
leaving erosion and releasing a yellow-coloured discharge that forms a crust on the skin (Cole
and Gazewood, 2007). Factors that contribute to impetigo are poor hygiene, restricted access to
clean water, overcrowded living conditions and hot humid climates (Cole and Gazewood, 2007,
Mahe and Hay, 2005, Valery et al., 2008).

1.3.2 Immune sequelae resulting after GAS infection
Following infection with GAS, the development of serious autoimmune disorders can occur such
as; acute rheumatic fever (ARF), rheumatic heart disease (RHD), acute poststreptococcal
glomerulonephritis (APSGN) and controversially paediatric autoimmune neuropsychiatric
disorders associated with streptococcal infection (PANDAS) (Cunningham, 2008, Henningham et
al., 2012, Walker et al., 2014). ARF may develop following superficial GAS infection and is a
systemic auto-inflammatory disorder, where inflammation of the joints (arthritis) and heart
tissue (carditis) are the most common manifestations (Special Writing Group of the Committee
on Rheumatic Fever and Kawasaki Disease of the Council on Cardiovascular Disease in the Young
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of the American Heart, 1992). Cross reactive antibodies or molecular mimicry between GAS
protein epitopes and host connective tissue are thought be the driving factor of disease pathology
(Cunningham, 2014, Lee et al., 2009). Carditis due to ARF, may cause long term damage to the
cardiac tissue, in which case it is deemed RHD. APSGN is an autoimmune disease arising after GAS
infection that affects the kidneys and leads to long-term morbidity (Carapetis et al., 2005). APSGN
is most likely caused by GAS antigen deposition in the kidneys and culminates as acute kidney
damage (Rodriguez-Iturbe and Musser, 2008, Satoskar et al., 2020). GAS infection has also been
suggested to cause the neuropsychiatric disorder PANDAS, presenting as obsessive-compulsive
behaviours or Tourette’s-like symptoms (Swedo et al., 1998). Some clinical risk factors of
PANDAS have been acknowledged (Murphy et al., 2012), however epidemiological studies have
not conclusively linked GAS to these neurological conditions (Mell et al., 2005).

1.3.3 Invasive GAS infections
Entry of GAS into normally sterile environments of the body constitutes invasive GAS disease,
which can result from deep penetrating injuries, burns, trauma or surgery. Invasive GAS
infections include; cellulitis, necrotising fasciitis, bacteraemia, pneumonia, meningitis and
endocarditis (Walker et al., 2014). Further complications arising from invasive disease include
sepsis and streptococcal toxic shock syndrome (STSS) (Walker et al., 2014). Generally, the aged
or immunocompromised are most prone to invasive infections, however GAS have the ability to
evade the immune system and cause disease in otherwise healthy individuals (Walker et al.,
2014). Cellulitis is an invasive GAS disease of the skin and subcutaneous tissue, characterised by
the hallmarks of inflammation; redness, swelling, heat and pain at the site of infection (Stevens et
al., 2014). Deeper penetrating invasive skin infections can develop into necrotising fasciitis (NF,
commonly called the “flesh eating disease”), causing necrosis of skin, subcutaneous tissue (fascia)
and muscle (Stevens et al., 2014). Gangrene may occur due to tissue necrosis and patients often
require multiple aggressive surgical interventions or amputation (Stevens et al., 2014). Patients
suffering peripheral vascular disease, diabetes mellitus, decubitus ulcers, Fournier gangrene and
post-surgery are at highest risk of NF (Stevens et al., 2014). Penetrating infections such as NF can
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facilitate bacterial presence into the blood (bacteraemia). Bacteraemia facilitates dissemination
to sensitive areas such as the brain, which in turn is how GAS meningitis may develop. Mortality
rates of patients with invasive GAS disease are between 8-23% in the first 7 days (Walker et al.,
2014). Both swift disease progression and diagnostic difficulties contribute to this statistic
(Stevens et al., 2014).
Over-stimulation of the immune system and development of sepsis or STSS, where unregulated
inflammation contributes to disease pathology, is a significant risk during invasive GAS infection
(Sriskandan and Altmann, 2008). These acute systemic complications often culminate in organ
failure (Lappin and Ferguson, 2009), with mortality rates from STSS between 23-81% within 7
days post infection (Walker et al., 2014). Release of GAS superantigens induces excessive T-cell
activation, cytokine production and chemokine release that contribute to the advancement to
STSS (Lappin and Ferguson, 2009). Hypotension, multiple organ failure and systemic toxicity are
the results of STSS and are attributed to the ability of GAS superantigens to bypass normal major
histocompatibility complex antigen processing restriction (Lappin and Ferguson, 2009,
McCormick et al., 2001). On top of bacterial factors, inadequate inflammatory regulation and
function of host cells such as neutrophils, drives disease pathology. These scenarios therefore
require not only antibiotic treatment of bacteria but also suppression of toxin production and
regulation of the host immune response (Lappin and Ferguson, 2009). Extensive tissue damage
is a clinical hallmark of invasive infection due to hyper stimulation of the host innate immune
system, leaving aggressive surgical removal of infected tissue and fluid transfusions as the only
additional treatments available (Stevens et al., 2014, Stevens and Bryant, 2016).

1.3.4 Global Epidemiology of GAS disease
GAS is responsible for approximately 517,000 deaths annually, where the most recent reports in
2005 estimating total prevalence of 18.1 million serious cases, with 1.78 million new cases each
year (Carapetis et al., 2005, World Health Organisation, 2005). The highest burden of GAS disease
can be attributed to RHD, where prevalence is conservatively estimated to be 15.6 million cases,
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growing at a rate of 282,000 cases, and causing 233,000 deaths, annually (Carapetis et al., 2005,
World Health Organisation, 2005). RHD is the largest cause of paediatric heart disease globally,
yet affordable preventative measures addressing the initial GAS infection could significantly
impact the worldwide disease burden (Lee et al., 2009). The lack of global systematic reporting
makes accurate GAS disease estimation difficult, as poor surveillance in areas of highest incidence
may have obstructed the true figures of the most recent approximations (Carapetis et al., 2005,
Ralph and Carapetis, 2013, World Health Organisation, 2005). Estimates in 2005 predicted that
15% of school aged children and 4-10% of adults suffer from GAS pharyngitis each year
(Carapetis et al., 2005). These figures are for high-income (industrialised) countries, with
incidence in low-income countries estimated to be five to 10 times higher (Carapetis et al., 2005).
Whilst all GAS strains are believed to be able to cause disease, a strong correlation between emmtype and infection of either the skin of throat tissue has been reported in the literature (Bessen
and Lizano, 2010, Bessen et al., 1996). However, a longitudinal study following 457 Fijian school
children over 10 months did not observe said tissue tropism (Campbell et al., 2020), though
different results may be observed in different regional contexts. It must also be noted that GAS
populations are extensively heterogenetic due to recombination events, with the largest
phylogenetic study to date unable to correlate lineages to clinical association (Davies et al., 2019).
Further studies are needed to determine if a link between genotype and invasive phenotype
exists, though some common genetic features were statistically identified in isolates associated
with invasive disease (Davies et al., 2019).
A 2009 systematic review compiling 38,081 GAS isolates identified emm1, emm12, emm28, emm3
and emm4 as globally the most common strains, accounting for 51.7% of all samples (Steer et al.,
2009b). Further, high-income countries in North America and Europe have low emm-type
diversity, whilst regions with high disease burden such as Africa and the Pacific (World Health
Organisation, 2005) have high emm-type diversity and no dominant outlying serotypes (Steer et
al., 2009b). Although the predominate burden of disease is due to a small number of emm-types,
the rate of surveillance may significantly influence this figure. GAS research has reflected the
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prevalence of serotypes in more developed countries, with research favouring emm1, emm12,
emm28, emm3 and emm4 (Figure 1.1). If treatments are developed in an emm-type-specific
manner, it is plausible that areas that suffer the highest rates of infection may not benefit, as high
diversity of emm-types would mean limited efficacy.

Number of publications
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Figure 1.1: Number of publications by year on GAS that quote emm-type. Searches of peer reviewed
articles were performed (PubMed, NIH, Bethesda, MD, USA) using the terms “Streptococcus pyogenes” or
“Group A Streptococcus” and “emm*” (title/abstract) or “emm1” (title/abstract) or “emm1” (title/abstract)
and “emm3” (title/abstract) and “emm4” (title/abstract) and “emm12” (title/abstract) and “emm28”
(title/abstract), shown per year (National Center for Biotechnology Information, 2021).

Although low-income countries and areas of poverty (in high income countries) have an
increased disease burden, invasive GAS infections occur in all settings, where the frequency of
severe disease has been increasing since the 1980s (Carapetis et al., 2005). 663,000 new cases of
invasive GAS infection are estimated to occur annually, resulting in 163,000 deaths (Carapetis et
al., 2005, World Health Organisation, 2005). The burden of severe or invasive GAS infections is
commonly associated with M1, M3, M12 and M28 serotypes (Metzgar and Zampolli, 2011).
Additionally, more recent investigation has also identified that emm1, emm3, emm4, emm6,
emm12, emm28 and emm89 account for the majority of GAS serotypes isolated from invasive
infection (Gherardi et al., 2018). Both the aforementioned studies focus on high income areas, and
although these serotypes are represented in areas such as the Pacific, as noted above, there are
generally no predominant serotypes in these regions (Baroux et al., 2014). The resurgence of
severe GAS disease has been in part attributed to strains that release streptococcal superantigens,
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genetic rearrangement and the acquisition of additional virulence factors through phage
insertions (Aziz et al., 2005, Aziz and Kotb, 2008, Banks et al., 2002, Beres and Musser, 2007,
Beres et al., 2004, Fittipaldi et al., 2012, Reglinski and Sriskandan, 2014). Globally, emm1 GAS is
highly represented (Steer et al., 2009b), in part due to the emergence of highly virulent subtypes
(Musser et al., 1995). In particular, GAS subtype M1T1 is frequently isolated from various
infection types in urban settings and global dissemination has been reported (Ato et al., 2008,
Cleary et al., 1992, Cole et al., 2011, Sumby et al., 2005). Most concerning however, is its
association with life threatening diseases such as NF, STSS and sepsis (Aziz et al., 2010, Aziz and
Kotb, 2008, Cole et al., 2011). Due to its prevalence and persistence in invasive disease globally,
M1T1 GAS has been a significant focus of research on invasive disease mechanisms and
therapeutic development.

1.3.5 Oceanic epidemiology
In the Oceanic Region GAS disease is endemic in some Pacific Island, ‘top end’ Aboriginal
Australian and Māori populations (Clucas et al., 2008, Le Hello et al., 2010, May et al., 2016,
McDonald et al., 2008). Constant and recurrent skin and pharyngeal infection in these regions
underlie the highest global rates of autoimmune sequelae (Le Hello et al., 2010, McDonald et al.,
2006, McDonald et al., 2007, McDonald et al., 2008, Milne et al., 2012a, Milne et al., 2012b).
Furthermore, while infection rates of 2-3 per 100,000 are reported in high income settings
(Lamagni et al., 2008, O'Grady et al., 2007, O'Loughlin et al., 2007, Sharkawy et al., 2002), some
Aboriginal Australian and Pacific Island populations suffer rates of 13.2-82.5 per 100,000
(Carapetis et al., 1999, Norton et al., 2004, Whitehead et al., 2011) and 9.6-11.6 per 100,000 (Steer
et al., 2008, Steer et al., 2009a) respectively (Walker et al., 2014). This increased burden,
especially in Australia, highlights significant social inequity within affected communities as
overcrowded accommodation, poverty and limited access to health care are contributing factors
(Steer et al., 2002). As discussed previously, the epidemiology of infection in these regions is
distinct from that in higher income regions within those countries, with increased and different
emm-type diversity and no dominant emm-type (Baroux et al., 2014, Campbell et al., 2020, Le
J.G.W
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Hello et al., 2010, McDonald et al., 2007, McDonald et al., 2008, Richardson et al., 2010, Steer et
al., 2009a). This leads to the emergence of many rare and unique strains in these communities.
Although intervention and surveillance has improved over recent years, the disparity in the
health statistics of these populations is a major global health concern.

1.3.6 Current clinical practices for the treatment of invasive GAS infection
Currently no vaccine is available for distribution to prevent GAS disease (Davies et al., 2019). GAS
remains susceptible to penicillin, however invasive infections require a multi-pronged approach
to do more than just kill bacteria. If a patient is suffering from aggressive soft tissue infection
(Necrotising fasciitis) or shows signs of systemic toxicity (sepsis or STSS) and antibiotic therapy
alone is ineffective (Datta et al., 2005, Stevens et al., 2014), surgical intervention is essential
(Anaya and Dellinger, 2007, McHenry et al., 1995, Stevens et al., 2014). Surgery allows for the
removal of dead/necrotic tissue and to assess the extent of the damage. In some cases, the affected
area cannot be recovered, and amputation is required to limit the spread of infection and avoid
the onset of sepsis. Hypotension may cause great fluid losses for the patient, where 10-20 L per
day may need to be supplemented via intravenous drip (Stevens and Bryant, 2016). Antibiotic
therapy is an essential part of treatment, where high doses of penicillin and clindamycin are
normally given (Stevens et al., 2014). There have been rare reports of GAS resistance to
clindamycin in the USA (Stevens and Bryant, 2016), with clindamycin able to assist in toxin and
cytokine suppression (Stevens et al., 2014). Penicillin allergies in patients are common, however
in such cases vancomycin, linezoid, daptomycin or quinupristin may be administered (Stevens et
al., 2014). Erythromycin is often used to treat non-severe GAS infections (Stevens et al., 2014),
however acquisition of erythromycin resistance in GAS is of ‘considerable concern’ in the USA
(Centers for Disease Control and Prevention, 2019).
Streptococcal toxins also play a role in the development of STSS (Lappin and Ferguson, 2009).
Intravenous immunoglobulin has been used as a therapy to act as a neutralising antibody to some
of these toxins (Stevens et al., 2014, Stevens and Bryant, 2016). Though the treatment regime
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seems thorough, mortality from severe invasive GAS infections, particularly those that develop
sepsis or STSS, remains unacceptably high, as antibiotic failure can be reported and limited
additional treatment options exist (Stevens et al., 2014). The development of novel treatments to
limit tissue destruction and control inflammation could assist to decrease this mortality statistic.
Such treatments require a targeted approach, for which mechanistic understanding of the process
is essential. The idea of novel treatments targeting inflammatory mediators have been
hypothesised for use during sepsis (Katsenelson et al., 2019), and could be applicable during
severe invasive GAS infection, however further investigation is required. Additional
understanding of innate immune mediation of inflammation may also assist in the development
of novel targeted therapies for severe invasive GAS infections.

1.4 The innate immune response to bacterial infection
The innate immune system combats infection and tissue injury, and in turn influences
inflammation. It provides a rapid, non-specific defence where epithelial cells, neutrophils,
macrophages, natural killer (NK) cells and dendritic cells (DCs) all play a role during the immune
response to GAS infection (Goldmann et al., 2005, Goldmann et al., 2004, Loof et al., 2007,
Mishalian et al., 2011, Zinkernagel et al., 2008). These cells drive a coordinated response to
phagocytose bacteria, release inflammatory mediators, produce antimicrobial peptides (AMPs)
and undergo cell death in order to invoke an appropriate immune response. The host-pathogen
interactions of the innate immune system are described here, outlining important elements
relevant to GAS infection.

1.4.1 Pathogen recognition
The innate immune system may become activated due to the presence of invading bacteria
through the binding of conserved non-self and self-molecules to pattern recognition receptors
(PRRs) on the cell-surface of leukocytes. PRRs detect common (non-self) pathogen-associated
molecular patterns (PAMPs) that are often structural or essential components for bacterial
survival such as; bacterial nucleic acids, flagellin, peptidoglycan cell wall components,
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lipopolysaccharide and lipoteichoic acid (Newton and Dixit, 2012). Also detected by PRRs are
endogenous (self) danger-associated molecular patterns (DAMPs), alerting the system to
damaged or dying host cells (Roh and Sohn, 2018). Common DAMPs are adenosine triphosphate,
cytokines, cytoplasmic and nuclear proteins (Newton and Dixit, 2012, Roh and Sohn, 2018).
Binding of PAMPs and DAMPs to PRRs cascades signalling for production and release of cytokines
and chemokines, promoting immune cell recruitment. Though much is known about PRRs,
knowledge of immune cell recognition of GAS is still limited (Fieber and Kovarik, 2014,
Tsatsaronis et al., 2014).
The most well characterised PRRs are the Toll-like receptors (TLRs), of which 10 functional TLRs
have been described in humans (Takeuchi and Akira, 2010). TLRs are membrane bound, where
signalling occurs through the myeloid differentiation factor 88-dependant pathways and TIRdomain-containing adapter-inducing interferon-β-dependent pathways (Kawai and Akira, 2010,
O'neill et al., 2013). TLR signalling can occur on the cell-surface (TLR; 1, 2, 4, 5, 6) or at the plasma
membrane following endocytosis (TLR; 3, 4, 7, 8, 9), resulting in type I interferon (IFN-I) or other
cytokine production (O'neill et al., 2013). TLRs and their corresponding recognition ligand have
been summarised along with host innate immune cells for GAS (Figure 1.2). Macrophages and
DCs are best known for their signalling ability, where immune cell activation during GAS infection
has been attributed to a combination of TLR signals, rather than a single TLR (Loof et al., 2008).
In mammalian cells, GAS have been shown to interact with; TLR2 (Fieber et al., 2015, Joosten et
al., 2003, Matsumura et al., 2019, Miettinen et al., 2008, Rizzo et al., 2013, Sigurdardottir et al.,
2010, Wu et al., 2015, Wu et al., 2016), TLR3 (Miettinen et al., 2008), TLR4 (Rizzo et al., 2013, Wu
et al., 2016), TLR7 (Miettinen et al., 2008), TLR8 (Eigenbrod et al., 2015) and TLR9 (Fieber and
Kovarik, 2014, Keller et al., 2019, Uchiyama et al., 2012, Zinkernagel et al., 2012). In vivo, TLRmediated GAS recognition is essential for bacterial clearance and to control inflammation (Hafner
et al., 2019). Additionally, it is also known that TLR activation can initiate apoptotic cell death
(Aliprantis et al., 2000, Salaun et al., 2007). Although mechanistic understanding is beyond the
scope of this review, it is important to consider that GAS recognition by immune cells is a

UOW

31

Characterising the neutrophil response to Group A Streptococcus
multifaceted process. Further contributing to the complexity of immune recognition of GAS,
immune cell activation by GAS has also been demonstrated independently from the three
predominate TLRs (2, 4 and 9) (Gratz et al., 2008).
Immune cell recognition of GAS can also occur intracellularly through non-TLR pathways using
nucleotide-binding and oligomerisation domain (NOD)-like receptors (NLRs) (Kersse et al.,
2011). NLRs are more diverse than TLRs, with 22 known in humans (Ting et al., 2008), of which
there are four subfamilies NLRA, NLRB, NLRC and NLRP (Chen et al., 2009, Kim et al., 2016).
Activated NLRs have various functions including inflammasome activation via caspase-1, signal
transduction, transcriptional activation and cell death (Kersse et al., 2011, Kim et al., 2016).
Inflammasome formation is important in the inflammatory death pathway pyroptosis and
promotes the release of inflammatory cytokines interleukin (IL)-1β and IL-18 (Man and
Kanneganti, 2016, Man et al., 2017). There are limited studies describing the interaction of NLRs
with GAS, however they have been summarised in immune cells (Figure 1.2). Activation of the
NLRP3 inflammasome has only been described in macrophages in response to M1 and M3 GAS,
where both haemolytic exotoxin streptolysin-O (SLO) and the M1 protein are have also been
implicated in triggering inflammasome activation (Harder et al., 2009, Latvala et al., 2014,
Valderrama et al., 2017). Additionally, the NLRP4 and NLRX1 receptors have been shown to play
a role in the autophagic processing of GAS by HeLa cells (Aikawa et al., 2018, Jounai et al., 2011,
Nozawa et al., 2017). To date, only three different GAS serotypes have been investigated in NLR
focused studies, where published work has focus on immortalised cell lines (HEK293, THP-1 and
HeLa cells). NLR pathways and inflammasome activation stand out as important areas of future
investigation in order to better understand the inflammatory nature of streptococcal diseases.
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Figure 1.2: Toll-like receptor and NOD-like receptor interactions with GAS. GAS infection upregulates
the expression of Toll-like receptor (TLR)2 and TLR3 on macrophages (Miettinen et al., 2008). Activation
of macrophages occurs via TLR2, TLR4 and TLR9 in response to GAS (Fieber and Kovarik, 2014, Uchiyama
et al., 2012, Wu et al., 2015, Wu et al., 2016, Zinkernagel et al., 2012), which releases inflammatory
cytokines. Activation of macrophages can also occur via TLR8 detection of GAS RNA (Eigenbrod et al., 2015)
and TLR4 detection of streptolysin O (SLO) (Park et al., 2004), resulting in cytokine release. The NOD,
leucine rich repeat and pyrin domain protein (NLRP)3 inflammasome is activated in macrophages by GAS,
SLO and the GAS M1 protein (Harder et al., 2009, Latvala et al., 2014, Valderrama et al., 2017), resulting in
caspase-1 activation and IL-1β release. Dendritic cell activation also occurs via TLR2 and TLR9 in response
to GAS (Fieber and Kovarik, 2014, Loof et al., 2008) and via TLR9 detection of GAS DNA (Keller et al., 2019),
resulting in cytokine release. Activation of monocytes occurs following the binding of the GAS M1 protein
to TLR2 (Påhlman et al., 2006), which releases inflammatory cytokines.

1.4.2 Inflammation
The release of cytokines and chemokines following pathogen recognition recruits additional
immune assistance to an area of infection. Inflammation encourages the recruitment of
leukocytes to an area, facilitated by increased blood flow and symptomatically causing heat
production, redness and swelling at the site. During infection, epithelial cells are often first to
release inflammatory signals as they have direct contact with bacteria. In a model using the
keratinocyte cell line HaCaT, GAS infection invokes the release of inflammatory regulators such
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as IL-1α, IL-1β, IL-6 and IL-8 (Wang et al., 1997), where IL-6 and IL-8 attract monocytes (Tsai et
al., 2006). Upon the arrival of immune cells at the site of infection, macrophages and DCs are
thought to take the predominant role controlling inflammatory signalling. In response to GAS
infection, macrophages have been shown to release tumour necrosis factor (TNF)-α, IL-1β
(Harder et al., 2009, Lin et al., 2015, Valderrama et al., 2017), IL-6 (Gratz et al., 2008), IL-8 (Fieber
et al., 2015) and IFN-β (Dinis et al., 2014). Inflammatory responses can vary between strains,
where emm-type and invasive status appear to influence TNF-α, IL-6 and IL-8 release (Dinis et al.,
2014). Neutrophils have only recently been widely recognised for their contribution as cytokine
producers (Tecchio et al., 2014), even though they are abundant at sites of GAS infection
(Edwards et al., 2018). Although many cytokines act to recruit neutrophils, neutrophils
themselves have also been shown to release IL-8 (Uchiyama et al., 2015), TNF-α, IL-6 and IL-1β
(Tsatsaronis et al., 2015) during GAS infection. DCs link the innate and adaptive branches of the
immune system, releasing TNF-α, IL-6 (Fieber et al., 2015) and IL-12 (Loof et al., 2008) in
response to GAS infection. DCs play a significant role in GAS-mediated immunity via IL-12
signalling, where depletion of DCs hinders effective GAS control and subsequently reduces the
release of IL-12 (Loof et al., 2007). The release of IL-12 however, along with IFN-β and IL-6, by
NK cells has also been shown to exacerbate GAS infection (Goldmann et al., 2005). Mice depleted
of NK cells, have increased GAS resistance and reduced histopathology (Goldmann et al., 2005).
Inflammation is essential to effective GAS removal, however inflammatory mediators need
regulatory control so as not to exacerbate infection and potentiate excessive tissue damage.
Of the aforementioned cytokines, TNF-α and IL-1β are the most frequently reported mediators of
inflammation. TNF-α binds to the TNF receptor I, triggering a multitude of leukocyte activators
and leukocyte recruiters and can even induce cell death (Newton and Dixit, 2012). Though
mortality during invasive GAS infection is often associated with high amounts of TNF-α release
(Norrby-Teglund et al., 2000), it is also essential for an appropriate immune response in vivo
(Mishalian et al., 2011). IL-6 has been shown to play an important anti-inflammatory role,
regulating the effects of TNF-α release which decreased mortality in a murine model of invasive
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GAS infection (Diao and Kohanawa, 2005). The release of IL-6 is complex however as the cytokine
can also have an inflammatory role, where upregulation has been used to diagnosis sepsis during
the early stages of an infection (Hou et al., 2015, Ma et al., 2016). Increased amounts of IL-6 are
reported during GAS infection of THP-1 cells (Verma et al., 2016) as well as clinical paediatric
cases of severe invasive infection (Wang et al., 2008). IL-1α and IL-1β signal through the same
receptor, IL-1 receptor, however only IL-1β is critical for GAS defence (Hsu et al., 2011, Lin et al.,
2015). IL-1β is a neutrophil chemoattractant (Chen et al., 2007), and GAS killing is heavily reliant
upon IL-1β release and neutrophil mediated killing (Hsu et al., 2011). In mice, abrogation of the
IL-1 receptor reduces neutrophil-driven inflammation but increases susceptibility to GAS
infection (Hsu et al., 2011, Lin et al., 2015), highlighting the importance of the IL-1 receptor in
innate immunity. IFN-Is have been shown to work in homeostasis with IL-1β to regulate
inflammation during GAS infection, potentially playing an important protective role during GAS
infection (Castiglia et al., 2016, Gratz et al., 2011). In most cases, inflammation is a self-limiting
process, however an unregulated inflammatory response can exacerbate disease and hinder the
resolution of infection.

1.4.3 Phagocytes and the complement system
Phagocytic cells such as macrophages, DCs and neutrophils use a number of techniques to identify
intruders (Beutler, 2004). Phagocytosis is a form of endocytosis used to internalise and digest
pathogenic material, providing protection to the host (Erwig and Henson, 2008). The release of
DAMPs and inflammatory mediators by infected or damaged host cells aids in phagocytic cell
migration to, and accumulation at, the site of infection. Neutrophils are primarily the first
responders, with monocytes and macrophages generally arriving at the site of infection at a later
stage (Serhan et al., 2007).
Upon arrival at the infection site, phagocytic cells use PAMPs to both distinguish bacteria from
host cells (Janeway Jr, 1989, Kumar et al., 2011) and recognise dying host cells for removal (Erwig
and Henson, 2008). As described previously (Chapter 1.4.1), GAS recognition occurs through
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multiple pathways via PRRs. Following recognition, pathogenic or dying material is internalised
by the cell as the cell membrane extends to encapsulate the material in a compartment called the
phagosome. The phagosome fuses with lysosomes inside the cell, which contain strong digestive
enzymes, forming the phagolysosome and degrading the pathogenic material (Vieira et al., 2002)
in macrophages (Pitt et al., 1992). In contrast, neutrophils do not involve a specific phagocytic
pathway and instead the phagosome may bind with one of the many stored granules that have
enzymatic, antimicrobial or oxidative activity (Mayadas et al., 2014, Nordenfelt and Tapper,
2011).
Phagocytosis can be assisted by molecules called opsonins, which attach to the surface of
pathogenic material in a process known as opsonisation. Opsonisation amplifies the availability
of phagocytic receptors. Antibodies are one example of opsonins, increasing phagocytic capacity
through binding to Fcɣ receptors binding by phagocytes. The complement system, made from
over 30 molecules circulating in blood, is an additional pathogen surveillance mechanism
employed by the innate immune system that may follow three tightly connected pathways;
classical, lectin and alternative (Ricklin et al., 2010). The interaction of GAS with elements of the
complement system can greatly dictate the outcomes of infection, where further reading can be
found in a recent review (Laabei and Ermert, 2019).
Investigations describing the interaction of GAS with phagocytes attempt to provide a basis for
bacterial persistence and development of disease (Fieber and Kovarik, 2014, Tsatsaronis et al.,
2014, Valderrama and Nizet, 2018). Neutrophils are the fastest phagocyte (Segal et al., 1980) and
the predominate immune cell found at the site of GAS infection (Edwards et al., 2018, Kobayashi
et al., 2018). Neutrophils are already known to play an important role in the immune response to
GAS in mice (Goldmann et al., 2010), however further characterisation of the neutrophil response
is needed in order to better understand the progression of invasive GAS disease.
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1.4.4 Neutrophil bactericidal defence
Neutrophils are an essential component of host innate immune defence. Reduction of circulating
concentrations (neutropenia) or hindrance of regular function result in an increased
susceptibility to infections. For patients with neutropenia, even a minor infection can present
significant risk as the mounted immune response is not strong enough to successfully clear a
pathogen. Effective neutrophil function is essential for clearing GAS infection. In a chronic
granulomatous disease mouse model of GAS infection, in which the oxidative burst potential of
neutrophils is reduced (Nguyen et al., 2017), increased mortality is observed during GAS infection
(Saito et al., 2001). Recent research has observed a subpopulation of ‘primed neutrophils’
(approximately 10% of total neutrophils) in both mice and humans (Fine et al., 2019). Primed
neutrophils in circulation, defined by cluster of differentiation (CD)63high, CD66ahigh and CD11bhigh
expression, are thought to be the first responders to acute inflammation, and although
neutropenia may present in cases, the level of primed neutrophils, not total neutrophils, dictates
ability to fight infection (Fine et al., 2019). These new findings add an additional complexity to
immune cell characterisation but collectively help to further identify the important role
neutrophils play in innate immune-mediated defence.
Neutrophils use oxygen-independent and oxygen-dependant mechanisms to combat bacterial
pathogens. Following neutrophil phagocytosis, bacteria in the phagosome are challenged with
strong cytotoxic molecules as they undergo fusion with pre-stored cytoplasmic granules
(azurophilic, secondary or specific) that contain enzymes, antimicrobials and oxidants (Hirsch
and Cohn, 1960). Granules are present in high abundance in neutrophils and are extremely
heterogeneous. They contain molecules such as but not limited to; neutrophil elastase, cathepsin
G, proteinase 3, defensins, lysozyme, myeloperoxidase, collagenase, gelatinase, lactoferrin and
LL-37 (Borregaard et al., 2007, Mayadas et al., 2014). The abundance of enzymes and AMPs
contained within neutrophil granules are just one of the reasons they are considered the most
efficient phagocyte (Lim et al., 2017). These molecules collectively cause damage to the bacteria
contained within the phagosome, resulting in complete bacterial removal (Borregaard and
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Cowland, 1997). Neutrophil activation may also initiate the fusion of neutrophil granules with the
plasma membrane for extracellular release, more commonly called degranulation. Along with
pathogen degradation, degranulation of AMPs such as LL-37, may cause inflammation (Choi et al.,
2012). LL-37 release promotes neutrophil recruitment, chemokine and cytokine release while
also supressing neutrophil apoptosis (Choi et al., 2012).
The generation of ROS by neutrophils following phagocytosis often referred to as
oxidative/respiratory burst, is another major component of bactericidal activity used to degrade
and kill pathogens. The activation of the nicotinamide adenine dinucleotide phosphate oxidase
complex promotes the production of ROS in neutrophils such as superoxide, hydrogen peroxide
and hydroxyl radicals (Nguyen et al., 2017). Myeloperoxidase acts as a catalyst to reactions that
produce free radicals (Lambeth, 2004, Nguyen et al., 2017), where the oxygen derivatives are
thought to kill bacteria through direct and indirect methods (Mayadas et al., 2014). Like granules,
the production of ROS in the phagosome can result in intracellular and extracellular release
(Nguyen et al., 2017). Additional to the antimicrobial potential of ROS, their production can
further induce degranulation (Vorobjeva et al., 2017), release of neutrophil extracellular traps
(NETs) (Björnsdottir et al., 2015), production of cytokines (Naik and Dixit, 2011) and induction
of neutrophil apoptosis (Lundqvist-Gustafsson and Bengtsson, 1999). Though intended to be
defensive mechanisms, uncontrolled extracellular release of granular contents and ROS are
thought to be a driving factor behind host tissue destruction in some infectious and inflammatory
diseases (Mayadas et al., 2014, Nguyen et al., 2017).

1.4.5 Anti-inflammatory programmed cell death
In neutrophils, programmed death is an important defence mechanism and can occur following
activation. Due to their limited lifespan, it is well understood that neutrophils undergo apoptosis
when aged (Hidalgo et al., 2019). Bacterial infection is also understood to induce neutrophil death
(Lawrence et al., 2020). Anti-inflammatory death pathways are deemed immunologically silent
and assist in the resolution of infection. Apoptosis is the most well-recognised and well-described
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death pathway, however efferocytosis and autophagy are two additional anti-inflammatory
pathways that provide pathogen defence (Bratton and Henson, 2011, Germic et al., 2019). The
anti-inflammatory pathways have been summarised (Figure 1.3).
1.4.5.1

Apoptosis

Apoptosis is the most well-defined death pathway, coordinating turnover and safe removal of
aged or dying neutrophils in granulopoiesis but also providing a mechanism of pathogen-induced
cell death used to remove bacteria in an immunologically silent manner. An apoptotic neutrophil
response can assist during infection as it has been shown to resolve inflammation (Kobayashi et
al., 2003b). Apoptosis is characterised by cell shrinking, cellular blebbing, chromatin
condensation and deoxyribose nucleic acid (DNA) fragmentation and can be initiated by extrinsic
and intrinsic pathways (Taylor et al., 2008). Careful deconstruction of the cell ensures the internal
contents are not released into the surrounding area, which is particularly important for granular
cells such as neutrophils. Intrinsic activation of apoptosis can occur due to neutrophil age or
stress, where B-cell lymphoma 2-associated X protein interacts with the mitochondria to reduce
membrane potential while releasing cytochrome c, which in turn binds apoptosis protease
activating factor 1. Oligomerisation of apoptosis protease activating factor 1 forms the
apoptosome and activates caspase-9, cascading the cleavage of caspase-3 then caspase-7 to
execute apoptosis (Jorgensen et al., 2017, Kennedy and Deleo, 2009, Taylor et al., 2008).
Intracellular production of ROS, such as that following the phagocytosis of bacteria, and extrinsic
death domain signalling can also activate caspase-8 and in turn also cause the cleavage of caspase3 (Kennedy and Deleo, 2009, Lundqvist-Gustafsson and Bengtsson, 1999). Extracellular signalling
occurs following binding to Fas ligand (CD95L), TNF-α receptor and TNF-related apoptosisinducing ligand. Both the subsequent death domains Fas-associated death domain and TNF-α
receptor-associated death domain that form result in the activation of caspase-8 (Fox et al., 2010).
Apoptosis coincides with inflammatory pathways here, as activation of caspase-8 allows cleavage
of receptor interacting kinase 1 (RIPK1) and through a negative feedback inhibits necroptosis
(Lin et al., 1999). Caspase-8 has also been implicated in inflammatory pathways (Chen et al.,
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2020), and cleaves the pyroptotic effector gasdermin D (GSDMD) (Chen et al., 2019), however it
is less effective than caspase-1 in this process (Chapter 1.4.6.1). The induction of cell death is not
ideal for an intracellular pathogen, as it removes a niche for replication, however ‘delayed
apoptosis’ as a result has been linked to disease (Kennedy and Deleo, 2009). Pathogens have
evolved mechanisms to inhibit host cell apoptosis, thus, alternative death pathways (such as
inflammatory) must be executable by the immune system.
1.4.5.2

Efferocytosis

Cells that undergo apoptosis have their contents encapsulated, although they must then be
removed by another phagocyte or they risk undergoing secondary necrosis (Poon et al., 2014).
The removal of apoptotic neutrophils is performed predominantly by macrophages, via the also
immunologically silent pathway called efferocytosis (Bratton and Henson, 2011). Efferocytosis,
is coordinated through the expression of ‘Find-me’, ‘Eat-me’ and ‘Don’t eat-me’ signals on the cellsurface (Bratton and Henson, 2011, Poon et al., 2014). ‘Find-me’ signals are immune cell
chemoattractants, while ‘Eat-me’ and ‘Don’t eat-me’ signals respectively increase or suppress
macrophage receptor recognition (Bratton and Henson, 2011). The release of adenosine
triphosphate, uridine triphosphate and other DAMPs can act as non-selective ‘Find-me’ signals
for further recruitment of immune cells (Chekeni and Ravichandran, 2011, Ravichandran, 2010).
Apoptotic cells can also release fractalkine, lysophosphaditylcholine and sphingosine-1phosphate to specifically recruit macrophages, monocytes and DCs (Chekeni and Ravichandran,
2011, Ravichandran, 2010). Another common feature of apoptotic cells is the externalisation of
phosphatidylserine (PS) (Koopman et al., 1994). PS is an ‘Eat-me’ signal, facilitating the removal
of apoptotic bodies by signalling to macrophages (Greenberg et al., 2006). Viable cells also need
a means of preventing their removal until they reach the end of their lifespan. CD31 and CD47 are
two ‘Don’t eat-me’ signals specifically identified on neutrophils (Hart et al., 2000, Park et al., 2008)
that also become down regulated during the induction of apoptosis (Brown et al., 2002, Lawrence
et al., 2009). The removal of apoptotic cells via efferocytosis promotes the release of antiinflammatory cytokines from macrophages (Fadok et al., 1998, Huynh et al., 2002). Failure to
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clear dying cells can result in secondary necrosis of apoptotic bodies, cellular crowding and
release of inflammatory products into the surrounding tissue, potentially contributing to
pathogenicity (Silva, 2010). Although predominantly considered a post-apoptotic response,
efferocytosis also occurs after the induction of other death pathways. Following inflammatory
forms of cell death, neutrophils may act as the secondary phagocyte, clearing cellular debris in
place of macrophages (Jorgensen et al., 2017).
1.4.5.3

Autophagy

Autophagy is an intracellular process of degradation and recycling (xenophagy) in order to
maintain homeostasis within a cell (Bhattacharya et al., 2015, Mizushima et al., 2004). Internal
cellular contents and components can be sanctioned into an autophagosome, where enzymatic
degradation occurs following fusion with lysosomes or within vacuoles (Bhattacharya et al., 2015,
Germic et al., 2019, Kim et al., 2019). Autophagy emerges as an important mechanism of
neutrophil-mediated pathogen defence as recent reviews summarise roles in phagocytosis,
degranulation, ROS production, cytokine release (IL-1β) and cell death (Germic et al., 2019).
Autophagy can be summarised as occurring in five mechanistic steps: initiation, elongation,
autophagosome completion, fusion with the lysosome and degradation (Yang and Klionsky,
2010). Neutrophil autophagy has been shown to be initiated via phagocytosis-independent and
phagocytosis-dependent mechanisms, where ROS activation is a promoter (Mitroulis et al., 2010).
Autophagy is known to play a role in epithelial cell defence against GAS (Aikawa et al., 2018),
while strains isolated from invasive infection have also demonstrated evasion of autophagy to
facilitate intracellular replication (Barnett et al., 2013).
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Figure 1.3: Anti-inflammatory mechanisms of cell death. Extrinsic apoptosis occurs following FASligand (FASL), tumour necrosis factor (TNF)-α receptor and TNF-related apoptosis-inducing ligand
(TRAIL) binding, which results in activation of caspase (CSP)-8. Reactive oxygen species (ROS) production
or cellular stress can initiate intrinsic apoptosis, causing caspase-8 activation or release of cytochrome c
(Cyt c) from the mitochondria (MT) and caspase-9 activation, respectively. Autophagy is a five-step
intracellular process that degrades pathogens via fusion with lysosomes. Following the induction of
apoptosis, cells release “find me” signals (including phosphatidylserine (PS) “flipping”, adenine
triphosphate (ATP) and uridine triphosphate (UTP) release) and lose “don’t eat me” signals, initiating
clearance of debris by macrophages via efferocytosis. Anti-inflammatory cytokines are released by
macrophages during efferocytosis and promote the resolution of inflammation. Abbreviations: APAF,
apoptotic protease activating factor; BAK, bcl-2 antagonist/killer; BAX, bcl-2-associated x protein; FADD,
Fas-associated protein death domain; IL, interleukin; PAF, platelet-activating factor; PCSP8, pro-caspase-8;
RIPK, receptor-interacting protein kinase; SMAC, second mitochondria-derived activator of caspases; TGF,
transforming growth factor; TRADD, tumour necrosis factor receptor 1-associated death domain protein;
XIAP, x-linked inhibitor of apoptosis protein.
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1.4.6 Pro-inflammatory programmed cell death
Historically, it was thought that all necrotic or lytic cell death was an uncontrolled/accidental
pathway of cell death with no defining molecular mechanisms. It is now understood that many
examples of necrotic or lytic cell death are alternative or fail-safe mechanisms of immunity that
can be distinguished via defining mechanistic features. Pyroptosis, necroptosis and NETosis are
all inflammatory death pathways described in neutrophils that can be distinguished from one
another due to their unique components that coordinate the outcome (Figure 1.4). The induction
of inflammatory methods of cell death must be controlled or balanced in order to not cause
further damage to the host or exacerbate disease pathologies. Recent reviews have highlighted
that despite distinct differences, many of the inflammatory pathways share common elements
and may be more interlinked than initially perceived (Chen et al., 2020, Lawrence et al., 2020).
1.4.6.1

Pyroptosis

Pyroptosis is the regulated inflammatory cell death pathway resulting in cell lysis, executed in
human cells by caspase-1 activation or alternatively caspase-4 or caspase-5 activation (Man and
Kanneganti, 2016). Pyroptotic death amplifies the inflammatory response through release of
DAMPs and downstream events (LaRock and Cookson, 2013). Pyroptosis has been identified in
neutrophils responding to bacterial infection (Ryu et al., 2017), however most research advances
in understanding pyroptosis and inflammasomes have focused on macrophages. Initiation can
occur through canonical (caspase-1-dependent) and non-canonical (caspase-1-independent)
pathways, both triggering the cleavage of GSDMD and culminating in cell pore formation and
release of inflammatory cytokines IL-1β and IL-18 (Man et al., 2017). Caspase-1 dependent
pyroptosis commences following PAMP or DAMP recognition by NLRs, absent in melanoma 2 or
Pyrin (Man et al., 2017). Each sensor activates the organisation of a particular macromolecular
complex called an inflammasome, consisting of the initiating sensor, an adaptor protein (ASC)
and caspase-1 (Man and Kanneganti, 2015, Man and Kanneganti, 2016). The inflammasome
activates the bound caspase-1 and can further cleave and activate GSDMD, IL-1β and IL-18.
GSDMD forms pores in the cell membrane whereas cytokines further promote inflammatory
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activity. The process of non-canonical caspase-1-independent pyroptosis varies however, as
cytosolic bacterial toxins or lipopolysaccharide are detected directly by caspase-4 or caspase-5
in human cells, forming the non-canonical inflammasome (Man et al., 2017). These caspases then
go on directly to cleave GSDMD. Cleaved GSDMD similarly forms pores in the cell membrane but
may also activate the NOD, leucine rich repeat and pyrin domain protein (NLRP)3 inflammasome,
which in turn results in activation of caspase-1 and then IL-1β and IL-18 (Man et al., 2017).
Though inflammasomes are essential to pyroptosis, it is believed that the formation of an
inflammasome does not automatically lead to cell death (Chen et al., 2020).
Pyroptosis is an alternative method of cell death-mediated host immunity, as cell lysis promotes
the further recruitment of immune cells, and also deprives the pathogens of the intracellular
environment (LaRock and Nizet, 2015). Following lysis, pathogens then confront increased
numbers of primed immune cells that are assumed to be more effective (Miao et al., 2010).
Through the use of caspase-knockout mice, the induction of pyroptosis has been demonstrated
to be beneficial during both gram-positive and gram-negative infections in vivo, though this has
not been shown for GAS infection specifically (Man et al., 2017). Pyroptosis has been
demonstrated in macrophages in response to GAS infection (Valderrama et al., 2017). During
macrophage pyroptosis the formation of pore-induced intracellular traps, similar to that of NETs,
has been reported to occur for Salmonella enterica serovar Typhimurium (Jorgensen et al., 2016).
Pore-induced intracellular traps limit the escape of intracellular bacteria during pyroptotic
macrophage lysis and assist neutrophils during their clean-up role in efferocytosis (Jorgensen et
al., 2016). IL-1β release enhances inflammation during pyroptosis but is also a hallmark of
invasive GAS infection (LaRock and Nizet, 2015). Disruption to release or failure to regulate IL1β may lead to lethal inflammatory disease (Castiglia et al., 2016). Lytic neutrophil death has been
reported during emm1 and emm98.1 GAS infection (Kobayashi et al., 2003a, Tsatsaronis et al.,
2015), however it is unclear if this is due to pyroptosis. Induction of neutrophil pyroptosis has
been demonstrated for other invasive pathogens such as Pseudomonas aeruginosa (Ryu et al.,
2017) and S. aureus (Rasmussen et al., 2019). Additionally, comprehensive models for
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investigating pyroptosis in leukocytes have since been proposed (Tran et al., 2019), though
characterisation of neutrophils during GAS infection trials behind other pathogens.
1.4.6.2

NETosis

Neutrophils can release NETs in response to pathogens (Brinkmann et al., 2004), during the
inflammatory process referred to as NETosis. During NETosis, neutrophils expel intracellular
chromatin and histones (which form NETs), along with granular proteins (such as MPO and LL37) and DAMPs, as a pro-inflammatory method of trapping and killing extracellular bacteria
(Brinkmann et al., 2004). NET formation can occur through lytic or non-lytic pathways
(Castanheira and Kubes, 2019). Lytic NET release is initiated by NADPH oxidase activation,
following a response to lipopolysaccharide or TNF-α and is ROS dependent (Castanheira and
Kubes, 2019). Non-lytic NET release occurs due to TLR4 (Clark et al., 2007), TLR2 (Monti et al.,
2017) and complement (Yuen et al., 2016) receptor binding, where NETs are secreted via vesicles
and neutrophils remain alive (Castanheira and Kubes, 2019). Additionally, cleavage of GSDMD in
response to intracellular gram-negative pathogens has been demonstrated, establishing a
caspase-dependent mode of NETosis and a further link with pyroptosis (Chen et al., 2018).
NETosis has been shown to prevent systemic dissemination (Yipp et al., 2012). The process is far
slower than other neutrophil defence mechanisms and occurs over a period of 2-4 h (Clark et al.,
2007). Quantification methods are also difficult and subjective, as most rely upon fluorescence
microscopy and colocalisation of chromatin and proteins such as myeloperoxidase outside the
cell (Fuchs et al., 2007). It is known that GAS infection can induce NETosis (Yipp et al., 2012),
however multiple virulence factors have been identified that may assist in bacterial escape from
NETs (Lauth et al., 2009, Uchiyama et al., 2015, Walker et al., 2007). NETosis may occur in
conjunction with other death pathways (Lawrence et al., 2020) and it is unlikely the host response
is restricted to a single pathway, but rather is a balancing act between many.
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Figure 1.4: Inflammatory mechanisms of neutrophil cell death. Canonical pyroptosis involves the
formation of a NOD, leucine rich repeat and pyrin domain protein (NLRP), NOD, leucine rich repeat and
CARD domain protein (NLRC), absent in melanoma (AIM)2 or pyrin inflammasome, which activates
caspase (CSP)-1. Caspase-1 cleaves gasdermin D (GSDMD), forming pores, and promotes the maturity and
release of interleukin (IL)-1β and IL-18. Non-canonical activation directly activates caspase-4/-5 which
cleaves GSDMD. Necroptosis occurs during caspase-8 inactivation following FAS-ligand (FASL), TNF-α
receptor (TNFR) and TNF-related apoptosis-inducing ligand (TRAIL) binding. Receptor-interacting protein
kinase (RIPK)1 then binds with RIPK3 (necrosome) and both become phosphorylated (P). Mixed lineage
kinase domain-like protein (MLKL) then associates with the necrosome, becoming phosphorylated and
oligomerising. MLKL oligomers form and create pores in the cell membrane, release DAMPs. Lytic NETosis
occurs following reactive oxygen species (ROS) production, causing chromatin decondensation (via protein
arginine deiminase (PAD)4 and myeloperoxidase (MPO)) and cleavage of GSDMD by neutrophil elastase
(NE), resulting in nuclear and cell membrane pore formation and release of DNA and histones as NETs.
Non-lytic NETosis may also occur following Toll-like receptor (TLR)2 and TLR4 binding, instigating PAD4mediated chromatin decondensation. Nuclear membranes are disrupted where histones and DNA are
released from the cell via vesicles. Abbreviations: FL, full-length; PCSP8, pro-caspase-8.
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1.4.6.3

Necroptosis

Necroptosis is a pro-inflammatory caspase-independent death pathway, where significant
developments in understanding necroptosis have been made over the past decade (Berghe et al.,
2014, Tait et al., 2014). Induction of necroptosis occurs when caspase activation fails and
safeguards against pathogens that may be trying to use the cell for immune evasion or replication.
Activation of necroptosis in neutrophils can occur following TNF-⍺ receptor binding, TLR binding,
the detection of intracellular pathogen DNA or ribonucleic acid (RNA) and treatment with
granulocyte-macrophage colony-stimulating factor (GM-CSF) (Wang et al., 2016). Necroptosis
relies upon receptor interacting protein kinase (RIPK)1 and RIPK3 (Cho et al., 2009, He et al.,
2009). In the presence of caspase-8, RIPK1 and RIPK3 are cleaved, preventing necroptosis (Feng
et al., 2007, Lin et al., 1999). Inhibition of caspase-8 allows RIPK1 and RIPK3 to associate to oneanother through receptor interacting protein homotypic interaction motif domains. The
RIPK1/RIPK3 complex joins with FADD and caspase-8 to form the necrosome and becomes
phosphorylated (Vandenabeele et al., 2010). Mixed-lineage kinase domain-like protein (MLKL)
associates to the RIPK3 portion of the necrosome. MLKL becomes phosphorylated (pMLKL)
(Barbosa et al., 2018) and phosphorylation initiates oligomerisation of pMLKL molecules as a
four-helix bundle (Murphy et al., 2013, Orozco et al., 2014, Wu et al., 2014). Insertion of the
pMLKL oligomers into the plasma membrane subsequently forms pores (Weber et al., 2018). The
following membrane localisation is essential to necroptosis but does not induce cell death
(Hildebrand et al., 2014). Two models have arisen to explain the function of membrane localised
MLKL; recruitment of calcium and sodium ion channels at the plasma membrane (Cai et al., 2014,
Chen et al., 2014) and MLKL as a membrane bound pore-forming complex (Dondelinger et al.,
2014, Su et al., 2014, Wang et al., 2014). Cellular swelling and loss of plasma membrane integrity
are phenotypic characteristics of necroptosis (Malanski et al., 2003), where lysis promotes
inflammation via the release of DAMPs and granular molecules (Kaczmarek et al., 2013,
Pasparakis and Vandenabeele, 2015). DAMPs commonly released during necroptosis include high
mobility group box 1 protein, IL-1α, uric acid, DNA fragments, adenosine triphosphate and
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mitochondrial contents (Eigenbrod et al., 2008, Kono et al., 2010, Krysko et al., 2008, Sauter et al.,
2000). The induction of necroptosis has been demonstrated in human neutrophils (GreenleeWacker et al., 2017) and murine immune cells (Kitur et al., 2016) in response to S. aureus,
although these reports conflict on whether necroptosis aids or hinders the resolution of infection.
The role of neutrophil necroptosis in GAS disease however, remains unclear and requires further
investigation. The overlap of molecules from both anti-inflammatory and proinflammatory
pathways further indicates that all cell death is a complex and dynamic mechanistic process.

1.5 Development of invasive GAS infection
Although the human immune response is comprehensive, bacteria that cause invasive disease
often display resistance to, modulation of or evasion of neutrophil defence mechanisms, outlined
above (Chapter 1.4). GAS have been shown to resist, modulate, and evade the human immune
response in order to gain a survival advantage, though often this increases their propensity to
cause invasive disease. The bacterial-host interaction dictates entry into sterile sites such as the
blood, where modulation of immune cell death may in turn influence inflammation and tissue
destruction at sites of invasive GAS infections (Casadevall and Pirofski, 2000). Bacterial virulence
factor expression has been a focus area of GAS disease research, and numerous GAS proteins have
been shown to contribute to the development of invasive disease (Reglinski and Sriskandan,
2014, Walker et al., 2014). The host immune response to GAS however, is less well-characterised,
particularly for neutrophils, even though disruption to homeostatic immune responses impact
the progression of invasive GAS disease (Lawrence et al., 2018, Lawrence et al., 2020). The
hyperinflammation seen during invasive GAS infections, may be a product of both bacterial
virulence factors expression such as toxins, but also disruption caused to the hosts immune
system. A new perspective for invasive GAS infection that incorporates both host and bacterial
factors simultaneously may provide a more comprehensive understanding of disease
progression.
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1.5.1 Genetic vulnerability to invasive infection
Genetic differences between hosts also may play a role in the development and outcomes of
invasive GAS infection. Individuals can have reduced susceptibility to severe systemic GAS
disease due to the expression of different human leukocyte antigen class II haplotypes
(DRB1*1501/DQB1*0602) (Kotb et al., 2002). Additionally, susceptibility to invasive GAS disease
has also been associated with human leukocyte antigen class II haplotype DRB1*07/DQB1*0201
(Kotb et al., 2002), where these host factors can dictate inflammation. Differences in the outcomes
of GAS infection when using murine models have also been observed, where some mouse strains
experience increased bacterial proliferation and excessive cytokine production (Goldmann et al.,
2003). In mice, age has also been shown to be a contributing factor to GAS infection susceptibility,
due to the senescence of immune cells with age (Goldmann et al., 2010). Furthermore, a systems
genetics approach has been used to map the susceptibility to severe GAS disease among mouse
genotypes, identifying a quantitative trait locus that predicts disease and accounts for 25-30% of
variance (Abdeltawab et al., 2008). Although the use of murine cells and models is extremely
common for infection studies, this evidence highlights that caution should be taken when
selecting an appropriate mouse strain. Likewise, it justifies the use of multiple donors when
studying primary human cells, to account for possible genotypic differences that may correspond
to differences in susceptibility to GAS.

1.5.2 Subversion of neutrophil mediated defence
GAS express a broad array of cell-surface and secreted virulence factors that promote resistance
to and evasion of the host immune response (Bisno et al., 2003, Courtney et al., 2002, DiPersio et
al., 1996, Hynes, 2004, Tsatsaronis et al., 2014). Although neutrophils are essential to bacterial
clearance, GAS are able to respond with a range of counterattacks that reduce the effectiveness of
the host immune response and can further promote inflammation (Walker et al., 2014). Virulence
factor expression is controlled by several regulatory systems, such as response regulators and
two-component signal transduction systems that respond to environmental stimuli
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(Kreikemeyer et al., 2003 268 268). Differences in virulence factor expression can be seen not
only between GAS strains associated with different disease states but also after “genetic
switching” during an infection (Fiebig et al., 2015, Hollands et al., 2010, Kilsgård et al., 2016).
Higher expression of virulence factors associated with immune evasion are evident in strains that
have undergone genetic switching (Kilsgård et al., 2016). GAS virulence factors that bestow
resistance to neutrophil-mediated immunity and influence inflammation have been briefly
described (Table 1.1).
1.5.2.1

Hyaluronic acid capsule

Hyaluronic acid (HA) on the GAS cell-surface encapsulates the bacteria and can subvert detection
by host immune cells, as it is structurally identical to HA found in human connective tissue
(Cunningham, 2000). GAS HA limits the surface binding of antibodies and interferes with
complement deposition, providing increased protection from opsonophagocytosis (Dale et al.,
1996, Dinkla et al., 2007, Foley and Wood Jr, 1959). GAS strains with upregulated capsule
expression are regularly isolated from invasive infections, with HA absence attenuating disease
in mouse models of infection (Moses et al., 1997, Stollerman and Dale, 2008, Wessels et al., 1991).
HA also increases the resistance of GAS to neutrophil killing by enhancing survival within NETs
(Cole et al., 2010). GAS M and M-like proteins bestow resistance to innate immunity and may be
secreted or attached to the cell-surface. Complement deposition can be inhibited through binding
of M protein to host factors fibrinogen, factor H and plasminogen (Courtney et al., 2006,
Horstmann et al., 1988, Ly et al., 2014). M protein further disrupts phagocytosis via
immunoglobulin binding (Fagan et al., 2001) or impairment to neutrophil phagosome maturation
(Staali et al., 2006). When working in conjunction with HA, M protein also provides resistance to
neutrophil granular antimicrobial peptide LL-37 (Cole et al., 2010).
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Table 1.1: Virulence factors of GAS bestowing resistance to host innate immunity and causing inflammation.
Virulence factor
Hyaluronic acid capsule
(HA)

Gene
hasA

Area of immunity
Opsonisation

Streptococcal inhibitor of
complement-mediated
lysis
IgG-degrading enzyme of
Streptococcus pyogenes
Streptococcal pyogenic
exotoxin A (SpeA)
Streptococcal pyogenic
exotoxin B (SpeB)

sic

speB

Dissemination
Opsonisation
AMP resistance

Streptococcal C5a
peptidase
S. pyogenes cell envelope
protease (SpyCEP)
Streptococcus ADP-ribosyl
transferase
Streptodornase 1 (Sda1)

scpA
spyCEP

Phagocytosis
Chemotaxis
Chemotaxis

spyA

Inflammation

Mechanism
Molecular mimicry to extracellular matrix avoids opsonisation
Blocks antibody access to surface
Inhibits complement deposition
Resistance to opsonophagocytosis
Enhances survival within NETs
Fibrinogen binding blocks C3 convertase cell-surface deposition
Plasminogen binding prevents C3b opsonisation
Binds factor H accelerating C3b degradation
Bind IgA and IgG at the Fc regions, inactivating
Impairs phagosome maturation when internalised
Working in conjunction with HA provides resistance to LL-37
Inactivates complement C4b through protein H, and increases epithelial invasion
Disrupts neutrophil phagocytosis by forming hydrophilic pores in membranes
Host cell lysis of lymphocytes, erythrocytes, macrophages and platelets
Release of cytotoxic inflammatory molecules from neutrophils
Disrupts host neutrophil, macrophage and epithelial membranes
Resistance to endosomal and lysosomal formation
Allows translocation of NADase into host cells
Facilitates SpeA penetration of cells, resulting in inflammation and tissue damage
Disrupts clathrin-dependent pathways of internalisation
Binds and inhibits complement C5b67
Inactivates leukocyte protease inhibitor, lysozyme, human α-defensin-1 and LL-37
Increase epithelial cell adherence and mucosal colonisation
Degrades IgG at Fc region and CD11b, inhibiting opsonophagocytosis
Inhibit neutrophil activation and ROS production via CD16 binding
Activation of host immune cells and resulting cytokine release
Binds human leukocyte antigen class II invoking cytokine release
Degrades host extracellular matrix components via protease activity
Degrades IgG, IgA, IgM, IgD and IgE
Inactivates and cleaves antimicrobial peptide LL-37
Release of dermatan sulphate
Cleaves C5a
Cleaves C5a binding site on neutrophil cell-surface
Degrades neutrophil attractant IL-8 by cleavage
Post-transcriptionally dampens epithelial IL-8 release
Invokes IL-1β release

M-protein and M-like
proteins

mga

Neutrophil killing
Opsonisation

sda1

Cell-wall anchored nuclease A
Streptokinase
NAD-glycohydrolase

spnA
ska
nga

NETs
Inflammation
Activation
NETs
Dissemination
Cytotoxicity
Chemotaxis

Degrade NETs with DNase activity
Reduces macrophage release of IFN-α and TNF-α
Reduces TLR9 recognition of pathogen-associated molecular patterns
Degradation of NETs through nuclease activity
Activates host protein plasminogen which degrades host extracellular matrix
Production of cyclic adenosine diphosphate-ribose
Inhibited directed migration due to limited activation

Streptolysin S (SLS)

sag(A-I)

Streptolysin O (SLO)

slo

mac
speA

Phagocytosis
Oxidative burst
AMP resistance
Cellular invasion
Phagocytosis
Inflammation
Inflammation
Phagocytosis
Cytotoxicity
Tissue damage
Phagocytosis
Opsonisation
AMP resistance
Adherence
Opsonisation
Oxidative Burst
Inflammation

References
(Cunningham, 2000)
(Dinkla et al., 2007)
(Dale et al., 1996)
(Dale et al., 1996, Foley and Wood Jr, 1959)
(Cole et al., 2010)
(Courtney et al., 2006)
(Ly et al., 2014)
(Horstmann et al., 1988)
(Fagan et al., 2001)
(Staali et al., 2006)
(Cole et al., 2010)
(Ermert et al., 2013)
(Datta et al., 2005, Miyoshi-Akiyama et al., 2005)
(Goldmann et al., 2009, Ofek et al., 1970)
(Nilsson et al., 2006)
(Bricker et al., 2002, Goldmann et al., 2009, Timmer et al., 2009)
(Håkansson et al., 2005)
(Karasawa et al., 1995, Madden et al., 2001, Stevens et al., 2000)
(Brosnahan et al., 2009)
(Logsdon et al., 2011)
(Åkessont et al., 1996, Fernie-King et al., 2001)
(Fernie-King et al., 2002, Fernie-King et al., 2004, Frick et al., 2003)
(Hoe et al., 2002, Lukomski et al., 2000)
(Åkesson et al., 2006, Lei et al., 2001, Von Pawel-Rammingen et al., 2002)
(Kawabata et al., 2002, Lei et al., 2001)
(Norrby-Teglund and Johansson, 2013)
(Kotb et al., 2002)
(Kapur et al., 1993a; Burns et al., 1996)
(Schmidtchen et al., 2002)
(Schmidtchen et al., 2002)
(Schmidtchen et al., 2001)
(Chen and Cleary, 1990, O'Connor and Cleary, 1986)
(Demaster et al., 2002)
(Edwards et al., 2005, Zinkernagel et al., 2008)
(Soderholm et al., 2018)
(Lin et al., 2015)
(Buchanan et al., 2006, Walker et al., 2007)
(Uchiyama et al., 2012)
(Uchiyama et al., 2012)
(Chang et al., 2011)
(Sun et al., 2004)
(Madden et al., 2001, Stevens et al., 2000)
(Stevens et al., 2000)

Abbreviations: AMP, antimicrobial peptide; IFN, type I interferon; Ig, immunoglobulin; NETs, neutrophil extracellular traps; ROS, reactive oxygen species; TNF,
tumour necrosis factor.
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1.5.2.2

Streptolysins

Leukocidins such as SLO and streptolysin S (SLS) are extracellular pore-forming toxins secreted
by GAS, contributing to β-haemolysis. SLO oligomerises and disrupts host cell membranes
including erythrocytes, neutrophils, macrophages, platelets and epithelial cells (Bhakdi et al.,
1985, Bricker et al., 2002, Goldmann et al., 2009, Limbago et al., 2000, Sierig et al., 2003, Timmer
et al., 2009). Rupture of neutrophil membranes releases cytotoxic molecules which can also act
to promote inflammation (Nilsson et al., 2006). Intracellular secretion of SLO facilitates
endosomal escape within phagocytic cells, reducing bacterial killing and contributing to
dissemination in vitro (Håkansson et al., 2005). SLO expression enhances virulence of GAS strains
in a murine bacterial sepsis model (Sierig et al., 2003). The abrogation of SLO (slo gene) however,
results in increased survival of mice (Ato et al., 2008, Limbago et al., 2000, Timmer et al., 2009),
indicating a role in disease severity. SLS acts similarly to cause host cell lysis (Goldmann et al.,
2009), where pore formation in neutrophil membranes can protect GAS from phagocytosis in vivo
(Miyoshi-Akiyama et al., 2005). GAS that succumb to neutrophil phagocytosis continue to release
SLS, which can then continue to have cytotoxic effects upon the cell (Miyoshi-Akiyama et al.,
2005). Evidence suggests that SLS-mediated lysis contributes to GAS pathogenesis, inhibiting
phagocytosis, increasing bacterial dissemination and activating host inflammatory pathways
(Ginsburg, 1999, Heath et al., 1999, Ofek et al., 1970). Abrogation of the SLS associated genes
(sagA – sagI) can reduce GAS virulence (Betschel et al., 1998, Datta et al., 2005). In a mouse model
of bacterial sepsis, M3 GAS virulence is increased by expression of both SLO and SLS (Sierig et al.,
2003). In another mouse model of invasive GAS infection, when slo and sagA are abrogated
together, lesion size and bacterial load are significantly reduced (Goldmann et al., 2009). SLS also
works synergistically with proteases and oxidants, causing host cell injury in vitro (Ginsburg,
1999).
1.5.2.3

Streptococcal pyogenic exotoxins

GAS produce numerous streptococcal pyogenic exotoxins (Spe) that all have roles in averting host
immunity. Of notable mention is the superantigen SpeA, which is encoded by a mobile genetic
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element speA (Weeks and Ferretti, 1984). SpeA promotes the activation of host immune cells via
the release of cytokines, but can lead to the development of invasive disease due to hyper-immune
stimulation (Norrby-Teglund and Johansson, 2013). In contrast, SpeB acts as a broad-spectrum
protease, degrading many host factors of immunity. Degradation of the host ECM by SpeB allows
bacterial dissemination (Burns Jr et al., 1996, Kapur et al., 1993). SpeB also degrades
immunoglobulins (Ig) and antimicrobial peptides (LL-37), to increase bacterial survival
(Schmidtchen et al., 2002).
1.5.2.4

Other enzymatic activity

GAS further impair neutrophil recruitment and function via degradation to key host components.
S. pyogenes cell envelope protease (SpyCEP), as the name suggests, is a cell-wall associated GAS
peptidase that cleaves molecules such as IL-8 (Edwards et al., 2005), that promotes neutrophil
chemotaxis (Kunkel et al., 1991). SpyCEP is upregulated during in vivo GAS infection, cleaving
IL-8 which decreases neutrophil migration and neutrophil mediated killing (Zinkernagel et al.,
2008). Using a genetic mutant, the abrogation of SpyCEP results in attenuated virulence in vivo
(Zinkernagel et al., 2008). GAS isolated from blood or invasive infection show increased
degradation of IL-8, therefore suggesting a role for SpyCEP in the development of invasive disease
(Edwards et al., 2005). Complement is another important host factor that assists with
phagocytosis and has been mentioned previously (Chapter 1.4.3). The streptococcal C5a
peptidase is another cell-surface associated virulence factor that enables proteolytic cleavage of
complement factor C5a, upon binding to the bacterial wall (Cleary et al., 1992, Edwards et al.,
2005). Cleavage of C5a reduces GAS phagocytosis and increases bacterial survival in vivo (Chen
and Cleary, 1990, O'Connor and Cleary, 1986, Zinkernagel et al., 2008), where streptococcal C5a
peptidase activity also stops neutrophil chemotaxis by cleaving the binding site (Cleary et al.,
1992, Demaster et al., 2002). The final mode of degradation that will be mentioned is GAS
nuclease activity. As previously discussed (Chapter 1.4.6.2), in response to pathogens neutrophils
release NETs made from DNA and histones to ensnare bacteria (Brinkmann et al., 2004). GAS
impair NET formation via the release of nucleases including streptodornase (Sda)1 and cell wall-
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anchored nuclease A (Buchanan et al., 2006, Chang et al., 2011, Walker et al., 2007). Sda1
facilitates the escape of GAS from NETs, promoting GAS hypervirulence (Walker et al., 2007) and
plays an essential role during the development of invasive GAS disease in vivo (Buchanan et al.,
2006) Similarly, cell wall-anchored nuclease A promotes GAS survival in both whole blood and
neutrophil killing assays through the destruction of NETs (Chang et al., 2011).
Regardless of which of the above virulence factors are involved, bacteria that bypass host
immunity have an increased likelihood of causing invasive infections. Thus, a large portion of GAS
host-pathogen research has focused upon virulence factors to date. A discussion of all GAS
virulence factors is beyond the scope of this review, however further reading of other
comprehensive reviews can provide additional information (Reglinski and Sriskandan, 2014,
Walker et al., 2014).

1.5.3 CovRS and M1T1 propensity to cause invasive infection
GAS virulence factor regulation is influenced by the environment but also controlled by
regulatory feedback systems. The control of virulence regulatory system (CovRS) is a twocomponent system controlling between 10-15% of GAS genome expression (Graham et al., 2002,
Sumby et al., 2006), and contributing to the bacterial stress response (Dalton and Scott, 2004).
The regulatory system is comprised of a sensor kinase (CovS) and response regulator (CovR).
Under normal conditions, CovS is able to bind CovR and control the metabolically expensive
production of virulence factors involved in innate immune resistance and tissue destruction such
as; streptokinase, SLO, HA, SLS, SpeA, cell wall-anchored nuclease A, Sda1, immunoglobulindegrading enzyme S, streptococcal inhibitor of complement and SpyCEP (Graham et al., 2002,
Sumby et al., 2006, Treviño et al., 2009). Mutations to the covRS disrupt either the gene for the
sensor (covS) or regulator (covR) and can result in over production of these virulence factors,
increasing virulence and resistance to innate immunity (Maamary et al., 2010, Sumby et al., 2006)
and often triggering invasive disease (Cole et al., 2011, Sumby et al., 2006, Walker et al., 2007).
During the upregulation of many factors during covRS mutation the downregulation of SpeB also
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occurs, reducing the degradation of bacterial cell-surface proteins and allowing increased
interactions with host blood components (Maamary et al., 2010).
Increased GAS resistance to phagocytosis and neutrophil killing (Sumby et al., 2006) further
confers hypervirulence in mouse models of systemic infection (Engleberg et al., 2001, Walker et
al., 2007). Although strains isolated from invasive infection commonly have covR/S mutations
(Maamary et al., 2010), it is not essential in order to cause invasive disease (Davies et al., 2019).
Studies have shown that M1T1 GAS have a higher propensity for covR/covS mutation and may be
in part a reason for its frequent identification in invasive disease (Aziz et al., 2004). “Genetic
switching” of M1T1 is thought to occur following colonisation, which sees the selective rise of
covR/covS mutants, down regulating expression of factors for colonisation and upregulating
expression of factors for dissemination and immune evasion (Walker et al., 2007). Three distinct
genetic events are in part held responsible for the prevalence of the M1T1 clone, acquisition of a
prophage encoding deoxyribonuclease (DNase) Sda1 (1969), the superantigen SpeA (1973) and
the recombination event involving NAD-glycohydrolase and SLO (1988) (Maamary et al., 2012,
Nasser et al., 2014, Sumby et al., 2005). Additionally, evidence has shown that covR/covS mutant
strains are able to avoid clearance by apoptotic immune cells, redirecting immune cell death
through an inflammatory mediated pathway (Goldmann et al., 2009, Tsatsaronis et al., 2015).
However, limited studies have focused on the interplay between immune cell resistance,
inflammatory responses and immune cell death. Two well-characterised covS GAS mutants
5448AP (M1T1, containing a mutation obtained following animal passage) (Aziz et al., 2004) and
NS88.2 (M98.1,naturally occurring mutation acquired during clinical infection) (McKay et al.,
2004) both display a single change in nucleotide sequence of covS (Figure 1.5). The result is
increased bacterial resistance to neutrophil killing and increased propensity to cause invasive
disease in mouse models of GAS infection (Maamary et al., 2010). As such, these strains may serve
as models for studying the immune response during invasive GAS infection, allowing better
understanding of the host inflammatory response and potential factors contributing to the
development of invasive disease.
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Figure 1.5: Mutations to the control of virulence regulator system influence the regulation of
multiple genes in GAS. NS88.2 has a point mutation, guanine to adenine, in covS of nucleotide 581
(Maamary et al., 2010), while 5448AP also has an adenine insertion in covS at nucleotide 887 (Walker et
al., 2007). Mutations to the control of virulence regulator system (CovRS) upregulate speA, sag, ska, spd,
grab and has expression and upregulates Mga controlled genes emm, fbs, scIA, scpA, sic, slo and sof via RofA like protein IV regulator X (RivRX) and two-component regulator system X (TrxSR) (Fiedler et al., 2010).

1.5.4 GAS modulation of neutrophil function
Neutrophils, being the front line of innate immunity, are known to underpin the effectiveness of
bacterial eradication during infection (Lawrence et al., 2020). Alteration to neutrophil function
however can contribute to inflammatory pathology. ‘Neutrophil dysfunction’ (as it is sometimes
called) is best described during the inflammatory condition sepsis, where neutrophil; function,
migration, oxidative burst, bacterial killing and cytokine release have all been reported to be
affected (Hotchkiss et al., 2013). A previous review has outlined the role that GAS superantigens,
M1-mediated heparin binding release and SLO play in contributing to excessive host
inflammation and invasive disease (Tsatsaronis et al., 2014). Bacterial modulation of neutrophil
death is another mechanism that can contribute to the development of invasive infection. Two
reports have identified that GAS isolated from invasive infection can accelerate neutrophil
apoptosis, then cause secondary necrosis (Kobayashi et al., 2003a), and induce a lytic form of
neutrophil death (Tsatsaronis et al., 2015). Though it has been mentioned that inflammatory
death pathways may be an alternative mechanism of host defence (Chapter 1.4.6), increased
survival and reduced phagocytosis of GAS is seen during these instances. Therefore, cell lysis,
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instead of apoptosis, may contribute to reduced antibacterial activity and proinflammatory action
of neutrophils during GAS infection. Further research is needed to determine if GAS induce
specific inflammatory death pathways in neutrophils, and if so, is this common among isolates
from invasive disease. Host cells have also been shown to act as a reservoir for GAS survival.
Though neutrophils normally initiate a hostile internal environment for phagocytosed GAS,
bacterial cells can survive inside neutrophils (Medina et al., 2003a, Staali et al., 2003). It is
assumed that GAS are able to modulate the internal neutrophil environment and the cell provides
protection from other elements of immunity that may be circulating in the blood. This ability to
exploit an upregulated inflammatory response may constitute yet another mechanism by which
GAS infection may progress to invasive disease.

1.6 Bacterial disruption to the homeostatic balance of cell death
Leukocyte death is essential for host resilience against GAS infection (Gamradt et al., 2016), and
although inflammation in response to bacterial infection is essential for pathogen clearance, its
resolution is equally important for control of infection. Neutrophil populations during infection
should increase immediately, yet reduce after 24 h (Bratton and Henson, 2011). Sustained
increase in neutrophil population and overstimulation of inflammatory reactions can be
detrimental to the host and counteract defensive mechanisms, where GAS infection severity
correlates with the increased amounts of inflammatory mediators (Johansson et al., 2010, Kotb
et al., 2002, Norrby-Teglund et al., 2000). The ability of GAS to cause toxic shock is one such
example of deregulation of inflammatory processes (Lappin and Ferguson, 2009, Norrby-Teglund
and Johansson, 2013). A theoretical model outlines the homeostatic balance between
inflammatory and anti-inflammatory neutrophil death pathways during infection control (Figure
1.6), where disruption to either side could promote conditions favouring the development of
invasive disease (Lawrence et al., 2020). Hence, the mode by which neutrophils die during GAS
infection may make a significant contribution to the development of invasive disease. If there is
mechanistic understanding of neutrophil processes induced during GAS infection, this may
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provide a basis for the development of novel therapeutics aimed to restore neutrophil function
and control excessive inflammation.

Figure 1.6: Theoretical model outlining how neutrophil inflammatory and anti-inflammatory death
pathways work in homeostasis to control bacterial infection. GAS infection results in the induction of
inflammatory and anti-inflammatory neutrophil death. During inflammatory neutrophil death, neutrophils
release inflammatory cytokines and internal contents (danger associated molecular patterns (DAMPs)),
further promoting neutrophil recruitment to the site of infection. Increased neutrophils assist in bacterial
killing and the removal of debris. Inflammation and inflammatory death is down regulated upon the
mounting of an appropriate inflammatory response. Anti-inflammatory death may occur simultaneously
but contains pathogen and cell material within a membrane. Signalling to macrophages occurs, inducing
the clearance of neutrophils through efferocytosis and release of anti-inflammatory cytokines, resolving
infection.
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1.7 Project aims
High mortality rates associated with GAS infection underpin the need for research into invasive
GAS disease. Whilst GAS serotypes prevalent in urbanised populations have been extensively
studied, comparatively little work has focused on genetically diverse isolates from areas with the
highest rates of invasive disease. Resistance to the host immune response or modulation of
neutrophil function is a common among isolates from invasive disease, however the neutrophil
response during infection to GAS from diverse serotypes is not well understood. This project aims
to characterise the neutrophil response to; globally disseminated emm1 (M1T1) strain 5448 and
hypervirulent animal passaged variant 5448AP (covS), and unique Northern Territory emm98.1
bacteraemia isolate NS88.2 (covS) and avirulent variant NS88.2rep (covS restored to wildtype).
Although neutrophils are essential to GAS defence, their response is still not completely
understood, where mode of cell death, contribution to inflammation and cell-surface signalling is
still ambiguous.
Hence the specific aims of this project were to;
•

Optimise human neutrophil protein extraction and evaluate methods of immunoblot
normalisation for the investigation of neutrophil caspase activation during GAS infection.

•

Characterise the human neutrophil response to emm98.1 GAS in vitro.

•

Characterise the human neutrophil response to emm1 GAS in vitro.

•

Investigate the role of and characterise neutrophils in vivo using a murine model of
invasive emm1 GAS infection.
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2 General materials and methods
2.1 Plasticware
For experiments performed in this thesis, plasticware was sourced from the providers outlined
in Table 2.1.
Table 2.1: Plasticware used in this thesis.
Item

Volume/size

Product code/s

Supplier 1

Flow cytometry tubes

5 mL

55.1579

Sarstedt

Tube

1.5 mL

616201

Griener Bio-One

Tube

2 mL

0030120.094

Eppendorf

Tube

5 mL

60.9921.524

Sarstedt

Tube

15 mL

188271

Greiner Bio-One

50 mL

227261

Inoculation loops

10 µL

86.162.010

Sarstedt

Petri dish

90 x 14 mm

10603503

Techno Plas

Pipette tips

10 µL

2340S3

Neptune

200 µL

2100

1000 µL

2370.N

Pipette tips

5000 µL

BH780308

Sartorius

Pipette tips

200 µL

73920

Greiner Bio-One

1000 µL

740290

Pipette tips

10 µL

39710

Interpath Services

Cellstar culture plates

6-well

657160

Greiner Bio-One

24-well

662160

96-well

655180

Plate flat-bottom

96-well

655101

Greiner Bio-One

Plate v-bottom

96-well

651101

Greiner Bio-One

Plate v-bottom

96-well

74039

BioLegend

1 Sarstedt, Nümbrecht,

Germany; Griener Bio-One, Kremsmünster, Austria; Eppendorf, Hamburg, Germany;
Techno Plas, St Marys, Australia; Neptune, Tallassee, AL, USA; Sartorius, Göttingen, Germany; Interpath
Services, Heidelberg West, Australia; BioLegend, San Diego, CA, USA.

2.2 Bacterial strains and culture conditions
Bacterial strains used throughout this study are described in Table 2.2. Streptococcus pyogenes
(Group A Streptococcus, Group A Streptococci, GAS) strains were routinely cultured at 37°C on
horse-blood agar (Oxoid, Basingstoke, United Kingdom) and enumerated on 1% (w/v) yeast
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extract (Sigma-Aldrich, St. Louis, MO, USA) supplemented Todd-Hewitt Broth (THY, Bacto
Laboratories, Mt Pritchard, Australia) agar (1.5% (w/v), Astral Scientific, Taren Point, Australia).
Static overnight cultures were grown in 1% (w/v) yeast (Sigma-Aldrich) supplemented ToddHewitt broth (THY, Bacto Laboratories) at 37°C then sub-inoculated (1:10) into fresh THY and
grown to mid-logarithmic phase (OD600 = 0.4), determined in 10 mm polystyrene semi-micro
cuvettes (Sarstedt, Nümbrecht, Germany) using an Ultrospec 10 Cell Density Meter (Biochrom
Ltd, Cambridge, United Kingdom). Bacterial load was determined for each stain at mid-log by
serial dilution and plating on THY agar, where results were used for the calculation of multiplicity
of infection (MOI). For long term storage, GAS strains were stored in Trypticase Soy Broth (BD)
supplemented with 15% (v/v) glycerol (Merck, Kenilworth, NJ, USA). Antibiotics were added
when required (100 μg/ml ampicillin and 200 μg/ml kanamycin, Sigma-Aldrich). Bacterial pellets
were washed twice with phosphate buffered saline (PBS, Appendix A) then resuspended at the
specified multiplicity of infection (MOI) and assay specific media conditions. Escherichia coli were
routinely cultured on lysogeny broth (LB, Appendix A) agar (1.5% (v/v)) or in liquid LB and
supplemented with antibiotics when required. For long term storage, E. coli strains were stored
in 1% (w/v) casein hydrolysate acid (Oxoid) supplemented with 10 % (v/v) glycerol (Merck).
Bacterial strains were stored long term at -80°C.

2.3 Flow cytometry
Data obtained through the use of flow cytometry was performed on different machines and
specific details are outlined within each chapter.

2.4 Green fluorescent protein GAS
2.4.1 Construction of green fluorescent protein vector pLZ12Km2-P23R-TA:GFP for
GAS
Stable green fluorescent protein (GFP) expression by GAS was created by synthesising the
ribosomal binding site (RBS) and gfp (gfpmut2) from pDCerm-GFP (Ly et al., 2014) into pUC57 at
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Bsp68I, within the multiple cloning site (GenScript, Piscataway, NJ, USA), resulting in pUC57RBSGFP (Figure 2.1). The following plasmid construction was performed by Heema K. N. Vyas
and Jason D. McArthur. RBS and gfp from pUC57-RBSGFP were sub-cloned using NotI (Fermentas,
Burlington, Canada) into the toxin–antitoxin (TA) stabilized expression plasmid pLZ12Km2P23R:TA, kindly provided by Associate Professor Thomas Proft (University of Auckland, New
Zealand) (Loh and Proft, 2013), to produce pLZ12Km2-P23R-TA:GFP. The resultant plasmid
system utilises the Streptococcal ω–ε–ζ TA cassette to achieve segregational plasmid stability
under non-selective conditions (Lioy et al., 2010).
Table 2.2: Bacterial strains and plasmids utilised in this study.
Strain
Streptococcus pyogenes
NS88.2

Description

Source/Ref

Invasive bacteraemia isolate. Emm98.1.

(McKay et al., 2004)

Naturally occurring mutation to covS.
NS88.2rep

NS88.2 derivative strain with repaired covRS

(Maamary et al., 2010)

function.
5448

Isolated from patient with invasive GAS

(Chatellier et al., 2000)

infection, bacteraemia. Emm1, M1T1 isolate.
5448AP

Animal passaged (AP) variant of 5448 with

(Aziz et al., 2004)

acquired mutation to covS. Recovered following
infection with 5448 in BALB/c mouse.
Hypervirulent in a mouse model of infection.
Escherichia Coli
MC1061

Transformation host with high efficiency

Laboratory Stock

Plasmids
pDCerm-GFP

GFP expression using erythromycin resistance.

(Ly et al., 2014)

pUC57

Common plasmid cloning vector isolated from

Genscript, Piscataway,

DH5α E. coli.

NJ, USA

Streptococcal ω–ε–ζ toxin-antitoxin-stabilised

(Loh and Proft, 2013)

pLZ12Km2-P23R:TA

plasmid.
pLZ12Mk2-P23R-TA:GFP

Stable GFP expression vector containing the RBS

This study (Williams et

and GFP from pDCerm-GFP in the toxin-antitoxin

al., 2021)

expression plasmid pLZ12Km2-P23R:TA.
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NotI

A
3

P2

XbaI

NotI
R
S B

:

NotI

NotI
PstI

3

P2

:

B

Figure 2.1: Construction of stable GFP expression by GAS using a toxin-antitoxin system. (A) RBS and
gfp from pUC57-RBSGFP were sub-cloned using NotI into pLZ12Km2-P23R:TA to make pLZ12Km2-P23RTA:GFP. Plasmid structures have not been confirmed by genetic sequencing, only positive GFP expression.
(B) Genetic sequence of RBS and gfp, flanked by NotI restriction sites, synthesised by Genscript into pUC57.

Plasmids pLZ12Km2-P23R:TA and pUC57-RBSGFP (engineered with RBS and gfp from pDCermGFP) were first transformed into chemically competent E. coli MC1061 (Laboratory stock) via
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electroporation (Gene Pulser, Pulse Controller, and Capacitance Extender, Bio-Rad, Hercules, CA,
USA). The plasmids were then retrieved and purified from E. coli cultures using a Wizard® Plus
SV Minipreps Deoxyribose Nucleic Acid (DNA) Purification System (Promega, Madison, WI, USA),
according to the manufacturer’s instructions and outlined below (Chapter 1.4.2). The pLZ12Km2P23R:TA plasmid was digested with 20 U NotI enzyme and further treated with 5 U shrimp
alkaline phosphatase (Fermentas). The pUC57-RBSGFP plasmid was incubated with 20 U NotI to
excise the RBS and gfp gene from pUC57-RBSGFP, which were then ligated into digested
pLZ12km2-P23R:TA plasmid. The resulting plasmid, pLZ12Km2-P23R-TA:GFP, was then
transformed using electroporation (Gene Pulser, Pulse Controller, and Capacitance Extender, BioRad) and cloned in MC1061 E. coli for storage.

2.4.2 Wizard Plus SV Mini-prep DNA purification
E. coli strain MC1061 pLZ12Km2-P23R-TA:GFP was grown overnight at 37°C on LB agar
containing 200 ug/mL kanamycin (Km200, kanamycin sulphate, Sigma-Aldrich). The
manufacturer’s instructions for the Wizard Plus SV Mini-prep DNA purification system (Promega,
Madison, WI, USA) were followed for plasmid purification and instructions are outlined. Using an
inoculation loop, E. coli were scraped from the plate and resuspended in 250 μL of cell
resuspension solution in a 1.5 mL tube. To each tube 250 μL of cell lysis solution was added,
inverted four times and incubated at room temperature (RT) until solution became clear or for a
maximum of 5 min. To each tube 10 μL of alkaline protease solution was added, inverted four
times and incubated at RT for a further 5 min. Following, 350 μL of neutralisation solution was
added, inverted four times and then centrifuged (20,000 x g for 10 min). Clarified lysate was
transferred carefully to a new spin column and centrifuged (20,000 x g for 1 min), discarding the
flow through. To the column 750 μL of cell wash solution was added and centrifuged (20,000 x g
for 2 min), followed by an additional 250 μL of cell wash solution followed by centrifugation
(20,000 x g for 2 min). The column was relocated into a new 1.5 mL tube and 30 μL of nuclease
free water (Promega) added, covering the filter and allowing to stand for 1 min at RT. The tube
and column were centrifuged (20,000 x g for 1 min) to elute the DNA, with a further 20 μL of
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water added and the centrifugation repeated. DNA concentration was determined with a
NanoDrop 2000c Spectrophotometer (Thermo Fisher, Waltham, MA, USA).

2.4.3 Transformation of GAS using electroporation
GAS transformation was performed using established methods (McLaughlin and Ferretti, 1995).
GAS were grown to between OD600 of 0.2-0.25 and centrifuged (5,000 x g for 10 min). The
bacterial pellet was washed with 10 mL of ice cold 0.625 M sucrose solution (Astral Scientific)
then centrifuged as above. The washed equilibrated pellet was resuspended in 1 mL of sucrose
solution, moved to a 1.5 mL tube and centrifuged again as above. The pellet was resuspended in
160 μL of sucrose solution and placed on ice. THY was mixed with sucrose solution at a ratio of
2:3 to make the THY-sucrose solution. Eighty μL of GAS suspension was added into a HiMax 2 mm
electroporation cuvette longelect (Cell Projects, Kent, United Kingdom) followed by 1-2 μg of
plasmid DNA, and the cuvette was placed on ice for 5 min after mixing. Current was applied to the
electroporation cuvette (2.5 kV, 25 μF, 200 Ω with an optimal time constant of 4.2–4.6) with the
electroporation unit (Gene Pulser, Pulse Controller, and Capacitance Extender) and following the
transformation, the mixture was immediately combined with 500 μL of THY-sucrose solution in
a 1.5 mL tube and incubated at 30°C for a minimum of 2 h. Cultures were plated onto LB Km200
and grown at 30°C for 2 d. GAS transformation with pLZ12Km2-P23R-TA:GFP was confirmed by
bacterial GFP fluorescence, determined using an LSR II flow cytometer (BD, San Diego, CA, USA,
ex488

nm em525/50 nm).

2.5 Isolation of human neutrophils from venous blood
2.5.1 Ethics statement
All experiments involving the use of human blood were conducted with informed consent of
healthy female and male adult volunteers (range 21-65 y/o), approved and authorised by the
University of Wollongong Human Research Ethics Committee (Wollongong, Australia, Protocol
HE08/250).
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2.5.2 Isolation of human neutrophils
Venous human blood was drawn into 10 mL lithium heparin-coated Vacutainer (BD) tubes using
a Safety-Lok Blood Collection Set with 21 G needle (BD). Blood was then gently layered over an
equal volume of Polymorphprep (Axis Shield, Oslo, Norway) in a 50 mL tube, equilibrated to RT,
and centrifuged with a swing bucket rotor (500 x g at RT for 35 min) with zero deceleration. The
resulting layer of neutrophils were isolated by aspiration and relocated into a new sterile 50 mL
tube using a pipette. Cells were washed with sterile Hank’s balanced salt solution (HBSS, without
Ca2+ or Mg2+, Corning Inc., Corning, NY, USA, Appendix A) by filling the tube up to 50 mL, followed
by centrifugation with a swing bucket rotor (350 x g at RT for 10 min). Erythrocytes were
hypotonically lysed by resuspending the pellet with 5 mL of sterile deionised water (Milli-Q QPOD, Millipore, Burlington, MA, USA) and rotating the tube for no more than 30 sec. Isotonic
concentration was restored by adding HBSS to 50 mL. Hypotonic lysis was repeated. Prior to
experimentation neutrophils were resuspended in a minimal volume of incomplete medium,
Roswell Park Memorial Institute (RPMI)-1640 medium (Life Technologies, Carlsbad, CA, USA,),
where a sample was diluted 1:1 with Trypan Blue (Sigma-Aldrich), and the cell concentration and
viability determined using a haemocytometer (Reichert, Buffalo, NY, USA) and ICC50 HD light
microscope (Leica Microsystems, Wetzlar, Germany). Autologous plasma was heat-inactivated by
heating at 56°C for 30 min, followed by cooling at 0-4°C for 30 min, then centrifuged at 1000 x g
for 10 min and supernatant kept. Neutrophils were diluted in complete medium (RPMI-1640
medium containing 2% (v/v) heat-inactivated autologous plasma and 2 mM L-glutamine (Life
Technologies)) to the desired concentration unless otherwise stated. Neutrophil purity was
assessed using an LSR Fortessa X-20 flow cytometer (BD) via distinct forward scatter-area (FSCA) and side scatter-area (SSC-A) profiles or peridinin chlorophyll protein (PerCP)/cyanine
(Cy)5.5-conjugated mouse anti-human cluster of differentiation (CD)66b monoclonal antibody
(clone G10F5, BD) expression (ex488 em695/40). Neutrophils were maintained at RT throughout
processing.
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2.6 Neutrophil immunoblotting
2.6.1 Lysate preparation
Purified human neutrophils were seeded into 6-well plates and incubated at 37°C and
5% CO2 as indicated. Each well was gently aspirated into a separate 15 mL tube. Remaining cells
were washed from the well with cold PBS with inhibitors (PBSI, 1 x PBS, 2 x cOmplete protease
inhibitor cocktail (Roche, Basel, Switzerland), 1 mM phenylmethylsulphonyl fluoride (SigmaAldrich), 2 mM sodium fluoride (Sigma-Aldrich), 5 mM sodium pyrophosphate (Sigma-Aldrich),
5 mM sodium molybdate (Sigma-Aldrich) and 5 mM β-glycerophosphate (Sigma-Aldrich)) and
added to the tube. Cells were centrifuged in a swing bucket rotor (350 x g at 4°C for 10 min) and
supernatant removed. Carefully, the cells were resuspended in 2 mL of cold PBSI and
centrifugation

repeated.

Neutrophils

were

lysed

with

200

µL

of

a

modified

radioimmunoprecipitation assay (RIPA) buffer (RIPA 2, 150 mM NaCl (Univar Solutions, Downers
Grove, IL, USA), 5 mM ethylenediaminetetraacetic acid (EDTA, Univar Solutions), 50 mM Tris
(Astral Scientific), 1.0% (v/v) Triton X-100 (Sigma-Aldrich), 0.1% (w/v) Sodium dodecyl sulphate
(SDS, Sigma-Aldrich), 0.5% (w/v) sodium deoxycholate (DOC, Sigma-Aldrich), 2 x cOmplete
protease inhibitor cocktail, 1 mM phenylmethylsulphonyl fluoride, 10 mM sodium fluoride, 10
mM sodium pyrophosphate, 10 mM sodium molybdate and 10 mM β-glycerophosphate) by
incubation on ice for 30 min, with intermittent vortexing. The soluble fraction was separated via
centrifugation (20,000 x g at 4°C for 20 min), and the majority (180 uL) of supernatant was
transferred to a new tube, with a 10 µL aliquot diluted 1:10 with PBS and snap frozen in liquid N2
for protein quantification. 5 x PAGE loading buffer (containing 5% (v/v) 2-mercaptoethanol,
(Sigma-Aldrich), Appendix A) was added to the clarified lysate, mixed, and then heated at 95°C
for 5 min. The sample was centrifuged 500 x g 10 s then snap frozen with liquid N2 (-160°C).
Samples were stored at -80°C for no longer than a week before analysis.
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2.6.2 Quantification of protein concentration using the DC protein assay
Quantification of protein in neutrophil lysates (diluted 1:10 with PBS) was determined as per the
Microplate Assay Protocol of the DC Protein Assay (Bio-Rad). In brief, a set of protein standards
(0-2000 μg/mL) was made using bovine serum albumin (BSA, Sigma-Aldrich) in corresponding
RIPA buffer diluted 1:10 with PBS. Working Reagent A was made by adding 20 μL of Reagent S to
each mL of Reagent A. Using a clean 96-well microplate, 5 μL of standard or sample was added to
a new well, then 25 μL of working Reagent A was added to each well, followed by 200 μL of
Reagent B to each well. The plate was gently agitated to mix and left at RT, protected from light,
for 15 min to develop. The absorbance (A750) was measured using a POLARstar Omega plate
reader (BMG Labtech, Ortenberg, Germany). Protein concentration was determined in samples
by comparison to a standard curve for bovine serum albumin (BSA, Sigma-Aldrich) (Appendix C).

2.6.3 Tris-Glycine Polyacrylamide gel electrophoresis
Proteins were routinely separated in the presence of SDS via Polyacrylamide gel electrophoresis
(PAGE) using 4-20% Tris-Glycine eXended (TGX) Stain-Free Precast Gels (Bio-Rad) and the MiniPROTEAN system (Bio-Rad). Neutrophil lysates were defrosted and briefly heated (95°C for 3
min) prior to loading (20 μg) into precast gels. Electrophoresis was performed by applying 200 V
for 35 min using a PowerPac 300 Supply Unit (Bio-Rad), in PAGE running buffer (Appendix A).
Protein size was estimated on gels by comparison to the Precision Plus Protein Dual Colour
Standards (Bio-Rad). Gels were activated under UV light for 5 min, to visualise total lane protein,
and imaged using a ChemiDoc XR (Bio-Rad). Total lane protein was determined using the ImageJ
software (National Institutes of Health, Bethesda, MD, USA).

2.6.4 Western transfer
Following PAGE, gels were equilibrated in cold western transfer buffer (Appendix A) at 4°C for
20 min. Transfer was performed using the Mini Trans-Blot Module (Bio-Rad) in the MiniPROTEAN Tetra Cell (Bio-Rad). Immun-Blot (PVDF) Membrane (Bio-Rad) was cut to the
equivalent gel size and activated in methanol (RCI Labscan, Bangkok, Thailand) for 5 min. Foam
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pads (Bio-Rad) and blot filter paper (Bio-Rad) were pre-soaked in cold western transfer buffer.
The transfer cassette was constructed as per the manufacturer’s instructions, inserted into the
Mini Trans-Blot module then placed in the Mini-PROTEAN Tetra Cell. The Mini-PROTEAN Tetra
Cell was filled with cold western transfer buffer as dictated by the manufacturer. Proteins were
transferred to the PVDF membrane by applying 100 V for 1 h at 4°C with an MP-3AP power supply
(Major Science, Saratoga, CA, USA).

2.6.5 Immunoblotting and antibodies
Following transfer, PVDF membranes were briefly washed in Tris-buffered saline containing
0.1% (v/v) tween 20 (TBST, Appendix A). PVDF membranes were blocked for 1 h at RT with
gentle agitation to reduce non-specific antibody binding, using BSA or skim milk powder (SMP,
Oxoid, Basingstoke, United Kingdom) in TBST, as specified in Table 2.3. Blocking buffer was
removed and PVDF membrane was incubated in primary antibody (Table 2.3) overnight at 4°C
with gentle agitation. The membrane was then removed and washed once in TBST for 10 min,
then twice for 5 min, using gentle agitation. The corresponding horseradish peroxidase (HRP)conjugated secondary antibody was then applied (Table 2.3), and membranes incubated for 1 h
at RT with gentle agitation. The membranes were then removed and washed once in TBST for
10 min, then twice for 5 min using gentle agitation. Antibody detection was performed via
chemiluminescence using the Clarity or Clarity Max Western ECL Blotting Substrates (Bio-Rad)
and imaged (Amersham AI600, GE Healthcare, Chicago, IL, USA). Visible protein bands were
quantified using the ImageJ software (National Institutes of Health), and area under the peak was
normalised over total lane protein.
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Table 2.3: Antibodies and blocking buffers used for immunoblot analysis of neutrophil lysates.
Antibody

Company

Product # /Clone

Dilution 1

Blocking
buffer

Primary
Rabbit anti-human caspase-1 pAb

CST

2225/-

1:2000

5% SMP

Rabbit anti-human caspase-3 pAb

CST

9662/-

1:2000

5% SMP

Rabbit anti-human caspase-4 pAb

CST

4450/-

1:1000

5% BSA

Rabbit anti-human caspase-8

CST

4790/D35G2

1:1000

5% BSA

Rabbit anti-human GSDMD pAb

Sigma-Aldrich

G7422/-

1:500

5% SMP

Mouse anti-human β-actin mAb

CST

3700/8H10D10

1:1000

5% SMP

Rabbit anti-human GAPDH mAb

Abcam

ab181602/ERP16891

1:10,000

1% BSA

Secondary
Goat anti-mouse IgG HRP pAb

Abcam

ab97023/-

1:20,000

5% SMP

Goat anti-rabbit IgG HRP pAb

Invitrogen

65-6120

1:5000

5% SMP

mAb

1 Dilution

dictates antibody: buffer ratio.
Abbreviations: BSA, bovine serum albumin; CST, Cell Signalling Technologies, Danvers, MA, USA; GSDMD,
gasdermin D; HRP, horseradish peroxidase; IgG, immunoglobulin G; mAb, monoclonal antibody; pAb,
Polyclonal antibody; SMP, skim milk powder.

2.7 In vitro infection of neutrophils with GAS
For all experiments freshly isolated neutrophils were washed by centrifugation (350 x g for 10
min at RT) in a swing bucket rotor prior to resuspension, unless otherwise stated. Temperature
change was limited and buffers were equilibrated to RT unless otherwise stated. Prior to infection
of neutrophils with GAS, strains were routinely serially diluted and plated on THY agar to ensure
the correct bacterial load for the desired MOI (Appendix B).

2.7.1 GAS survival and proliferation
Human neutrophils were seeded into flat-bottom 96-well plates (2 x 105 cells/well) and infected
with GAS at MOI 1:10. Alternatively, human neutrophils were first lysed via three freeze (-160°C)thaw (37°C) cycles, using liquid N2, and an equivalent amount of lysate infected as above. Plates
were incubated at 37°C in 5% CO2 for the indicated times. To block phagocytosis through actin
polymerisation, neutrophils were preincubated with 10 μM cytochalasin D (Cayman Chemicals,
Ann Arbor, MI, USA) in complete medium at 37°C for 30 min prior to infection. At indicated time
points neutrophils were hypotonically lysed with deionised water and surviving bacteria serially
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diluted before plating on THY agar. ‘Gas survival (%)’ was determined as a percentage of bacteria
growth in the absence of neutrophils using the following formula:

!"# %&'()(*+ (%) =

!"# 012/45 )6 7ℎ9 :'9%96;9 <= 69&7'<:ℎ)+% 100
?
!"# 012/45 )6 7ℎ9 *>%96;9 <= 69&7'<:ℎ)+%
1

2.7.2 GAS internalisation (gentamicin protection assay)
Human neutrophils were seeded into flat-bottom 96-well plates (2 x 105 cells/well) and infected
with GAS at MOI 50:1. Following incubation at 37°C for 30 min medium was removed from all
wells. Wells to determined associated GAS were washed thrice with complete medium before
serial dilution and plating on THY agar, while wells to determine internalised GAS were incubated
in medium containing 200 µg/mL gentamicin at 37°C for 60 min. Cells were then washed thrice
with complete medium before serial dilution and plating on THY agar. ‘Internalised GAS (%)’ was
determined as a percentage of total associated bacteria using the following formula:

B679'6*+)%9C !"# (%) =

B679'6*+)%9C !"# 012/45 100
?
"%%<;)*79C !"# 012/45
1

2.7.3 GAS phagocytosis
To assess phagocytosis of GAS, human neutrophils were seeded into flat-bottom 24-well plates
(5 x 105 cells/well) and infected with GAS expressing GFP at MOI 10:1. Cells were removed and
washed twice with 10% (v/v) heat-inactivated foetal bovine serum (FBS, Bovogen Biologicals,
Keilor East, Australia) diluted in PBS. Data was acquired by assessment of neutrophil GFP
fluorescence using an LSR II flow cytometer (BD, ex488 nm em525/50nm).

2.7.4 Reactive oxygen species production
The production of ROS in response to GAS was assessed using an established method (Kobayashi
et al., 2003a). Prior to infection, human neutrophils were incubated in complete medium
containing 25 μM 2’,7’-dichlorodihydrofluorescein diacetate (DCF, Molecular Probes, Eugene, OR,
USA) for 45 min at RT. Neutrophils were then seeded in 96-well plates (5 x 105 cells/well) and
infected with GAS at MOI 10:1. ROS production was measured fluorometrically (ex485 nm em520
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nm) every 60 s over 200 min at 37°C using a POLARstar Omega plate reader and a gain of 800.
Fluorescence was reported as change in fluorescence (∆RFU).

2.7.5 Immunoblotting
For assays where downstream immunoblot analysis was required to investigate cell death
markers, human neutrophils were seeded into flat-bottom 6-well plates (1.32 x 106 cells/well)
and infected with GAS at MOI 10:1. Plates were incubated at 37°C in 5% CO2 for the indicated
times. Following incubation each well was gently aspirated into a separate 15 mL tube and
methods were performed as previously outlined (Chapter 2.4).

2.7.6 Annexin-V/viability staining
To

assess

cell

viability,

human

neutrophils

were

seeded

into

24-well

plates

(5 x 105 cells/well) and infected with GAS at MOI 10:1. Plates were incubated at 37°C in 5% CO2
for the indicated times. Neutrophils were removed and washed with annexin-V assay buffer
(Appendix A) then incubated with Zombie Aqua Fixable Viability Kit (BioLegend) for 15 min at
RT. Cells were washed again once with annexin-V assay buffer, then once more with 10% (v/v)
FBS in annexin-V assay buffer and stained with fluorescein isothiocyanate (FITC)-conjugated
annexin-V (BioLegend) for 15 min at RT. Cells were analysed immediately using an LSR Fortessa
X-20 flow cytometer where fluorescence of Zombie Aqua (ex405 nm em525/50nm) and FITC (ex488
nm em525/50nm) were determined.

2.7.7 FAM-FLICA inflammatory caspase activation
To assess the activation of inflammatory caspases-1/-4/-5, human neutrophils were seeded into
24-well plates (5 x 105 cells/well) and infected with GAS at MOI 10:1. Plates were incubated at
37°C in 5% CO2 for the indicated times. Caspase-1 activation was measured using FAM-FLICA
Caspase-1 assay kit (ImmunoChemistry Technologies, Bloomington, MN, USA) as per the
manufacturer’s recommendations. Neutrophils, in the absence or presence of GAS, were removed
from culture at indicated times and washed with PBS. Cells were resuspended in serum-free
medium (RPMI-1640) containing 1 x FAM-YVAD-FMK for 60 min at 37°C, mixing intermittently.
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Cells were washed twice in 10% (v/v) FBS in PBS, then analysed for caspase activation with an
LSR Fortessa X-20 flow cytometer (ex488 nm em525/50nm).

2.7.8 Cytometric cytokine bead assay
The release of cytokines by neutrophils during GAS infection was assessed using a cytometric
bead assay and flow cytometry. Human neutrophils were seeded into flat-bottom 96-well plates
(8 x 105 cells/well) and infected with GAS at MOI 10:1. Plates were incubated at 37°C in 5% CO2
for the indicated times. Plates were centrifuged (350 x g for 5 min) and supernatant removed
then snap frozen in liquid N2 and stored at -80°C for a period no longer than 5 days. The
LEGENDplex™ 13-plex human inflammation panel bead-based immunoassay (interleukin-1β,
type I interferon-α2, type I interferon-γ, tumour necrosis factor-α, monocyte chemoattractant
protein-1, interleukin-6, interleukin-8, interleukin-10, interleukin-12p70, interleukin-17A,
interleukin-18, interleukin-23 and interleukin-33, BioLegend) was used as per manufacturer’s
instructions to screen for cytokines of interest. In brief, samples and standards were transferred
to a v-bottom 96-well polyethylene plate and incubated with beads and detection antibodies for
120 min at room temperature, with shaking (600 rpm) protected from light. R-phycoerythrin
(PE)-conjugated streptavidin was then added and incubated for a further 30 min at RT, with
shaking (600 rpm) protected from light. Beads were washed twice with LEGENDplex™ wash
buffer and data collected using an LSR Fortessa X-20 flow cytometer. Beads were initially gated
upon FSC-A and SSC-A (A and B populations). Cytokine-specific beads have a signature
allophycocyanin (APC, ex640nm em670/30nm) fluorescence, with quantitative expression of each
determined by the amount PE (ex561 nm em586/15nm) fluorescence, due to antibody binding, in
comparison to a set of cytokine standards. Data were analysed using the LEGENDplex™ software
V8.0 (VigeneTech Inc., Carlisle, MA, USA) to produce standard curves and interpolate samples
(Appendix D). The LEGENDplex™ 13-plex human inflammation panel was used for initial
experiments to screen for cytokines of interest (Appendix E), however repeat experiments were
performed with a reduced custom panel consisting of only beads and antibodies for IL-1β, TNFα, IL-8 and IL-18. Where some values were below the assay threshold, they were plotted as half
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the minimum detection limit. Where some values were above the assay threshold, were plotted
as the maximum detection limit.

2.7.9 Cluster of differentiation expression
Cell-surface CD expression was assessed during GAS infection. Human neutrophils were seeded
into 24-well plates (5 x 105 cells/well) and infected with GAS at MOI 10:1. Plates were incubated
at 37°C in 5% CO2 for the indicated times. Following, cells were removed and washed with PBS,
then routinely incubated with Zombie Aqua or NIR Fixable Viability Kits for 15 min at RT. Cells
were again washed in PBS, followed by washing with 10% (v/v) FBS in PBS. Neutrophils were
stained with fluorochrome-conjugated antibodies (Table 2.3) according to titrated volumes
(Appendix F) for 15 min at RT protected from the light. Neutrophils were washed with 10% (v/v)
FBS in PBS then analysed using an LSR Fortessa X-20 flow cytometer.
Table 2.4: Fluorochrome conjugated antibodies and fluorescent dyes used for human in vitro
experiments in this thesis.
Antibody/Dye
FITC anti-human CD11b

Company
BioLegend

Product #/Clone
301330/ICRF44

Volume per test (μL)
2

FITC anti-human CD16

BioLegend

556618/3G8

2

PE/Cy7 anti-human CD31

BioLegend

303118/WM59

1

PE anti-human CD47

BioLegend

323108/CC2C6

2

PE anti-human CD64

BioLegend

305008/10.1

3

PerCP/Cy5.5 anti-human CD66b

BioLegend

305108/G10F5

2

PerCP/Cy5.5 anti-human CD66b*

BD

562254/G10F5

3

Zombie NIR

BioLegend

423105/-

1

Zombie Aqua

BioLegend

423102/-

1

* Antibody was not titrated.
Abbreviations: CD, cluster of differentiation; Cy, Cyanine; FITC, fluorescein isothiocyanate; NIR, near
infrared; PE, r-phycoerythrin; PerCP, peridinin chlorophyll protein.

2.7.10 Data visualisation and statistical methods
All data were analysed using Prism 6.0 (GraphPad Software Inc., San Diego, CA, USA) or IBM SPSS
Statistics 25 (IBM® Corporation) and visualised using Prism 6 (GraphPad Software Inc.). Flow
cytometry data were analysed and presented using FlowJo software V10.6.1 (TreeStar Inc.).
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Cytokine release was analysed using the LEGENDplex™ software V8.0 (VigeneTech Inc.).
Densitometry was calculated using the ImageJ software (National Institutes of Health). Statistical
methods are outlined in each chapter.
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3 Optimisation of methods for isolation of intracellular
proteins in human neutrophils
3.1 Introduction
Neutrophils can be difficult target cells for research as they have a limited life span once in
circulation (Miyoshi-Akiyama et al., 2005), though the exact kinetics of the neutrophil life cycle is
still contentiously debated (Hidalgo et al., 2019). Some research indicates circulating life spans of
7-9 hours (Dancey et al., 1976), while others report life spans up to 5.4 days (Pillay et al., 2010).
Modelling experiments, however, place the real value somewhere in between (Lahoz-Beneytez et
al., 2016). Following isolation from blood, neutrophils must generally be used within a matter of
hours, limiting the techniques and investigations that can be performed with them.
Consequentially, neutrophils have not been as popular to use in research compared to other cell
types that are easier to use in vitro. Although neutrophils are the most abundant white blood cell
and have essential roles in immunity, reviews outline that compared to other cells, little is known
about neutrophil function (Bardoel et al., 2014).
The immortalised cell-lines HL-60, PLB-985, THP-1 and NB4 are commonly used to model human
neutrophils (Rennoll-Bankert et al., 2014, Rincón et al., 2018, Santos-Beneit and Mollinedo,
2000). Such cell lines can be useful as they are convenient and have extended life spans (Sheppard
et al., 2005). It is known however that immortalised cell-lines can vary from the original tissue or
provide false positives, as they are malignant in nature. In comparison, primary cells have higher
heterogeneity due to donor variation, though the functional capacity is more representative of
what is expected in vivo. Neutrophils have been compared to HL-60 and NB4 cells previously for
caspase-expression, where after 4 days of differentiation with dimethyl sulfoxide (DMSO), HL-60
cells have a similar profile to human neutrophils, though they do differ in the expression of the
apoptotic Bcl-2 related genes bax and bcl-xL (Santos-Beneit and Mollinedo, 2000). Following an
optimised differentiation protocol using DMSO, it has been verified through gene expression that
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both HL-60 and PLB-985 cells are phenotypically similar to human neutrophils and may be useful
for studies of chemotaxis, phagocytosis and oxidative burst (Rincón et al., 2018). In models of
bacterial infection however, HL-60 cells have been shown to have limited use and have reduced
antimicrobial activity, production of reactive oxygen species (ROS) and release of neutrophil
extracellular traps (NETs) in response to gram positive pathogen Staphylococcus aureus when
compared to primary human blood neutrophils (Yaseen et al., 2017). HL-60 cells lack specific
granules unlike neutrophils (Sheppard et al., 2005), which could reduce intraphagosomal
oxidative activity. Similarly, with Streptococcus pyogenes (Group A Streptococcus, Group A
Streptococci, GAS), bacterial internalisation and killing is reduced when comparing HL-60 cells to
primary human neutrophils, attributed to the reliance upon only azurophilic granules for
‘neutrophil’-mediated defences in HL-60 cells (Nordenfelt et al., 2009). Hence HL-60 cells may
not truly represent the phagocytic ability of primary human neutrophils.
The sensitive nature of neutrophils is well known, and when isolating to assess functions, such as
bacterial killing, certain considerations must be made. Maintaining physiological pH and room
temperature (RT), while using pyrogen-free labware with gentle handling are all techniques that
can maintain functional capacity of neutrophils during isolation (Kuhns et al., 2015). Additionally,
the use of buffers that are nominally free of Ca2+ and Mg2+ during isolation can prevent unwanted
activation as neutrophils require both these ions to be primed for activation (Oh et al., 2008).
Ignorance of these factors or treatment of neutrophils like immortalised cells can result in
premature activation, decreasing functional capacity and causing cell coagulation. Protocols for
the isolation of neutrophils for functional use are widely available and effective (Kuhns et al.,
2015, Oh et al., 2008), however upon the initiation of this project limited appropriate protocols
were available to allow investigation of markers of neutrophil cell death by immunoblotting.
The use of normalisation methods such as housekeeping proteins or total protein is essential for
immunoblot reproducibility and to allow comparison between experiments. Three common
housekeeping proteins used for normalisation of whole cell lysates are α-tubulin, β-actin and
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glyceraldehyde 3-phospahte dehydrogenase (GAPDH). Normalisation accounts for small
variations that may occur between samples or lanes and allows for semi-quantitative analysis of
immunoblot data. Housekeeping proteins are selected based upon their constitutive expression
and must be unaffected by experimental conditions. If this method is to be used, a linear
relationship must be demonstrated between the signal intensity and volume loaded for every
antigen, considering the linear range of this relationship can be limited by the chosen technique
(such as x-ray film radiography) (Fosang and Colbran, 2015). Alternatively, a large body of
evidence suggests that the use of total protein (such as through stain-free gels) as a normalisation
method is far more reliable than using housekeeping proteins, typically with an improved linear
relationship between protein concentration and detection (Aldridge et al., 2008, Colella et al.,
2012, Gilda and Gomes, 2013, Goasdoue et al., 2016).
Cell death is often investigated through screening for the activation or cleavage of caspases
(Shalini et al., 2015). Caspases are intracellular proteolytic enzymes, best known for their ability
to control cell death (Man and Kanneganti, 2016). When investigating death pathways,
neutrophils must be lysed to expose internal caspases. Granules stored in neutrophils contain
many enzymes, some of which have proteolytic activity that can induce inflammatory cell death
(Kambara et al., 2018), but can also damage proteins in tissue (Epstein and Weiss, 1989). Thus,
during lysis there is a risk of caspase-cleavage or sample degradation. Published methods to
prevent granular sample damage use a pre-incubation step in the toxic substance diisopropyl
flurophosphate (Quinn et al., 2007), which subsequently hinders further neutrophil functionality.
Therefore, this chapter aims to optimise a neutrophil lysis protocol that maximises detection of
intracellular proteins over a time course, while also determining the most appropriate
immunoblot normalisation technique for neutrophils, to provide quantitative analyses.

J.G.W

78

Optimisation of methods for isolation of intracellular proteins in human neutrophils

3.2 Materials and methods
3.2.1 Neutrophil lysis and cell wash buffer recipes
Human neutrophil preparation from healthy donors, handling, incubations and protein
determination using the DC Protein Assay (Bio-Rad, Hercules, CA, USA) were performed as
previously stated (Chapter 2.5-2.6.2), with substitutes for cell lysis buffers and cell wash buffers
listed (Table 3.1).

3.2.2 Physical lysis of neutrophils
When required, neutrophils were sonicated with a 250-Digital Sonifier (Branson, Danbury, CT,
USA) in lysis buffer on ice. A power of 30% was applied for 10 s, followed by 10 s rest, and
repeated two more times for a total time of 60 s. In some experiments, samples were quickly
sheared three times through a 25 G needle and 1 mL syringe, onto the wall of a 1.5 mL tube.
Protein concentration was determined in samples as previously stated (Chapter 2.6.2).

3.2.3 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
Proteins were routinely separated using sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) using the Mini-PROTEAN Cell System (Bio-Rad). For all experiments
10-well 12% (v/v) acrylamide resolving gels were cast with 4% (v/v) acrylamide stacking gels
for sample loading, using the Mini-PROTEAN Tetra Cell Casting System (Bio-Rad). Samples were
prepared with 5 x loading buffer (containing 5% (v/v) 2-mercaptoethanol) and heated at 95°C
for 5 min, allowed to cool briefly, then loaded into the gel. Protein size was estimated on gels by
comparison to the Precision Plus Protein Dual Colour Standards (Bio-Rad). Samples were
separated by applying 100 V for 10 min, followed by 180 V for 50 min using a PowerPac 300
Supply Unit (Bio-Rad), in PAGE running buffer (Appendix A). Protein bands were visualised by
staining in Coomassie Brilliant Blue rapid stain (Appendix A) with gentle agitation overnight.
Excess dye was removed by washing the gel in destain solution (Appendix A) with gentle
agitation, where the solution was frequently replaced until background staining was removed.

UOW

79

Characterising the neutrophil response to Group A Streptococcus
Gels were imaged using an AI600 Gel and Blot Imager (Cytiva Life Sciences, Marlborough, MA,
USA).
Table 3.1: Neutrophil lysis buffers and cell wash recipes.
Reagent
Nonidet P-40 (%)

NP-40
1.0

RIPA 1
-

Final concentration b
RIPA 2
RIPA 3
PBSI 1
-

Triton X-100 (%)

-

1.0

1.0

1.0

-

-

NaCl (mM)

150

150

150

150

-

-

Tris pH 8.0 (mM)

50

50

50

50

-

-

DOC 10% (%)

-

0.5

0.5

0.5

-

-

SDS 10% (%)

-

0.1

0.1

1.0

-

-

EDTA pH 8.0 (mM)

-

5

5

5

-

-

cOmplete PI tablet

1x

1x

2x

2x

1x

2x

PMSF (mM)

1

1

1

1

-

1

NaF (mM)

5

5

10

10

-

2

BGP (mM)

-

-

10

10

-

5

Na2MoO4 (mM)

-

-

10

10

-

5

Na4P2O7 (mM)

-

-

10

10

-

5

H2O to volume

✓

✓

✓

✓

-

-

PBS to volume

-

-

-

-

✓

✓

a

PBSI 2
-

Suppliers outlined in Chapter 2.6.1.
Percentages represent v/v.
Abbreviations: BGP, β-glycerophosphate; DOC, sodium deoxycholate; EDTA, ethylenediaminetetraacetic
acid; NP-40, nonidet P-40 lysis buffer; PBS, phosphate buffered saline; PBSI, phosphate buffered saline with
inhibitors; PI, protease inhibitor; PMSF, phenylmethylsulfonyl fluoride; RIPA, radioimmunoprecipitation
assay buffer; SDS, sodium dodecyl sulphate.
a

b

3.2.4 Flow cytometry
Data collection was performed using an LSR II (BD) flow cytometer with excitation laser blue (488
nm) and an LSR Fortessa X-20 (BD) with excitation laser blue (488 nm). Bandpass filter for
peridinin-chlorophyll-protein (PerCP)-Cyanine (Cy)5.5 (695/40) was used. Data were analysed
and presented using FlowJo software V10.6.1 (TreeStar Inc.). Compensation was not performed
for this chapter.
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3.2.5 Statistical analyses
Data were analysed and visualised using Prism 6 (GraphPad Software Inc.). Two-way ANOVA was
used to determine significant differences and adjusted using Tukey HSD corrections. Where an
effect was determined, significance of the post-hoc analysis was represented as *p<0.05;
**p<0.01; ***p<0.001; ****p<0.0001. Flow cytometry data were analysed and presented using
FlowJo software V10.6.1 (TreeStar Inc.). Densitometry was calculated and visualised using the
ImageJ software (National Institutes of Health).
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3.3 Results
3.3.1 Polymorphprep allows high purity neutrophil isolation
Methods of human neutrophil isolation from blood using density gradient medium
polymorphprep have been demonstrated to yield high neutrophil numbers and low levels of
contamination with other leukocytes (Thomas et al., 2015). Following isolation, the purity of the
cell population was screened using granulocyte marker CD66b and flow cytometry (Figure 3.1).
Cells selected as neutrophils from forward scatter-area (FSC-A) vs side scatter-area (SSC-A) plots
were routinely >95% pure, where this population was regularly >97% CD66b+ (Figure 3.1C).
Hence, the method of polymorphprep isolation was deemed appropriate for further
investigations requiring pure neutrophil populations.

A

C

B

Antibody stained
Unstained

Counts

Singlets

SSC-A

FSC-H

97.5
98.6

CD66b

+

Neutrophils

FSC-A

FSC-A

PerCP/Cy5.5 fluorescence

Figure 3.1: Neutrophil isolation with polymorphprep yields high purity of cells positive for CD66b.
Human neutrophils were purified using gradient centrifugation medium polymorphprep and purity was
determined using CD66b-PerCP/Cy5.5 and flow cytometry. Flow cytometry events were gated for (A)
singlets and then (B) neutrophils before being assessed for (C) PerCP/Cy5.5 fluorescence. (A-C) Flow
cytometry plots are representative of routine checks performed following isolation, where neutrophil
CD66b expression was routinely >97%. Result shown are representative of 6 individual donors.

3.3.2 Neutrophil lysis may degrade intracellular proteins
It is well appreciated in the field that neutrophils have high protease activity, and hence during
cell lysis for immunoblotting, steps must be taken to avoid sample degradation. Thus, with
immunoblot targets of interest and extended neutrophil incubations in mind, sample degradation
was assessed by comparing neutrophil lysates to the expected results for immortalised cell lines.
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Using a rabbit anti-human caspase-1 antibody, the exemplar immunoblot images provided by Cell
Signalling Technologies of THP-1 and HL-60 cell lysates (Cell Signalling Technologies, 2020) were
compared to immunoblot results for neutrophil lysates using two donors incubated for 60 and
180 min (Figure 3.2). In THP-1 and HL-60 cell lysates, multiple protein bands are detected when
probed for caspase-1, including full length (50 kDa), p46, p33 and p20 caspase-1 (Figure 3.1A).
In contrast, screening of neutrophil lysates resulted in limited detection of protein bands
corresponding to caspase-1 for both donors (Figure 3.1B). Given neutrophils are reported to
display constitutively high caspase-1 expression (Santos-Beneit and Mollinedo, 2000), reduced
detection of caspase-1 bands in neutrophil lysates may indicate protein sample degradation.
Hence optimisation of the lysis conditions, where sample degradation may be occurring, were
undertaken.

3.3.3 Selection of lysis buffer
To determine if an alternate lysis buffer was able to better preserve proteins in neutrophil lysates,
two

commonly

used

non-ionic

detergent

based

buffers

were

compared,

radioimmunoprecipitation assay (RIPA) buffer and nonidet P-40 (NP-40) buffer. Additionally,
sonication, a physical disruption method, was sometimes used as indicated to assist cell lysis.
Human neutrophils were lysed with NP-40 buffer, RIPA buffer 1, or RIPA buffer 1 and sonication
and the protein concentration determined using the DC Protein Assay. Protein concentrations in
NP-40 lysates were not determined due to readings being below the detection limit of the DC
Protein Assay (Table 3.2). RIPA lysates that underwent sonication yield a greater protein
concentration than those in RIPA alone (Table 3.2).
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A

B

PMN

THP-1 HL-60
kDa

Caspase-1

Time (min)

Donor 1

Donor 2

60

60

180

180

kDa
50 50 -

-50 kDa
-p46

40 -

Caspase-1
-50 kDa
-p46

37 -p33

30 -

-p33
25 -

20 -

-p20

20 -

-p20

Figure 3.2: Sample degradation occurs during the preparation of neutrophil cell lysates. (A) THP-1
and HL-60 cell lysates were prepared and caspase-1 assessed by immunoblot, with the image provided by
Cell Signalling Technologies on their website (Cell Signalling Technologies, 2020). (B) Human neutrophil
(PMN) lysates were prepared in RIPA buffer 1 (Table 3.1) following 60 and 180 min incubations and
caspase-1 assessed by immunoblot. Sample protein concentration was determined using the DC Protein
Assay (Bio-Rad) and equal amounts were loaded in each lane. A molecular weight marker was used to
determine approximate protein band size (kDa) and are indicated on the left-hand side of images. Results
are representative of one experiment.

Next, the above lysates were separated by SDS-PAGE and proteins were visualised with rapid
stain. Notably, proteins were visible in all three lysates, with fewer proteins present in the RIPA
1 and sonication lysate compared to the RIPA 1 lysate (Figure 3.3A). Prominent protein bands
could be seen in the sonicated RIPA 1 lysate below 15 kDa, indicative of protein degradation
(Figure 3.3A). Densitometry was performed on the gel images, and although protein
concentration was highest for the RIPA 1 and sonication sample, this sample showed signs of
degradation and had the lowest diversity and abundance of proteins when compared to both the
NP-40 and RIPA 1 lysates (Figure 3.3B). The abundance and intensity of protein bands was similar
for the NP-40 lysate and RIPA 1 lysate (Figure 3.3B). Due to the compatibility of RIPA buffer with
the DC Protein Assay, it was selected over NP-40 buffer for further experiments. Additionally,
sonication was excluded in further experiments due to sample degradation.
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Table 3.2: Protein concentration of neutrophil lysates separated via SDS-PAGE.
Lysis Method

Figure (Lane) a

Protein Concentration
(µg/mL) b

Amount
(µg)

Relative amount
(µg/1 x 106 PMNs)

NP-40

3.3 (1)

ND

ND

ND

RIPA 1

3.3 (2)

271

271

27

RIPA 1 and SON

3.3 (3)

575

575

58

RIPA 1

3.4 (1)

3374

675

67

RIPA 1 and SS

3.4 (2)

3142

628

63

RIPA 2

3.4 (3)

2256

451

45

RIPA 2 and SS

3.4 (4)

2368

474

47

RIPA 3 and SS

3.4 (5)

3496

699

70

RIPA 2 and PBSI 1

3.5 (1)

2571

514

43

RIPA 2 and PBSI 2

3.5 (2)

2694

539

45

Corresponding figure and lane are referenced and are representative of one experiment.
Protein concentration was determined in neutrophil (PMN) lysates using the DC Protein Assay by
comparison to standards made with bovine serum albumin.
Abbreviations: ND, not determined; NP-40, nonidet P-40 lysis buffer; PBSI, phosphate buffered saline with
inhibitors; PMN, neutrophil; RIPA, radioimmunoprecipitation assay buffer; SON, sonication; SS, sheer
stress.
a

b

3.3.4 Optimisation of RIPA buffer conditions for neutrophil lysis
Following the selection of RIPA buffer for cell lysis, it was explored if sheer stress would increase
protein yield or if increased concentrations of protease and phosphatase inhibitors (inhibitors)
and SDS would assist protein preservation. Neutrophil lysates were prepared with RIPA buffer 1,
RIPA buffer 2 (containing increased protease and phosphatase inhibitor concentrations) or RIPA
buffer 3 (containing increased protease and phosphatase inhibitor and SDS concentrations), in
the absence or presence of sheer stress. Protein concentration, determined with the DC Protein
Assay, revealed increased protein concentrations in lysates prepared with RIPA buffers 1 and 3
compared to RIPA buffer 2 (Table 3.2). Neutrophil lysates that were prepared with sheer stress
did not greatly differ in concentration from samples that were prepared without this step (Table
3.2).
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A

NP-40

+

-

-

RIPA

-

1

1

-

-

+

Sonication

B

kDa

NP-40

250 150 100 75 -

50 -

RIPA 1

37 -

25 RIPA 1 and sonication

20 -

250 kDa

-

-

15 10 kDa

Figure 3.3: Comparison of neutrophil lysis using detergent-based buffers and sonication by SDSPAGE. (A) Neutrophil lysates were prepared by lysing cells with NP-40 buffer, RIPA buffer 1, or RIPA buffer
1 and sonication. Protein concentration was determined via the DC Protein Assay and lanes were equally
loaded before separation by SDS-PAGE, then proteins visualised with rapid stain and imaging. Visual
corrections were made for presentation. (B) Densitometric histograms of SDS-PAGE lanes display
quantitative diversity and abundance of proteins as area under the curve. (A-B) Images are representative
of triplicate results.

The above neutrophil lysates were then separated by SDS-PAGE and proteins were visualised
with rapid stain. Protein was detected in all samples, however the most prominent protein bands
were evident in lysates prepared with RIPA buffer 2 compared to lysates prepared with RIPA
buffers 1 and 3 (Figure 3.4A). The effect of sheer stress on protein bands was evident only for
RIPA buffer 2, where sheering stress reduced the prominence of protein bands (Figure 3.4A).
Densitometry was performed on the gel images, where similarly the abundance and diversity of
protein was greatest for samples prepared in RIPA buffer 2 compared to RIPA buffers 1 and 3
(Figure 3.4B). The greatest protein degradation was observed in the lysate prepared in RIPA
buffer 3 with sheer stress (Figure 3.4B). The greatest protein preservation was observed for the
lysate prepared in RIPA buffer 2 without sheer stress (Figure 3.4B). Collectively these data
suggest that increasing SDS concentrations in the lysis buffer and methods of sheering stress may
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increase measurements of total protein but cause degradation. Protein in neutrophil lysates can
be preserved by using RIPA buffer with increased inhibitor concentrations (RIPA buffer 2) and
limited physical disruption.

A

B
RIPA

1

1

2

2

3

Sheering

-

+

-

+

+

RIPA 1

kDa
250 150 RIPA 1 and SS

100 -

75 -

50 37 -

RIPA 2

25 20 RIPA 2 and SS
15 -

250 kDa

-

-

RIPA 3 and SS

10 kDa

Figure 3.4: Optimisation of RIPA buffer lysis using sheer stress, increased protease and phosphatase
inhibitors and increased SDS. (A) Neutrophil lysates were prepared with RIPA buffer 1, RIPA buffer 2
(RIPA with increased inhibitors) or RIPA buffer 3 (RIPA with increased inhibitors and increased SDS) in
the absence or presence of sheer stress (SS). Sample protein concentration was determined via the DC
Protein Assay and lysates were equally loaded then separated via SDS-PAGE. Protein bands were visualised
by staining with rapid stain then imaged. (B) Densitometric histograms of SDS-PAGE lanes display
quantitative diversity and abundance of proteins as area under the curve. (A-B) Images are representative
of duplicate results.

3.3.5 Increased protein preservation through early inhibitor exposure
To further improve protein preservation in neutrophil lysates, increased protease and
phosphatase inhibitor concentrations in the cell wash buffer were explored. Prior to cell lysis with
RIPA, neutrophils were washed with PBSI 1 (containing low protease and phosphatase inhibitor
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concentration) or PBSI 2 (containing increased protease and phosphatase inhibitor
concentration). The protein concentration of neutrophil lysates was unchanged by the choice of
PBSI wash buffer when determined with the DC Protein Assay (Table 3.2 and Figure 3.5A). To
preserve sample volumes and improve lane loading consistency, neutrophil lysates were
separated by SDS-PAGE using Tris Glycine eXtended (TGX) stain-free gels, where total lane
protein was determined with ultraviolet activation and imaging (Figure 3.5B). Protein was
detected in lysates prepared with both PBSI 1 and PBSI 2, however increased protein bands were
evident when neutrophils were washed in PBSI 2, that is, increased inhibitor concentrations
(Figure 3.5B). Densitometry was performed on the gel images, where the abundance and diversity
of protein peaks in lysates was far greater when prepared with PBSI 2 compared to PBSI 1,
demonstrated by increased area under the curve (Figure 3.5C). Collectively these data indicate
that increased inhibitor concentrations in the cell wash buffer preserve a greater amount of
protein in neutrophil lysates. Further experiments utilised these optimisations, washing
neutrophils with PBSI 2 prior to lysis with RIPA buffer 2 to yield the greatest opportunity for
protein detection.

3.3.6 The use of optimised lysis conditions allows for improved caspase-1 detection
The optimised protocol, washing neutrophils with PBSI 2 and lysing with RIPA buffer 2, was
employed to detect caspase-1 in human neutrophils at multiple incubation time points.
Neutrophil lysates were prepared from three donors at 0, 30, 60 and 180 min, with protein
concentration determined using the DC Protein Assay. Lysates were equally loaded and separated
by SDS-PAGE before the amount of caspase-1 was determined by immunoblotting (Figure 3.6).
Multiple protein bands were detected in all samples from all donors when probed for caspase-1,
similar to observations for other cell types (Figure 3.2A), including full length caspase-1 (50 kDa),
caspase-1 p46 and caspase-1 33, though the caspase-1 p20 form was not detected (Figure 3.6). In
neutrophil lysates from all donors the most abundant form of caspase-1 identified was p46,
however all forms reduced in abundance over the 180 min incubation (Figure 3.6). Increased
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abundance of caspase-1 was detected (Figure 3.6) when compared to initial immunoblots (Figure
3.2B), confirming an optimised methodology for protein preservation in neutrophil lysates.
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Figure 3.5: Exposure to protease and phosphatase inhibitors during cell washing preserves protein
in neutrophil lysates. (A) Neutrophils were washed with PBSI 1 or PBSI 2 then lysed with RIPA 2 and
protein concentration determined with the DC Protein Assay. Results are the pooled means ± SD where
n=2. (B) Neutrophil lysates were equally loaded and separated by SDS-PAGE (TGX Stain-Free gels), where
protein bands were visualised by 5 min activation under UV and imaging. (C) Densitometric histograms of
SDS-PAGE lanes display quantitative diversity and abundance of proteins as area under the curve. (B-C)
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3.3.7 Selection of appropriate normalisation method for neutrophil lysate immunoblot
Having established the reliable detection of protein (caspase-1) in neutrophil lysates, an
investigation into the most appropriate immunoblot normalisation technique was undertaken to
allow quantitative analysis. Human neutrophil lysates collected at 0, 30, 60 and 180 min postincubation from six donors were assessed for detectable levels of total protein (Figure 3.7A) and
β-actin and GAPDH by immunoblotting (Figure 3.7B-C). Quantification of the three approaches
was determined by densitometry and represented as a relative value in order to compare
different donors (Figure 3.7D). Relative detection of neutrophil protein using all three techniques
was shown to decrease over 180 min (Figure 3.7D). In comparison to housekeeping proteins, total
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lane protein was found to retain the most consistent relative expression, with the smallest
deviation between donors and all time points (Figures 3.7A and D). The expression of relative βactin, seen as a 42 kDa band, was visually less prominent and significantly reduced at 180 min
when compared to both relative total protein and relative GAPDH (p<0.001, Figure 3.7B and D).
The expression of relative GAPDH, identified as a 37 kDa band, was similar to relative total protein
but displayed larger variation between donors and times than relative total protein (Figure 3.7C
and D). Thus, using the current optimised protocol to prepare neutrophil lysates over 180 min,
total protein appears the most consistent comparison for normalisation of lanes and across
samples.
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Figure 3.6: Caspase-1 detection in neutrophils by immunoblot following optimisation. Neutrophils
(PMNs) were washed with PBSI 2 then lysed with RIPA buffer 2 at 0, 30, 60 and 180 min. Protein
concentration in lysates was determined with the DC Protein Assay then 20 µg of lysates were loaded,
separated by SDS-PAGE and caspase-1 assessed by immunoblot. Three different donors are represented.
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3.4 Discussion
Due to potential issues with sample degradation, the development and optimisation of a protocol
to analyse neutrophil caspase activation during GAS infection was deemed essential to address
the aims of Chapters 4 and 5 in this thesis. A modified RIPA buffer with increased inhibitors (RIPA
2, outlined in Table 3.1) yielded the greatest protein preservation in neutrophil lysates when
assessed by SDS-PAGE and densitometry. Similarly, prior to neutrophil lysis, washing cells in a
PBS buffer containing inhibitors (PBSI 2) further improved protein preservation in lysates.
Physical methods of cell lysis such as sonication and sheer stress did not increase protein
preservation but resulted in increased sample degradation. Applying the optimised protocol, the
immunoblot normalisation techniques using total protein and β-actin and GAPDH by
immunoblotting were compared for neutrophil lysates incubated over 180 min. Total protein
varied least over the time points, with GAPDH by immunoblot being the second most consistent
normalisation method. The expression of β-actin varied greatly in neutrophil lysates, particularly
after 180 min. Collectively, these results facilitated the development of a method that can be used
for confident assessment of neutrophil proteins by immunoblot with the ability to perform
quantitative analysis in subsequent chapters.
Comparison of lysis conditions demonstrated that increased preserved protein was achieved in
neutrophil lysates when increased protease and phosphatase inhibitors were used in RIPA buffer.
The inability to detect protein via the DC Protein Assay in the NP-40 lysed samples could be due
to the threshold of this particular setup of the assay. Though the DC Protein Assay is detergent
compatible, samples still need to be diluted to ensure compatibility, but in doing so this may have
reduced the protein concentration below the sensitivity of the assay. Neutrophil granules contain
multiple serine proteases (neutrophil elastase, cathepsin G and proteinase 3) (Pham, 2006), and
upon cell lysis they may contribute to the sample degradation observed prior to increased
protease inhibitor concentrations. Additionally, it is vital to inactivate serine proteases during the
investigation of neutrophil caspases as neutrophil elastase can induce inflammatory neutrophil
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death through the cleavage of gasdermin D (GSDMD), and may influence planned cell death
investigations (Kambara et al., 2018). In the optimised RIPA buffer, phenylmethylsulfonyl
fluoride (Sigma-Aldrich, 2020b) and cOmplete Protease Inhibitor Cocktail Tablets (SigmaAldrich, 2020a) were added as they have broad spectrum activity to inactivate serine proteases
as well as cysteine proteases. Although the concentration of phenylmethylsulfonyl fluoride was
not changed, the concentration of cOmplete Protease Inhibitor Cocktail Tablets was doubled from
the product recommendation (Sigma-Aldrich, 2020a). Due to product patents however, the
specific chemical composition within each tablet is unknown. Protocols published after the
development of this method also address serine protease activity in neutrophil lysates, adding
neutrophil elastase inhibitor BAY-85-8501 for the investigation of inflammatory neutrophil death
(Sollberger et al., 2018), highlighting again the considerations that must be taking when
preparing neutrophil lysates. Similarly, exposure of neutrophils to increased protease and
phosphatase inhibitors during the cell wash steps increased the preservation of protein in cell
lysates. Although the chemical components of cOmplete Protease Inhibitor Cocktail Tablets are
not disclosed, it can be hypothesised that inhibitor exposure during the wash phase may allow
cell permeation, resulting in control of protease activity prior to neutrophil lysis and thus
protection of proteins at that point in time.
The assessment of normalisation methods for quantification of proteins in neutrophil lysates
revealed that housekeeping proteins β-actin and GAPDH are less reliable and consistent when
compared to total protein. This research agrees with the body of research previously mentioned,
identifying total protein as a superior normalisation technique compared to housekeeping
proteins (Aldridge et al., 2008, Colella et al., 2012, Gilda and Gomes, 2013, Goasdoue et al., 2016).
If total protein is unavailable, the choice of GAPDH over β-actin as a normalisation control for
neutrophils would be recommended, in line with findings from previous research using MDA-MB231 cells (Dittmer and Dittmer, 2006). The use of housekeeping proteins for normalisation is
decreasing, with scientific journals such as The Journal of Biological Chemistry preferencing total
protein for immunoblot normalisation (Fosang and Colbran, 2015). Additional to being a more
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transparent method of normalisation, the use of stain-free gels to measure total protein reduces
the sample volume required and removes the need to use concurrent gels or immunoblots for
housekeeping proteins, removing the risk of inter-experimental error.
Neutrophil purity following isolation from human blood with polymorphprep is high based upon
the results of >95% of cells within FSC-A vs. SSC-A gate and being CD66b+. CD66b is a granulocyte
specific marker (Torsteinsdóttir et al., 1999, Zhao et al., 2004) and combined with distinction of
size and granularity can be an accurate tool to identify neutrophils. Eosinophils also express
CD66b and it should be mentioned that methods using gradient centrifugation such as
polymorphprep result in higher contamination with eosinophils than those that use positive or
negative magnetic bead isolation (Thomas et al., 2015). The trade-off for lower eosinophil
contamination during neutrophil isolations is the higher cost and reduced yield of magnetic bead
isolation (Thomas et al., 2015). For the current application, cost and yield were prioritised.
Circulating eosinophil populations can vary greatly from donor to donor, however additional
methods that also distinguish CD16 expression on CD66b+ cells can be used to assess the
percentage of neutrophils (CD16bright) and eosinophils (CD16dim) (Thomas et al., 2015).
Using a systematic approach, a reliable neutrophil lysis protocol was established using a modified
RIPA buffer and cell wash solution containing increased protease and phosphatase inhibitors to
limit protein degradation in the sample. The development of an optimised neutrophil lysis
protocol now allows for the investigation of intracellular caspases with improved confidence and
reduced risk of sample degradation. Additionally, results outline that the use of total protein for
normalisation is the most appropriate method when undertaking immunoblot investigations of
human neutrophils over time. These findings and methods could be used for future studies
examining neutrophil death, with the possibility that they also may be applicable when
conducting research on the expression of other proteins in human neutrophils.
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4 Characterisation of the neutrophil response to emm98.1
Group A Streptococcus
4.1 Introduction
A large body of research has focused upon emm1 strains of Streptococcus pyogenes (Group A
Streptococcus, Group A Streptococci, GAS), though in demographics with increased risk and
burden of infection emm1 infections are rare (Carapetis et al., 1999) and GAS serotype
distribution is far more diverse with no distinct dominant strains (Hassell et al., 2004, Norton et
al., 2004, Richardson et al., 2010). Emm1 GAS have been shown to have a high propensity to
acquire mutations in covRS (Walker et al., 2007), however non-emm1 isolates have also been
cultured from invasive infections that have naturally occurring mutations in covS including
NS88.2 (emm98.1, invasive; blood, Australia) (McKay et al., 2004) and A20 (emm23, invasive;
blood, Japan) (Okamoto et al., 1966). Both NS88.2 and A20 display resistance to neutrophilmediated killing and have a high propensity to cause invasive disease in vivo (Maamary et al.,
2010). However, it is yet to be elucidated if invasive disease caused by covS mutant strains
induces a common neutrophil phenotype, independent of emm-type.
During severe invasive infection, the fate of neutrophils can influence the extent of the
inflammatory response (Kobayashi et al., 2018). Inflammatory neutrophil death pathways may
be induced in response to infection (Liu and Sun, 2019), where bacterial modulation to the fate
of neutrophils, causing excessive inflammatory death, may negative contribute to disease
progression (Lawrence et al., 2020). Unregulated neutrophil death poses a significantly larger
threat to the host, compared to other cell types, as the release of cytotoxic granular contents can
result in tissue destruction (Epstein and Weiss, 1989). The induction of a lytic form of neutrophil
death has previously been reported in response to emm98.1 GAS strain NS88.2 (Tsatsaronis et
al., 2015), however the neutrophil phenotype was largely uncharacterised.
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Characterisation of the host response to GAS has significant implications in further understanding
the development of invasive infections, as it is evident that during severe invasive disease
inflammation is deregulated (Johansson et al., 2010). Therefore, this body of research aims to
further characterise the neutrophil response to virulent and avirulent GAS in a non-emm1
background. Using an in vitro human neutrophil model, two emm98.1 GAS strains are temporally
described for their effect cell death, signalling and inflammatory profile. Further, we build on
previously established work comparing differences due to covS mutation using emm98.1 GAS
(Maamary et al., 2010). We propose that NS88.2 disrupts processes that promote the resolution
of infection, exacerbating the inflammatory response and decreasing neutrophil antibacterial
function. Investigation of non-emm1 GAS is essential to determine if there is a common neutrophil
phenotype during invasive infection.
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4.2 Materials and methods
4.2.1 Bacterial culture, neutrophil isolation and in vitro infection
Methods for bacterial culture, neutrophil isolation and subsequent techniques performed
during in vitro infection have previous been outlined in Chapter 2.

4.2.2 Flow cytometry
Data collection was performed using an LSR Fortessa X-20 (BD) with excitation lasers; violet (405
nm), blue (488 nm), yellow/green (561 nm) and red (640 nm) and an LSR II (BD) with excitation
laser blue (488 nm). Bandpass filters for Zombie aqua (525/50), fluorescein isothiocyanate
(FITC)/green fluorescent protein (GFP)/FAM FLICA (525/50), peridinin-chlorophyll-protein
(PerCP)-Cyanine (Cy)5.5 (695/40) R-phycoerythrin (PE, 586/15), PE-Cyanine (Cy)7 (780/60)
and allophycocyanin (APC, 670/30) were used. Data were analysed and presented using FlowJo
software V10.6.1 (TreeStar Inc.). Compensation was performed by single staining human
neutrophils at the time of peak CD expression.

4.2.3 Statistical analysis
Graphs were created using Prism 6 (GraphPad Software Inc.) and statistical analyses were
performed using Prism 6 and IBM SPSS Statistics 25 (IBM® corporation). Data were analysed
using repeated measures one-way and two-way ANOVA to determine significant differences and
adjusted using Tukey HSD corrections or as stated otherwise in the figure legend. To account for
the nested nature of the human neutrophil Annexin-V/Zombie and CD data with repeated
measures over time in the same donor, a linear mixed model was used to determine significant
interaction between treatment and time. Post-hoc tests were performed by multiple one-way
ANOVA at each time point where multiple comparisons were adjusted using Tukey HSD
corrections. Values presented for ‘p’ represent interaction (treatment*time) unless otherwise
stated. Where an effect was determined, significance of the post-hoc analysis was represented as
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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4.3 Results
4.3.1 GAS persistence occurs during a dampened neutrophil phagocytic response
Neutrophil-mediated phagocytosis and killing plays a large role in the removal of bacterial
pathogens (Kobayashi et al., 2018). A previous study has shown that the covS mutant NS88.2 is
resistant to neutrophil-mediated killing when compared to functional covS derivative NS88.2rep
(Tsatsaronis et al., 2015). GAS survival in the presence of human neutrophils was monitored over
a 180 min time period, where increased survival of NS88.2 was observed when compared to
NS88.2rep (p<0.05, Figure 4.1A). Further, in the presence of viable human neutrophils NS88.2
showed increased proliferation compared to NS88.2rep (Figure 4.1A). No difference in
proliferation between strains was detected when GAS was cultured with neutrophil lysates
(Figures 4.1B). Finally, pre-incubation of neutrophils with phagocytosis inhibitor cytochalasin D
increased NS88.2rep survival but not NS88.2 survival over 30 min (p<0.01, Figure 4.1C).
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Figure 4.1: NS88.2 resists neutrophil killing and proliferates in the presence of active neutrophils.
GAS strains were incubated in the presence of (A) active human neutrophils (n=8 donors) and (B) lysed
neutrophils (n=4 donors) over 180 min with surviving bacterial concentration determined as percentage
of inoculum. (C) GAS killing by human neutrophils at 30 min following pre-incubation with cytochalasin D
to inhibit phagocytosis (n=4 donors). (A-C) Two-way ANOVA using the Holm-Sá ı́dá k multiple comparison.
Results are the pooled means ± SD of triplicate measurements. *p<0.05, **p<0.01 and ****p<0.0001.

To further investigate the increased survival of NS88.2, GFP GAS variants were used and bacterial
association to neutrophils was assessed by flow cytometry (Figure 4.2A-D). In accordance with
previous findings (Tsatsaronis et al., 2015), NS88.2 has reduced association to human neutrophils
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compared to NS88.2rep over 300 min (p<0.05, Figure 4.2D). Internalisation of NS88.2 by
neutrophils was also reduced compared to NS88.2rep at 30 min (p<0.05, Figure 4.2E). Moreover,
NS88.2rep induced significantly greater neutrophil reactive oxygen species (ROS) production
compared to NS88.2 (Figure 4.2F). The rate of ROS production calculated between 30-60 min was
greater during NS88.2rep infection (2000 ± 540 RFU/min) when compared to uninfected (800 ±
200 RFU/min) and NS88.2 infected neutrophils (1000 ± 450 RFU/min) (p<0.05), where a
decreased ROS production suggests a dampened antibacterial response. Collectively these data
support previous work (Tsatsaronis et al., 2015) suggesting that increased survival of NS88.2 can
be attributed in part, to reduced phagocytic function and ROS production.
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Figure 4.2: NS88.2 is less readily phagocytosed by human neutrophils. Neutrophils (PMNs) were
incubated in the presence of GFP emm98.1 GAS and bacterial association to human cells determined by
flow cytometry. Neutrophils were sequentially gated on (A) singlets then (B) viable neutrophils and (C)
bacterial association determined by fluorescence. Flow cytometry plots are representative and show (A-B)
NS88.2 infected neutrophils at 30 min and the (C) histogram overlay of uninfected (purple), NS88.2 (red)
and NS88.2rep (blue) neutrophils at 30 min from one donor. (D) GAS association to human neutrophils
over 300 min (n=6 donors, Student’s t-test). (E) The internalisation of GAS by neutrophils determined by
gentamicin protection assay (n=5 donors, Student’s t-test). (F) Neutrophil ROS production when incubated
with NS88.2, NS88.2rep or in the absence of GAS. Representative of triplicate measurements from three
separate experiments (n=3 donors), shown as mean change in fluorescence units over time (ΔF.min-1). (DE) Results are the pooled means ± SD of triplicate measurements. *p<0.05, **p<0.01, ***p<0.001 and
****p<0.0001.
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4.3.2 Neutrophil death is delayed in response to NS88.2
Cell death in response to GAS infection has been described (Flaherty et al., 2015, Timmer et al.,
2009), however comparatively fewer studies have focused on neutrophils compared to other cell
types (Kobayashi et al., 2003a, Tsatsaronis et al., 2015). The exposure of phosphatidylserine (PS)
on the cell-surface is a common hallmark of numerous cell death pathways (Nagata et al., 2016).
To investigate GAS-induced neutrophil death, human neutrophils were incubated with
NS88.2rep, NS88.2 or in the absence of GAS and the binding of annexin-V (AV), as a measure of
PS exposure, and the uptake of Zombie Fixable Viability Kit (Z), as a measure of membrane
integrity, was assessed by flow cytometry (Figure 4.3). Cells were assessed over 300 min and
defined as viable (AV-Z-), PS exposed (AV+Z-) or dead (AV+Z+) (Figure 4.3C). Neutrophils incubated
in the absence of GAS remained >80% viable until 180 min (Figure 4.3D), where the percentage
of dead neutrophils and PS exposed cells were relatively unchanged over 300 min (Figure 4.3EF). In contrast, incubation with either NS88.2rep or NS88.2 reduced neutrophil viability, with
significantly reduced viability following NS88.2rep infection compared to NS88.2 infection
(p<0.01, Figure 4.3D). Neutrophil PS exposure (AV+Z-) was increased only during NS88.2rep
incubation at 60 min compared to uninfected neutrophils (Figure 4.3E). Neutrophil death
occurred in response to both strains, though increased neutrophil death was more evident during
NS88.2rep infection when compared to NS88.2 (p<0.05, Figure 4.3F). Results indicate a delayed
and reduced induction of neutrophil death in response to covS mutant NS88.2, compared to
NS88.2rep, suggesting extended neutrophil viability during early infection.
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Figure 4.3: GAS infection induces neutrophil death. Human neutrophils (PMNs) were incubated with
NS88.2, NS88.2rep or in the absence of GAS and stained with annexin V-FITC (AV) and Zombie Aqua
viability dye (Z) before being analysed by flow cytometry. Neutrophils were gated as (A) Singlets and then
total (B) neutrophils (live and dead). Cells were analysed by (C) fluorescence of annexin V-FITC and Zombie
Aqua binding. Flow cytometry plots (A-C) are representative and show uninfected neutrophils during early
indications of apoptosis (300 min). Neutrophils were sampled over 300 min to measure the percentage of
(D) Viable (AV-Z-), (E) PS exposed (AV+Z-), and (F) Dead (AV+Z+), neutrophils during GAS infection. (D-F)
Results are pooled means ± SD (n=3 donors). Linear mixed model ‘p’ values represent interaction
(treatment*time) or are stated. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, with black denoting
significance from control and grey between NS88.2rep and NS88.2.

4.3.3

Caspase-1 and caspase-4 are upregulated in neutrophils in response to emm98.1
GAS

To further explore neutrophil death occurring during GAS infection (Figure 4.3), human
neutrophil lysates were separated via SDS-PAGE and screened for the abundance of active
caspase-3, caspase-8, caspase-1 and caspase-4 via immunoblotting and quantified using
densitometry (Figure 4.4). Caspase-3 and caspase-8 are critical in neutrophil apoptosis (Daigle
and Simon, 2001), whereas caspase-1 and caspase-4 indicate inflammasome activation and can
cleave downstream effectors of pyroptosis (Miao et al., 2010, Sollberger et al., 2012). Uninfected
neutrophils displayed limited caspase-3 cleavage and decreasing amounts of caspase-8 over 180

UOW

101

Characterising the neutrophil response to Group A Streptococcus
min (Figure 4.4A, C, D and E). Infection of neutrophils with NS88.2rep significantly increased
caspase-3 p17 at 180 min (p<0.0001) and amounts of full-length caspase-8 (p<0.01) compared
to uninfected and NS88.2 infected neutrophils (Figure 4.4A, D, E). Uninfected neutrophils
displayed reduced amounts caspase-1 and caspase-4 over 180 min (Figure 4.4B, F-H). Infection
of neutrophils with GAS increased pro-caspase-1 amounts compared to uninfected neutrophils,
however these differences were not statistically significant (Figure 4.4B and F). Increased
amounts of caspase-1 p46 were detected during infection with both GAS strains when compared
to uninfected neutrophils (p<0.0001), where NS88.2rep infection invoked greater amounts of
caspase-1 p46 compared to NS88.2 (p<0.05, Figure 4.4B and G). Increased amounts of full-length
caspase-4 were detected in neutrophils during infection with both GAS strains compared to
uninfected cells (p<0.001), and again, NS88.2rep invoked greater amounts of caspase-4 compared
to NS88.2 (p<0.01, Figure 4.4B and I). Thus, in addition to delayed neutrophil death, neutrophils
infected with NS88.2 show a reduction in the detectable levels of multiple caspases compared to
NS88.2rep.

4.3.4 Neutrophils activate inflammatory caspases in response to GAS
To further explore human neutrophil death, cells were incubated with NS88.2rep, NS88.2 or in
the absence of GAS and inflammatory caspase activation was investigated using a fluorogenic flow
cytometric assay to detect active caspase-1, -4 and -5 (Figure 4.5). Uninfected neutrophils
exhibited decreasing inflammatory caspase activation over time, however a significant
interaction was only determined between treatments, not over time (Figure 4.5D). NS88.2rep
invoked increased inflammatory caspase activation at all time points when compared to
uninfected neutrophils or NS88.2 infected neutrophils (p<0.001, Figure 4.5D). In contrast, NS88.2
infection invoked increased inflammatory caspase activation at 180 min only (p<0.05, Figure
4.5D). Thus, neutrophil death following emm98.1 infection is accompanied by increased
expression of caspase-1 and caspase-4, and inflammatory caspase activation, but this response is
less evident in the presence of covS mutant strain NS88.2.
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Figure 4.4: NS88.2 infection increases abundance of inflammatory caspases and decreases
abundance of apoptotic caspases in neutrophils. Human neutrophil (PMN) lysates were prepared at 30,
60 and 180 min during GAS infection and compared to uninfected neutrophils by immunoblotting for (A)
caspase-3, caspase-8, GAPDH (B) caspase-1 and caspase-4. (A-B) Images shown are from a single donor
and are representative of triplicate experiments using different donors. SE=short exposure, LE=long
exposure. Immunoblot bands were quantified (ImageJ) and normalised against total protein to determine
the amount of (C) full length caspase-3, (D) caspase-3 p17, (E) full length caspase-8, (F) full length caspase1, (G) caspase-1 p46 and (H) full length caspase-4. Results are the pooled means ± SD from 3 separate
donors. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, with black denoting significance to control and
grey between NS88.2rep and NS88.2.
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Figure 4.5: GAS infection activates inflammatory caspases in human neutrophils. Inflammatory
caspase activation during GAS infection was further confirmed in human neutrophils (PMNs) using FLICA
(FAM-YVAD-FMK) and flow cytometry (A-D). Neutrophils were gated as (A) singlets then (B) viable
neutrophils, with (C) inflammatory caspase activation determined by fluorescence. Flow cytometry plots
are representative and show (A-B) uninfected neutrophils at 180 min and an (C) overlay histogram of
unstained (purple), NS88.2 (red) and NS88.2rep (blue) infected neutrophils at 180 min. (D) Inflammatory
caspase activation was determined at 60, 120 and 180 min following GAS infection and compared to
uninfected neutrophils. Results are the pooled means ± SD from 3 separate donors. *p<0.05, **p<0.01,
***p<0.001 and ****p<0.0001.

4.3.5 Neutrophils release IL-1b, TNF-a and IL-8 during infection with GAS
During invasive GAS infection, increased cytokine concentration negatively correlates to disease
severity and patient outcomes (Norrby-Teglund et al., 2000). Specifically, IL-1β and IL-18 release
can occur following caspase-1 activation and are associated with pyroptosis (Man et al., 2017).
Therefore, to investigate the contribution neutrophils play in cytokine production, human
neutrophils were incubated in with NS88.2rep, NS88.2 or in the absence of GAS and supernatants
analysed for cytokines using a flow cytometric bead assay (Figure 4.6). Uninfected neutrophils
released negligible amounts of IL-1b (Figure 4.6C), TNF-a (Figure 4.6D) and IL-18 (Figure 4.6F),
however released increasing amounts of IL-8 over 360 min (Figure 4.6E). In contrast, incubation
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of neutrophils with GAS invoked IL-1b release at 360 min (p<0.0001), with significantly more
IL-1b released in response to NS88.2rep compared to NS88.2 (p<0.0001, Figure 4.6C).
Neutrophils also released TNF-a in response to both GAS strains at 180 and 360 min (p<0.01),
where again significantly more TNF-a was released in response to NS88.2rep compared to
NS88.2 at 360 min (p<0.0001, Figure 4.6D). Increased IL-8 was detected at 60 min in response to
NS88.2rep, when compared to NS88.2 infected or uninfected neutrophils (p<0.05, Figure 4.6E).
Finally, neutrophils released very low amounts of IL-18 in response to NS88.2 infection only
(Figure 4.6F). Collectively, these results indicate the release of inflammatory cytokines IL-1b and
TNF-a in response to GAS infection, with an increased response seen during NS88.2rep infection.
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Figure 4.6: Avirulent and virulent GAS invoke differential cytokine release from neutrophils.
The release of cytokines from neutrophils (PMNs) during GAS infection was measured using the
LEGENDplex™ human inflammation cytometric bead assay and flow cytometry over 360 min. (A) Beads
were gated into two populations (Bead A and Bead B) and cytokine release determined by (B) PE vs APC
fluorescence. (A-B) Flow plots are representative and show supernatant from NS88.2 infected neutrophils
at 360 min using the 13-plex assay. Neutrophils differentially released (C) IL-1β, (D) TNF-α, (E) IL-8 and
(F) IL-18 in response to GAS infection (duplicate measurements, n=6 donors). (C-F) Results are the pooled
means ± SD. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001.
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4.3.6 Avirulent GAS invokes greater changes to neutrophil cell-surface CD expression
Neutrophil adhesion and activation are central to the innate immune response, with CD11b (Mac1) and CD66b (CEACAM8) playing key roles (Arnaout, 1990, Power et al., 2001, Skubitz et al.,
1996). To further explore the functionality of neutrophils during GAS infection, human
neutrophils were incubated in the absence or presence of NS88.2rep and NS88.2 and cell-surface
expression of CD11b, CD66b, CD16, CD31, CD47 and CD64 analysed by flow cytometry (Figure
4A-F). CD16 (FcγRIII) facilitates opsonisation of pathogens and is down-regulated during
apoptosis (Dransfield et al., 1994, Fossati et al., 2002), whilst down-regulation of CD31 (PECAM1) and CD47 (gp42) facilitates clearance of apoptotic neutrophils and the resolution of
inflammation (Brown et al., 2002, Kurosaka et al., 2003, Lawrence et al., 2009). Additionally, the
expression of CD64 (FcγRI) on neutrophils has been used as a biomarker for prediction of sepsis
(Barth et al., 2001). In the absence of GAS, or following incubation with NS88.2, neutrophils
displayed minor increases in CD11b expression over time (Figure 4.7C). In contrast, CD11b
expression decreased during infection with NS88.2rep, though differences were not statistically
significant upon post-hoc analysis (Figure 4.7C). Infection with NS88.2 rep significantly increased
CD66b expression by neutrophils 30 min post-infection in comparison to both uninfected and
NS88.2 infected neutrophils, though a statistical difference was only determined between
NS88.2rep infected and uninfected neutrophils (p<0.05, Figure 4.7D). Infection with NS88.2rep
resulted in a significant decrease in CD16 expression over time compared to both uninfected
neutrophils and those infected with NS88.2 at 30 (p<0.05), 60 (p<0.01) and 180 min (p<0.05)
post infection (Figure 4.7E). Similarly to CD16, infection of neutrophils with NS88.2rep
significantly reduced CD31 expression, at 60 and 180 min (p<0.01) compared to NS88.2 (Figure
4.7F). Differences in the expression of CD47 and CD64 on neutrophils were not observed
following any treatment (Figures 4.7G and H). Together, these data suggest that the neutrophil
response to NS88.2 is dampened and similar to uninfected neutrophils, whereas NS88.2rep
infection invokes greater changes to CD expression at the neutrophil cell-surface. Differences in
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cell-surface CD expression may be attributed to ineffective neutrophil activation and
phagocytosis of NS88.2.
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Figure 4.7: Infection with GAS changes neutrophil CD expression. Human neutrophils (PMNs) were
incubated in the absence or presence of GAS and assessed for cell-surface CD expression over 180 min by
flow cytometry. Neutrophils were sequentially gated as (A) Singlets then (B) viable Neutrophils, where
plots (A-B) are representative and show NS88.2 infected neutrophils at 30 min. Neutrophil (C) CD11b (n=4
donors), (D) CD66b (n=5 donors), (E) CD16 (n=4 donors), (F) CD31 (n=4 donors), (G) CD47 (n=6 donors)
and (H) CD64 (n=4 donors) was quantified relatively for each donor as mean fluorescence intensity. Results
are the pooled means ± SD. Linear mixed model ‘p’ values represent interaction (treatment*time) or are
stated. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, with black denoting significance from control and
grey between NS88.2rep and NS88.2.
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4.4 Discussion
The response of neutrophils to pathogens contributes significantly to the outcomes of infection
(Kobayashi et al., 2018). Previous work has identified a lytic form of neutrophil death in response
to emm98.1 infection (Tsatsaronis et al., 2015). This study furthers the understanding of the
human neutrophil response to GAS, addressing neutrophil death, cell-surface signaling and the
inflammatory profile during the early stages of emm98.1 (NS88.2 and NS88.2rep) infection in
vitro. We confirm an inflammatory neutrophil phenotype, as evidenced by increased casapase-1
and caspase-4 expression and inflammatory caspase activation during cell death in vitro. Further,
we elucidate differences between NS88.2 and NS88.2rep that aid in understanding the survival
and proliferation of GAS harbouring covS mutations in the presence of human neutrophils. We
conclude that in the emm98.1 genetic background, GAS mediated activation of inflammatory
caspases-1/-4/-5 and secretion of IL-1β by neutrophils is altered by covS mutation. For
NS88.2rep, expressing a functional covS, phagocytosis and production of ROS by neutrophils is
associated with rapid induction of neutrophil death as evidenced by cleaved caspase-3, caspase1 and caspase-4, decreased expression of CD16 and CD31, and loss of viability. In contrast, the
covS mutant strain NS88.2 limits neutrophil activation and production of ROS, which correlates
with prolonged neutrophil survival and reduced bacterial killing. We report retention of cellsurface proteins CD16 and CD31 during infection with NS88.2 that may impede the removal of
bacteria and clearance of neutrophils at sites of infection, preventing the resolution of
inflammation.
The induction of lytic neutrophil death, as inferred by loss of cell membrane integrity, has
previously been reported during emm1 and emm98.1 GAS infection (Kobayashi et al., 2003a,
Tsatsaronis et al., 2015). The current study identifies the activation of inflammatory caspases in
neutrophils during emm98.1 GAS infection, supporting a hypothesis that an inflammatory
regulated pathway may be activated. Inflammatory caspase activation was more evident for
NS88.2 rep than the covS mutant NS88.2, which may be attributed to differences in observed rates
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of phagocytosis. NS88.2 is highly resistant to phagocytosis, and in the current study, reduced
phagocytic uptake correlates with delayed neutrophil death. Similarly, the release of
inflammatory cytokines was different between the two strains, where increased inflammatory
caspase activation correlates with increased release of IL-1β. Reduced expression of caspase-3
and caspase-8 during NS88.2 infection was also observed and is indicative of reduced neutrophil
apoptosis (Daigle and Simon, 2001). A homeostatic relationship between apoptotic and
inflammatory pathways is thought to effectively facilitate the resolution of inflammation, during
the removal of bacterial pathogens (Lawrence et al., 2020). Disruption to this homeostatic
balance, as demonstrated during NS88.2 infection, may therefore be a contributing factor to the
development of invasive disease.
Multiple GAS virulence factors confer resistance to neutrophil-mediated killing (Walker et al.,
2014), and it is well-established that innate immune responses can dictate infection outcomes
(Kobayashi et al., 2018, Lawrence et al., 2020). In the current study, limited increases to CD66b
expression on cells infected with NS88.2 indicate low neutrophil activation and production of ROS
for oxidative burst (McFarlin et al., 2013, Skubitz et al., 1996). Furthermore, neutrophils showed
rapid loss of CD16 and CD31 during infection with NS88.2rep, whilst neutrophils infected with
NS88.2 retained these markers over time. CD31 retention, as observed for neutrophils infected
with NS88.2, can hinder the process of efferocytosis (Brown et al., 2002), limiting neutrophil
removal by macrophages (Kurosaka et al., 2003) and contributing to cellular crowding at the site
of infection. Infection of neutrophils with gram positive cocci Staphylococcus aureus has been
shown to prevent macrophage efferocytosis (Greenlee-Wacker et al., 2014). Neutrophil CD31
retention may have a similar effect during GAS infection, although this was not explored in the
current study. Moreover, neutrophils infected with NS882 retained CD16, which functions as a
receptor for immune complexes and opsonised bacteria, so this may indicate a reduction in
phagocytic function and apoptosis. Collectively, these data show that the neutrophil response to
covS mutant GAS is altered in a way that may favour a prolonged inflammatory response at sites
of infection.
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Reports for other pathogens such as Pseudomonas aeruginosa and S. aureus describe alteration to
neutrophil function and inflammatory death as contributing factors to disease development
(Bergsbaken and Cookson, 2009, Holzinger et al., 2012, Ryu et al., 2017). In murine neutrophils,
virulent GAS survive intracellularly, evading host defences and using the inflammatory response
for a competitive advantage to disseminate and increasing virulence (Medina et al., 2003a,
Medina et al., 2003b). These and other studies support the hypothesis that neutrophil death may
also contribute to the development of invasive GAS disease (Kobayashi et al., 2003a, Tsatsaronis
et al., 2015). The above data outlines that NS88.2 proliferates in the presence of viable
neutrophils, however proliferation is reduced when incubated in neutrophil lysates alone. This
indicates that GAS require the whole cell to proliferate and presents an argument to support the
idea that GAS use host neutrophils to further infection.
Commonalities can be drawn between infection with emm98.1 and emm1 GAS. Both serotypes
induce inflammatory caspase activation and cytokine release (Chapter 5), while reduced
neutrophil apoptosis occurs in response to strains that are highly virulent in vivo (Chapter 6)
(Tsatsaronis et al., 2015). A homeostatic relationship between apoptotic and inflammatory
neutrophil death is believed to determine the control of bacterial infections (Kobayashi et al.,
2018, Lawrence et al., 2020). Disruption to this relationship is now observed in response to
emm98.1 and will be further explored in response to emm1 GAS (Chapter 5). As invasive GAS
infections have high genetic diversity in areas with the highest incidence (Davies et al., 2019,
Richardson et al., 2010), it is essential to compare and contrast the neutrophil response to diverse
serotypes to identify similarities during invasive GAS infections.
In summary, the neutrophil response plays an important role in the removal of bacteria, where
the function of neutrophils during the early stage of infection can greatly influence outcomes.
Here, evidence is provided to show that neutrophil function is altered during infection with
emm98.1 GAS strain NS88.2, isolated from invasive disease. Alterations to anti-inflammatory
pathways inferred through cell-surface CD markers and caspase-cleavage, may hinder the
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resolution of infection, whilst inflammatory neutrophil death and cytokine release promote
further inflammation. The demonstration that diverse GAS serotypes are associated with
inflammatory caspase activation in neutrophils supports the need to further explore
inflammasome activation in response to GAS. Disruption to the equilibrium of apoptotic and
inflammatory neutrophil death may be a common mechanism occurring during invasive
infections. Additionally, targeted therapies may aim to not only control inflammatory neutrophil
death but also encourage the induction of anti-inflammatory pathways to limit severe pathologies
that contribute to invasive GAS disease progression.
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5 Characterisation of the neutrophil response to emm1
Group A Streptococcus
This chapter represents work published in Frontiers in Cellular and Infection Microbiology.
Williams, J. G., Ly, D., Geraghty, N. J., McArthur, J. D., Vyas, H. K. N., Gorman, J., Tsatsaronis, J. A.,
Sluyter, R. & Sanderson-Smith, M. L. 2021. Streptococcus pyogenes M1T1 Variants Induce an
Inflammatory Neutrophil Phenotype Including Activation of Inflammatory Caspases. Frontiers in
Cellular and Infection Microbiology, 10.

5.1 Introduction
The highly virulent emm1 Streptococcus pyogenes (Group A Streptococcus, Group A Streptococci,
GAS) M1T1 clone 5448 is well studied (Aziz and Kotb, 2008, Tart et al., 2007, Walker et al., 2007).
The propensity of emm1 GAS to cause invasive infections transpired from multiple genetic events
(Nasser et al., 2014). Additionally, high frequency of spontaneous mutations in the covRS locus of
emm1 GAS (Walker et al., 2007), differentially regulates virulence factor expression (Kilsgård et
al., 2016), attributing to enhanced immune resistance and increased pathogenesis (Sumby et al.,
2005, Sumby et al., 2006, Walker et al., 2007). 5448AP is a covS variant of 5448 that displays
resistance to killing by human neutrophils, has increased bacterial dissemination and results in
decreased survival in mouse models of infection (Fiebig et al., 2015, Maamary et al., 2010, Walker
et al., 2007). Used in tandem, these two strains have been employed as a model to explore
bacterial hypervirulence (Fiebig et al., 2015, Kilsgård et al., 2016, Maamary et al., 2010).
Furthermore, they also serve as valuable strains to investigate the host response to invasive GAS
infection.
In the majority of cases, virulence factors, not the host response, are considered as one of the most
significant factors influencing the outcome of infection. Although they certainly play an essential
role in the severity of infection, the host neutrophil response can dictate the degree of damage
and subsequent inflammation (Lawrence et al., 2020). Previous work outlines how GAS take
advantage of inadequate or exacerbated immune responses and focus upon the bacterial
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mechanisms involved (Cole et al., 2011). The induction of lytic neutrophil death in response to
emm1 GAS has previously been established (Kobayashi et al., 2003a), yet requires further
characterisation. Models to further investigate leukocyte inflammatory cell death have been
proposed (Tran et al., 2019), but not implemented in GAS research. Here, primary human
neutrophils have been infected with GAS to determine if inflammatory neutrophil death may be
a contributing factor to the development of invasive disease.
Although emm1 GAS, particularly 5448, is the focus of a large amount of research, a limited
number of studies have investigated the neutrophil response to emm1 GAS specifically
(Kobayashi et al., 2003a). This body of research aims to further characterise the neutrophil
response to virulent and hypervirulent GAS of emm1 background. Specifically, using an in vitro
model of human neutrophil infection, we temporally describe the effect GAS stains 5448 and
5448AP have upon neutrophil death, signalling and inflammatory profile. Additionally, we
identify differences in the neutrophil response to GAS due to covS mutation. We hypothesise that
changes to neutrophil function by GAS can promote invasive GAS infection by exacerbating the
inflammatory response, decreasing antibacterial capacity and inducing inflammatory neutrophil
death.
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5.2 Materials and methods
5.2.1 Bacterial culture, neutrophil isolation and in vitro infection
Methods for bacterial culture, neutrophil isolation and subsequent techniques performed
during in vitro infection have previous been outlined in Chapter 2.

5.2.2 Flow cytometry
Data collection was performed using an LSR Fortessa X-20 (BD) with excitation lasers; violet (405
nm), blue (488 nm), yellow/green (561 nm) and red (640 nm) and an LSR II (BD) with excitation
laser blue (488 nm). Bandpass filters for Zombie aqua (525/50), fluorescein isothiocyanate
(FITC)/green fluorescent protein (GFP)/FAM FLICA (525/50), peridinin-chlorophyll-protein
(PerCP)-Cyanine (Cy)5.5 (695/40) R-phycoerythrin (PE, 586/15), PE-Cyanine (Cy)7 (780/60)
and allophycocyanin (APC, 670/30) were used. Data were analysed and presented using FlowJo
software V10.6.1 (TreeStar Inc.). Compensation was performed by single antibody staining
human neutrophils at the time of peak CD expression.

5.2.3 Statistical analysis
Graphs were created using Prism 6 (GraphPad Software Inc.) and statistical analyses were
performed using Prism 6 and IBM SPSS Statistics 25 (IBM® corporation). Data were analysed
using repeated measures one-way and two-way ANOVA to determine significant differences and
adjusted using Tukey HSD corrections or in some cases using the Holm-Sá ı́dá k approach (stated in
figure legend). To account for the nested nature of the human neutrophil Annexin-V/Zombie and
CD data with repeated measures over time in the same donor, a linear mixed model was used to
determine significant interaction between treatment and time. Post-hoc tests were performed by
multiple one-way ANOVA at each time point where multiple comparisons were adjusted using
Tukey HSD corrections. Values presented for ‘p’ represent interaction (treatment*time) unless
otherwise stated. Where an effect was determined, significance of the post-hoc analysis was
represented as *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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5.3 Results
5.3.1 GAS persistence and proliferation occurs during a dampened neutrophil reactive
oxygen species response
Neutrophil phagocytic killing is a predominant and well-established mechanism of immune
defence. The covS mutant 5448AP has previous shown increased resistance to neutrophil killing
(Walker et al., 2007). Similarly here, 5448AP is resistant to neutrophil mediated-killing and
proliferates after 120 min compared to 5448 (p<0.01, Figure 5.1A). Further, in the presence of
viable human neutrophils, 5448AP proliferated to a greater extent than 5448 (Figure 5.1A).
Differential GAS proliferation required viable neutrophils, as 5448 and 5448AP proliferation in
the presence of neutrophil lysates was reduced and similar for both strains over 180 min (Figures
5.1B). Finally, pre-incubation of neutrophils with phagocytosis inhibitor cytochalasin D increased
5448, but not 5448AP, survival over 30 min (p<0.001, Figure 5.1C), indicating that 5448 killing is
predominantly mediated via a phagocytic-related pathway.
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Figure 5.1: GAS proliferates in the presence of human neutrophils. GAS strains were incubated in the
presence of (A) active human neutrophils (n=8 donors) and (B) lysed neutrophils (n=4 donors) over 180
min with surviving bacterial concentration determined as percentage of inoculum. (C) GAS killing by
human neutrophils at 30 min following pre-incubation with cytochalasin D to inhibit phagocytosis (n=4
donors). Post-hoc analysis was performed using the Holm-Sá ı́dá k approach. (A-C) Results are the pooled
means ± SD of triplicate measurements. *p<0.05, **p<0.01 and ****p<0.0001.

To further investigate phagocytic killing and the increased survival of 5448AP, fluorescent GAS
variants were used and bacterial association to neutrophils was assessed by flow cytometry
(Figure 5.2A-D). GAS rapidly associated to human neutrophils, with near maximal association
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observed within 30 min (Figure 5.2D). Higher percentage of neutrophils were associated with
5448 compared to 5448AP, at all times (p<0.0001, Figure 5.2D). Similarly, 5448 was more readily
internalised by neutrophils than 5448AP at 30 min (p<0.05, Figure 5.2E). 5448 and 5448AP
infection induced ROS production in neutrophils, though increased ROS production was observed
during 5448 infection when compared to uninfected and 5448AP infected neutrophils (Figure
5.2F). As such, the rate of ROS production calculated between 30-60 min was greater during 5448
infection (1600 ± 580 RFU/min) when compared to uninfected (400 ± 220 RFU/min) and 5448AP
infected neutrophils (700 ± 230 RFU/min) (p<0.01). Collectively, these data indicate that
compared to 5448, 5448AP associates less readily with human neutrophils and is less readily
phagocytosed. In addition, neutrophils show reduced ROS production and bacterial killing in
response to 5448AP leading to reduced ROS production and increased survival of this strain.

5.3.2 Neutrophil death is delayed during infection with 5448AP
GAS can induce death of human neutrophils (Kobayashi et al., 2003a, Tsatsaronis et al., 2015),
however the mechanism remains inadequately described. Phosphatidylserine (PS) exposure is a
hallmark of the induction of multiple death pathways including apoptosis and pyroptosis (Man
and Kanneganti, 2016, Wang et al., 2013). Human neutrophils were incubated with 5448, 5448AP
or in the absence of GAS then the binding of annexin-V (AV), as a measure of PS exposure, and the
binding of Zombie Fixable Viability Kit (Z), as a measure of membrane integrity, were analysed
by flow cytometry (Figure 5.3). Cells were defined as viable (AV-Z-), PS exposed (AV+Z-) or dead
(AV+Z+) (Figure 5.3C). Neutrophils incubated in the absence of GAS remained viable over 180 min
(Figure 5.3D), with 13% exposing PS (Figure 5.3E) and 3% dead after this time (Figure 5.3F). In
contrast, incubation of neutrophils with either 5448 or 5448AP resulted in increased PS exposure
and neutrophil death over 180 min, with significantly more neutrophil death during 5448
infection compared to 5448AP infection at 30 and 60 min (p<0.05, Figure 5.3F). Delay in the initial
induction of death in response to 5448AP suggests extended neutrophil viability during the early
stages of infection (30-60 min).
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Figure 5.2: Reduced phagocytosis of GAS by neutrophils occurs during a dampened reactive oxygen
species response. Neutrophils were incubated in the presence of GFP emm1 GAS and bacterial association
to human cells determined by flow cytometry. Neutrophils were sequentially gated on (A) singlets then (B)
viable neutrophils and (C) bacterial association determined by fluorescence. Flow cytometry plots are
representative and show (A-B) 5448 infected neutrophils at 60 min and (C) uninfected (purple), 5448
(blue) and 5448AP (red) infected neutrophils at 60 min from one donor. (D) GAS association to human
neutrophils over 300 min (n=6 donors, Student’s t-test). (E) The internalisation of GAS by neutrophils
determined by gentamicin protection assay (n=5 donors, Student’s t-test). (F) ROS production in the
absence or presence of emm1 GAS, representative of triplicate measurements from three separate
experiments (n=3 donors), shown as mean change in fluorescence units over time (ΔF.min-1). (D-E) Results
are the pooled means ± SD of triplicate measurements. *p<0.05 and ****p<0.0001.

5.3.3 GAS infection upregulates caspase-1 and caspase-4 in neutrophils
The above data (Figure 5.3) suggests that GAS induce rapid neutrophil death. To explore the
mechanism of GAS-induced neutrophil death human neutrophil lysates were separated by SDSPAGE and screened for the abundance of caspase-3, caspase-8, caspase-1, caspase-4 and GAPDH
via immunoblotting and quantified using densitometry (Figure 5.4). Neutrophils incubated in the
absence of GAS displayed limited evidence of caspase-3 cleavage (caspase-3 p17) and decreasing
amounts of caspase-8 over 180 min (Figure 5.4A, C-E). Infection of neutrophils with 5448
significantly increased the presence of caspase-3 p17 at 180 min compared to both 5448AP
infected and uninfected neutrophils (p>0.0001, Figures 5.4A and D). Full length caspase-8
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increased during 5448 infection (p<0.01), but not 5448AP infection, when compared to
uninfected neutrophils, however no cleaved forms of caspase-8 were clearly evident for any
group (figures 5.4 A and E). In the absence of GAS, neutrophils displayed decreasing amounts of
caspase-1 and caspase-4 over 180 min (Figure 5.4B, F-H). In contrast, incubation of neutrophils
with either GAS strain caused an upregulation of caspase-1 (Figures 5.4B and F-G). Compared to
uninfected neutrophils, 5448 infection significantly increased full length caspase-1 at 30 min, 60
min (p<0.05) and 180 min (p<0.01), whilst 5448AP infection only significantly increased full
length caspase-1 at 180 min (p<0.001, Figures 5.4B and F). Further, caspase-1 p46 expression
was sustained over 180 min in 5448 and 5448AP infected neutrophils compared with uninfected
neutrophils, though this difference was not statistically significant (Figures 5.4B and G). There
was no significant difference in expression of caspase-1 when comparing 5448 and 5448AP
infected neutrophils. Infection of neutrophils with 5448 increased caspase-4 expression at 30
(p<0.01), 60 (p<0.001) and 180 min, compared to uninfected neutrophils (p<0.0001, Figures 5.4B
and H). 5448AP infection however, only increased caspase-4 expression at 180 min (p<0.01,
Figures 5.4B and H). These data suggest change in the abundance of multiple caspases during
emm1 GAS infection of neutrophils.

5.3.4 Neutrophils activate inflammatory caspases in response to GAS infection
The above data suggests inflammatory caspases may be involved in neutrophil death during GAS
infection. To explore this possibility further, human neutrophils were incubated with 5448,
5448AP or in the absence of GAS and inflammatory caspase-activity assessed using a fluorogenic
flow cytometric assay that detects active caspase-1, -4 and -5 (Figure 5.5). Compared to
uninfected neutrophils, 5448 infected neutrophils showed increased inflammatory caspaseactivity at 60 and 180 min (p<0.05), whilst 5448AP infection increased inflammatory caspaseactivity at 180 min (p<0.05, Figure 5.5D). No significant differences were observed between
strains, although caspase-activity was slightly reduced during 5448AP infection, compared to
5448 (Figure 5.5D), similar to immunoblot data for caspase-1 p46 (Figure 5.4A and G). Thus, GAS
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infection of human neutrophils corresponds to increased caspase-1 and caspase-4 amounts and
increased inflammatory caspase activation.
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Figure 5.3: GAS infection induced neutrophil death. Human neutrophils (PMNs) were incubated in the
absence or presence of 5448 or 5448AP, stained with annexin V-FITC (AV) and Zombie Aqua viability dye
(Z) then analysed by flow cytometry. Neutrophils were gated as (A) Singlets and then total (B) neutrophils
(live and dead). Finally, cells were analysed by (C) fluorescence of annexin V-FITC and Zombie Aqua
binding. Flow cytometry plots (A-C) are representative and show 5448AP infected neutrophils at 30 min.
Neutrophils were sampled over 300 min to measure the percentage of (D) Viable (AV-Z-), (E) PS exposed
(AV+Z-), and (F) Dead (AV+Z+), neutrophils during GAS infection. (D-F) Results are pooled means ± SD (n=3
donors). Linear mixed model ‘p’ values represent interaction (treatment*time) or are stated. *p<0.05,
**p<0.01, ***p<0.001 and ****p<0.0001, with black denoting significance from control and grey between
5448 and 5448AP.
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Figure 5.4: Neutrophil death following GAS infection involves multiple caspases. Human neutrophil
(PMN) lysates were prepared in the absence (0, 30, 60 and 180 min) or presence of GAS (30, 60 and 180
min) and the activation of (A) caspase-3, caspase-8, GAPDH (B) caspase-1 and caspase-4 was investigated
via immunoblotting. (A-B) Images shown are from a single donor and are representative of triplicate
experiments using different donors. SE=short exposure, LE=long exposure. Immunoblot bands were
further quantified (ImageJ) and normalised against total protein to determine the amount of (C) full length
caspase-3, (D) caspase-3 p17, (E) full length caspase-8, (F) full length caspase-1, (G) caspase-1 p46, (H) and
full length caspase-4. Results are the pooled means ± SD from 3 separate donors. *p<0.05, **p<0.01,
***p<0.001 and ****p<0.0001, with black denoting significance to control and grey between 5448 and
5448AP.
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Figure 5.5: GAS infection activates inflammatory caspases in human neutrophils. Inflammatory
caspase activation during GAS infection was further confirmed in human neutrophils (PMNs) using FLICA
(FAM-YVAD-FMK) and flow cytometry (A-D). Neutrophils were gated as (A) singlets then (B) viable
neutrophils, with (C) inflammatory caspase activation determined by fluorescence. Flow cytometry plots
are representative and show (A-B) 5448AP infected neutrophils at 180 min and an (C) overlay histogram
of unstained (grey), uninfected (purple), 5448 (blue) and 5448AP (red) infected neutrophils at 60 min. (D)
Inflammatory caspase activation was determined at 60, 120 and 180 min in the absence or presence of GAS.
Results are the pooled means ± SD from 3 separate donors. *p<0.05.

5.3.5 Proinflammatory cytokines IL-1β and TNF-α are released by neutrophils in
response to GAS
The release of the inflammatory cytokine IL-1β can occur due to caspase-1 activation and is
associated with the induction of pyroptosis (Broz et al., 2010). The uncoordinated release of
various inflammatory cytokines however, can exacerbate infection (Tecchio et al., 2014). During
GAS infection, disease severity is negatively correlated to cytokine concentration (Norrby-
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Teglund et al., 2000). Therefore, human neutrophils were incubated with 5448, 5448AP or in the
absence of GAS and supernatants assessed for cytokines using a flow cytometric bead assay.
Neutrophils incubated in the absence of GAS failed to release IL-1β (Figure 5.6A) and TNF-α
(Figure 5.6B), despite releasing increasing amounts of IL-8 (Figure 5.6C) and very low amounts
of IL-18 (Figure 5.6D) over 360 min. Incubation with GAS induced IL-1β release from neutrophils
at 180 min and 360 min, with significantly greater release during 5448AP infection compared to
5448 at 180 and 360 min (p<0.05, Figure 5.6A). Incubation with GAS also induced significant
release of TNF-α from neutrophils at 180 min (p<0.001) and 360 min (p<0.0001), with
significantly greater release during 5448 infection compared to 5448AP at 360 min (p<0.0001,
Figure 5.6B). Compared to uninfected neutrophils, 5448 induced significant release of IL-8 from
neutrophils at 60 min and 180 min (p<0.05), with significantly greater release than 5448AP at 60
min (p<0.05, Figure 5.6C). Neutrophils released minimal amounts of IL-18 over 360 min, and this
response did not change following infection with either 5448 or 5448AP (Figure 5.6D), suggesting
that neutrophils have no major role in IL-18 release over 360 min under these conditions. These
data indicate that both 5448 and 5448AP induce IL-1β release from human neutrophils,
consistent with the hypothesis that both GAS strains may induce pyroptosis in these cells.
Moreover, the results indicate differential cytokine release from human neutrophils infected with
GAS, with 5448AP inducing greater IL-1β release and 5448 inducing greater TNF-α and IL-8
release.
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Figure 5.6: Neutrophils differentially release inflammatory cytokines during infection with GAS. The
release of cytokines from neutrophils (PMNs) during GAS infection was measured using the LEGENDplex™
human inflammation cytometric bead assay and flow cytometry over 360 min. Gating has previously been
described (Chapter 4.3.5, Figure 4.6). Neutrophils differentially released (A) IL-1β, (B) TNF-α, (C) IL-8 and
(D) IL-18 in response to GAS infection (duplicate measurements, n=6 donors). (A-D) Results are the pooled
means ± SD. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001.

5.3.6 GAS infection alters the neutrophil phenotype
The implication of changes to specific neutrophil CD expression used here have previously been
described (Chapter 4.3.6). Therefore, to further explore the impact of GAS on neutrophil function,
human neutrophils were incubated with 5448, 5448AP or in the absence of GAS and the
expression of cell-surface CD11b, CD66b, CD16, CD31, CD47 and CD64 was assessed using flow
cytometry (Figure 5.7). In the absence of GAS, neutrophils displayed minor increases in CD11b
expression over time. In contrast, incubation with GAS resulted in minor decreases over time,
with 5448 inducing a greater loss of CD11b than 5448AP, though these differences were not
statistically significant (p=0.289, Figure 5.7C). Neutrophils incubated in the absence of GAS
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revealed minor increases in cell-surface CD66b expression over time (Figure 5.7D). Incubation
with GAS further increased expression of CD66b, with 5448 inducing a slightly greater increase
than 5448AP, though these differences were also not statistically significant (p=0.162, Figure 4D).
Incubation of neutrophils in the absence of GAS resulted in a steady decline in CD16 expression
over time, a loss significantly increased by co-incubation with either GAS strain 180 min postinfection (p<0.0001, Figure 5.7E). Notably, infection with 5448 induced a significantly greater
loss of CD16 expression than uninfected and 5448AP infected neutrophils at 10, 30 and 60 min
post-infection (p<0.05, Figure 5.7E). Similar to CD16, incubation of neutrophils in the absence of
GAS resulted in a steady decline in CD31 expression over time, a loss significantly increased by
co-incubation with either GAS strain 180 min post-infection (p<0.0001, Figure 5.7F). Moreover,
incubation of neutrophils with 5448 induced a significantly greater loss of CD31 expression than
5448AP incubation at 10, 30 and 60 min (p<0.05, Figure 5.7F). Neutrophils incubated in the
absence of GAS decreased CD47 expression over 180 min, while infection with either GAS strain
sustained constant levels of CD47, though a statistically significant difference was not detected
(Figure 5.7H). In the absence of GAS, neutrophil CD64 expression decreased over 180 min, where
expression was unaltered during infection with either GAS strain (Figure 5.7I). Collectively, these
data indicate that 5448 and to a lesser extent, 5448AP, influence the expression of neutrophil cellsurface CD expression. A statistically significant impact upon neutrophil CD11b, CD66b, CD47 or
CD64 was not detected during GAS infection. The loss of CD16 and CD31 on neutrophils during
GAS infection however, may have implications for opsonisation of GAS and subsequent
efferocytosis of neutrophils by macrophages, during infection.

J.G.W

124

Characterisation of the neutrophil response to emm1 Group A Streptococcus

A

B

SSC-A

FSC-H

Neutrophils
Singlets

FSC-A

FSC-A

D

R e la t iv e C D 1 1 b e x p r e s s io n

5448

5448AP

PMN

500

5448

p = 0 .2 8 9

300

100

200

80

100

60
50

100

150

200

50

T im e ( m in )

60
40

100

150

5448AP

PMN

5448

100

40

****

**
*

20

**
*

0

****

80

50

100

T im e ( m in )

150

200

150

5448

5448AP
T im e p = 0 . 0 0 2

80
60
40

0

50

100

T im e ( m in )

150

200

0

50

100

150

T im e ( m in )

Figure 5.7: GAS infection changes neutrophil functionality. (A-I) Human neutrophils (PMNs) were
incubated with 5448, 5448AP or in the absence of GAS and assessed for cell-surface CD expression over
180 min by flow cytometry. Neutrophils were sequentially gated as (A) Singlets then (B) viable Neutrophils,
where plots (A-B) are representative and show uninfected neutrophils at 180 min. Neutrophil (C) CD11b
(n=4 donors), (D) CD66b (n=5 donors), (E) CD16 (n=4 donors), (F) CD31 (n=4 donors), (H) CD47 (n=6
donors) and (I) CD64 (n=4 donors) was quantified relatively for each donor as mean fluorescence intensity.
Results are the pooled means ± SD. Linear mixed model ‘p’ values represent interaction (treatment*time)
or are stated. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, with black denoting significance from
control and grey between 5448 and 5448AP.
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5.4 Discussion
Here we have mapped the human neutrophil response to GAS, addressing cell death, signalling
and the inflammatory profile during the early stages of emm1 GAS (5448 and 5448AP) infection.
We describe an inflammatory neutrophil phenotype, as evidenced by increased caspase-1 and
caspase-4 expression and inflammatory caspase activation in vitro, which may promote
inflammation and exacerbate GAS disease. Most notably, retention of cell-surface proteins CD16
and CD31 during infection with 5448AP, may impede the removal of bacteria and clearance of
neutrophils at sites of infection, hindering the resolution of inflammation. Further, we elucidate
differences between 5448 and 5448AP that aid in understanding the survival and proliferation of
GAS harbouring covS mutations in the presence of human neutrophils. We conclude that GAS
strains 5448 and 5448AP induce neutrophil inflammatory caspase-1/-4/-5 activation and release
of IL-1β. For wild type emm1 GAS strain 5448, phagocytosis and production of ROS by neutrophils
is associated with rapid induction or neutrophil apoptosis, as evidenced by cleaved caspase-3,
decreased expression of CD16 and CD31 and loss of viability, which correlates with the reduced
release of proinflammatory cytokine IL-1β. In contrast, the covS mutant strain 5448AP limits
neutrophil activation and production of ROS, which correlates to prolonged neutrophil survival
and reduced bacterial killing. Taken alongside the characterisation of covS mutant and avirulent
emm98.1 GAS strains (Chapter 4), we can now draw comparison between isolates from invasive
disease with a diverse genetic background (Chapter 7).
The temporal expression of neutrophil cell-surface markers has not previously been investigated
in the context of GAS infection prior to this thesis. These data show that significant reductions to
both CD16 and CD31 occur in neutrophils due to GAS infection in vitro. CD16 functions as a
receptor for opsonised bacteria and immune complexes (Fossati et al., 2002), whilst the loss of
CD16 has also been associated with the induction of apoptosis (Dransfield et al., 1994). The
induction of apoptosis following bacterial phagocytosis is advantageous to the host as it promotes
controlled removal of bacteria and the resolution of inflammation (Kobayashi et al., 2018). We
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hypothesise that the retention of CD16 during infection promotes a reduction in apoptosis and
prolonged degranulation at the site of infection. Further, CD31 expression is reduced during GAS
infection, facilitating the eventual removal of neutrophils from sites of infection (Kobayashi et al.,
2003b). Parallel to CD16, CD31 is retained during 5448AP infection of neutrophils to a greater
extent than 5448 infection in vitro. This may result in neutrophils remaining at sites of infection
longer, further increasing inflammation. Additionally, we report a trend towards increased cellsurface expression of CD11b and CD66b during GAS infection. Migration of neutrophils to sites of
infection, facilitated by CD11b-mediated neutrophil adhesion (Arnaout, 1990), may therefore be
affected during GAS infection. Down-regulation of CD11b can prevent accumulation of
neutrophils at inflammatory sites (Huston et al., 2009), however retention, such as that seen
during 5448AP infection may contribute to prolonged inflammation. Neutrophil activation can be
determined through the expression of cell-surface CD66b following stimulation (Skubitz et al.,
1996). Reduced cell-surface CD66b expression in response to 5448AP infection may therefore
indicate a reduction to neutrophil function and further explain the resistance to neutrophilmediated killing. Collectively, the neutrophil response is altered and inflammation prolonged at
sites of covS mutant GAS infection.
Disruption of the role neutrophils play during the resolution of GAS infection and induction of
inflammatory death pathways has been reported previously (Kobayashi et al., 2003a, Tsatsaronis
et al., 2015). Proinflammatory activation of the NLRP3 inflammasome in macrophages has been
demonstrated for M1 (emm1) GAS (Valderrama et al., 2017) and here we provide the first
evidence that GAS activates inflammatory caspases in human neutrophils. Immunoblot analysis
showed that caspase-1 abundance was sustained during infection with both emm1 isolates. Flow
cytometric analysis using FAM-YVAD-FMK, a probe which preferentially detects active caspase1, -4 and -5, showed an increase in inflammatory caspase activation by neutrophils following GAS
infection. However, consistent with previous in vivo studies of non-emm1 covS mutant GAS
(Tsatsaronis et al., 2015), the release of the inflammatory cytokine IL-1β, a hallmark of clinical
invasive infection (LaRock and Nizet, 2015), was only significantly increased in response to
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5448AP infection in vitro. In murine bone marrow-derived dendritic cells, caspase-1 activation is
essential for IL-1β release (Schneider et al., 2017). The activation of caspase-1/inflammatory
caspases in human neutrophils does not correlate directly to the amount of IL-1β released, and
an alternative mechanism may facilitate IL-1β maturation. Type I interferons are known
regulators of IL-1β in GAS infected mice (Castiglia et al., 2016), where increased IL-1β release
seen in this study may also be attributed to disruption of this homeostatic relationship. Increased
IL-1β, being a neutrophil chemoattractant, therefore may further promote inflammation at sites
of infection following release (Chen et al., 2007), supporting the hypothesis that covS mutant GAS
(5448AP) promote greater levels of inflammation during GAS infection.
Previous studies have characterised differences between 5448 and 5448AP, demonstrating
resistance to neutrophil-mediated killing in vitro and increased bacterial dissemination and
decreased survival in vivo following the acquisition of covS mutations (Fiebig et al., 2015,
Maamary et al., 2010, Walker et al., 2007). Here we show that neutrophil death is delayed in
response to covS mutant 5448AP, suggesting extended neutrophil viability during the early stages
of infection. Apoptosis occurs following phagocytic uptake, thus, delayed neutrophil death in
response to 5448AP compared to 5448 may be due to reduced neutrophil association and
phagocytosis of 5448AP. Alternatively, 5448AP may inhibit cell death pathways via another
mechanism. We demonstrate that 5448AP is not only resistant to neutrophil-mediated killing but
proliferates in the presence of functional neutrophils. GAS survival has been demonstrated
intracellularly in murine neutrophils and human macrophages (Medina et al., 2003a, Medina et
al., 2003b, O’Neill et al., 2016) and can even be facilitated by host red blood cells (Wierzbicki et
al., 2019). Increased 5448AP proliferation may result from the reduction in neutrophil ROS
response during infection. GAS has previously been shown to display resistance to ROS through
numerous virulence mechanisms (Henningham et al., 2015). The absence of a hostile
environment may further permit bacterial replication. Additionally, the increased production of
ROS can induce neutrophil death via apoptosis (Geering and Simon, 2011). Reduced neutrophil
ROS production during 5448AP infection may therefore further explain the reduction seen in
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caspase-3 activation (apoptosis). Previously it has been demonstrated that GAS emm1 strain
MGAS5005 modulates neutrophil apoptosis (Kobayashi et al., 2003a) and that non-emm1 GAS
harbouring covS mutation elicit non-apoptotic neutrophil death (Tsatsaronis et al., 2015), a
finding which is supported by the current study.
Changes to the function of neutrophils during the initial innate immune response have the
potential to hinder mechanisms essential for the resolution of infection. Disruption to these
processes during GAS infection may induce this neutrophil phenotype we have described, with
increased inflammatory properties and potential to exacerbate infection. Inflammatory caspaseexpression and activation during GAS infection of neutrophils indicates possible inflammasome
activation and death via pyroptosis. However, markers of alternative cell death pathways
including necroptosis and NETosis were not explored in the current study, and as such further
studies should explore the precise cell death mechanism. A reduction in apoptosis is evident
during covS GAS infection, as has been reported for non-emm1 GAS (Tsatsaronis et al., 2015),
whilst modulation of apoptosis has previously been implicated as a factor contributing to GAS
survival (Kobayashi et al., 2003a). The current study builds on previous findings to show that:
emm1 GAS harbouring covS mutations also elicit reduced apoptosis in neutrophils; emm1 GAS
increase caspase-1 and caspase-4 expression and inflammatory caspase activation in vitro; and
shows temporal changes in expression of neutrophil cell-surface markers during GAS infection.
This work aids in understanding the complex host-pathogen interaction identifying host factors
that may contribute to severe pathology of invasive GAS infection. Future studies may be able to
isolate host-specific targets that could be exploited to control inflammation and tissue damage
during invasive GAS infection.
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6 Characterising the response of neutrophils to Group A
Streptococcus in an intradermal murine model of
invasive infection
6.1 Introduction
Streptococcus pyogenes (Group A Streptococcus, Group A Streptococci, GAS) is commonly referred
to as a human specific pathogen, however mice have been used extensively to model invasive
disease, providing a complex and dynamic immune system in which to study GAS infection, in
contrast human in vitro/ex vivo studies using isolated populations (Ferretti et al., 2016, Roberts
et al., 2006). Specifically, intradermal and subcutaneous models of invasive GAS infection have
been performed successfully using the inbred background mouse strain C57BL/6J (Krishnan et
al., 2016, Lei et al., 2019, Tsatsaronis et al., 2015). Intradermal/subcutaneous injection of GAS in
C57BL/6J mice drives the formation of necrotic lesions, invoking inflammation including the
recruitment of immune cells such as neutrophils (Krishnan et al., 2016, Lei et al., 2019,
Tsatsaronis et al., 2015), similar to the response seen clinically during invasive disease in humans
(Stevens and Bryant, 2017). Detailed characterisation of the responding immune cells, including
neutrophil and monocytes in vivo is limited however. Further investigation of these cell types
during the early stages of infection may provide more information regarding the development of
invasive disease.
As previously discussed in depth (Chapter 1.4.4), neutrophils play an essential role in bacterial
clearance during the early stages of infection. Murine neutrophils differ from their human
counterparts and are typically characterised by the expression of Ly-6G (Stackowicz et al., 2020).
Monoclonal Ly-6G antibodies are also used to deplete neutrophils (Daley et al., 2008), where
neutrophil depletion in mice can increase the mortality of a previous low-virulence GAS strain
(Hidalgo-Grass et al., 2006). Furthermore in a mouse model of chronic granulomatous, where
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neutrophil function is inhibited, the function of neutrophil oxidative burst is reduced during GAS
infection (Nguyen et al., 2017), which results in increased mouse mortality (Saito et al., 2001).
These models highlight the importance of neutrophils in mice during GAS infection, but limited
studies have investigated the inflammatory phenotype of neutrophils during infection.
Monocytes are a heterogenous cell population and the precursor of macrophages. They play a
role in phagocytic clearance of bacteria and can heavily influence inflammation (Shi and Pamer,
2011). In particular, inflammatory monocytes (iMOs) account for 2-5% of circulating immune
cells in healthy mice and rapidly move to sites of infection, where they have both
proinflammatory and antimicrobial roles (Geissmann et al., 2003, Serbina et al., 2008). Murine
iMOs can be characterised by flow cytometry as CD11b+/Ly-6G-/Ly-6Chigh populations, with
distinctly higher Ly-6C expression than neutrophils and a lack of Ly-6G expression (Terrazas et
al., 2017). The role of iMOs during host defence has been investigated for lung pathogens such as
Streptococcus suis, where iMOs are essential to control systemic inflammation in mice (Auger et
al., 2020). The role of iMOs in invasive GAS infection is yet to be determined. Macrophages also
play an important role in innate immunity during bacterial infection and have long been
characterised in mice by flow cytometry using the marker F4/80 (Austyn and Gordon, 1981).
Using a model of macrophage depletion, it has been demonstrated that macrophages play an
essential role in the control of soft-tissue GAS infection in mice (Goldmann et al., 2004, Mishalian
et al., 2011). Further, a recent comprehensive review outlines that GAS can escape from
macrophage killing and influence inflammation, which in turn contributes to disease progression
(Valderrama and Nizet, 2018).
Neutrophils have been the primary focus of this thesis, and hence this chapter aims to
characterise the neutrophil response to emm1 GAS in vivo. Additionally, iMOs and macrophages
will also be characterised for their response to emm1 GAS in vivo. Using a 6 and 24 h murine model
of intradermal GAS infection, immune cell migration, death, inflammatory caspase activation,
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signalling and cytokine release were selected for study based upon results arising from studies
investigating the human neutrophil response to emm1 GAS in vitro (Chapter 5).
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6.2 Materials and methods
6.2.1 Ethics statement
All experiments involving the use of animals were approved and authorised by the University of
Wollongong (UOW) Animal Ethics Committee (AEC) under Protocol AE18/10.

6.2.2 Animals
Equal numbers of 6-8 week old male and female C57BL/6J mice (Mus musculus, Australian
BioResources, Moss Vale, Australia) were housed according to their sex and litter status under
standard conditions, at room temperature (RT) in the UOW Animal Research Facility. Cohorts of
six mice were used, where eight cohorts were needed to make a total of 48 mice (eight mice per
treatment, per time).

6.2.3 Murine intradermal GAS infection
Methods of intradermal GAS infection were based on previous studies (Ly et al., 2014, Maamary
et al., 2010, Tsatsaronis et al., 2015). One day prior to infection, hair was removed from both the
left and right flanks using clippers (KM2 Speed, Wahl, Sterling, IL, USA) then chemical depilatory
(Veet, Reckitt Benckiser, Slough, United Kingdom) to expose bare skin. Mid-logarithmic cultures
of GAS strains 5448 and 5448AP were prepared from overnight culture (Chapter 2.2) and
resuspended in 0.7% (w/v) NaCl (Sigma-Aldrich) solution at a concentration of 1 x 109 CFU/mL.
Mice were briefly anesthetised via isoflurane inhalation (4% induction, 2% maintenance) using a
Stinger Streamline Anaesthetic Gas Machine (Darvall, Gladesville, Australia) and injected
intradermally using a 21 G Needle (BD) and 1 mL syringe (Livingstone, Mascot, Australia) with 1
x 108 CFU 5448, 1 x 108 CFU 5448AP or 100 µL 0.7% NaCl solution. O2 supplemented recovery
was performed on a heat pad following injection before returning each mouse to its home cage.
Infection was allowed to proceed for 6 or 24 h with clinical observations monitored (body weight,
lesion size and clinical scoring) and recorded twice daily, or until the ethical endpoint was
reached (0 instances).
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6.2.4 Euthanasia and tissue collection
At endpoint, mice were euthanised using slow fill CO2 asphyxiation. Tissue processing and
analysis was performed on the day of euthanasia. Cardiac puncture was performed with a 25 G
needle (Livingstone) and 1 mL syringe (Livingstone) to collect blood and as a secondary method
of euthanasia. Blood was separated into two aliquots, one for serum cytokine analysis and one for
immune cell flow cytometric analysis. Blood for serum was allowed to clot for 1 h at RT then
placed on ice until further processing. The remaining blood was mixed with anticoagulant, 20 µL
0.5% (w/v) sodium citrate (Sigma-Aldrich) per mL of blood, in a 1.5 mL tube and placed on ice
until further processing. Images of the injection site were taken for some mice following 24 h
infection. Following, both sites of injection were lavaged with 1 mL of 0.7% NaCl solution, where
fluid from the left and right flanks was pooled into one 2 mL tube. A 10 μL aliquot was taken and
diluted 1:10 in 0.7% NaCl solution, for bacterial enumeration. The remaining lavage fluid was
centrifuged at 350 x g for 5 min and the pellet resuspended in 500 μL of phosphate buffered saline
(PBS), all samples were kept on ice prior until processing. Incisions were made on the abdomen
of each mouse, then both the liver and spleen were removed to separate 2 mL homogenising tubes
(Benchmark, Tempe, AZ, USA) tubes containing two Zirconium 3 mm triple-pure homogenisation
beads (Benchmark) per tube, topped up to 1.5 mL with PBS and placed on ice.

6.2.5 Blood processing
Serum was prepared from clotted blood by centrifugation at 1200 x g for 10 min at 4°C. The top
serum fraction was removed to a new 1.5 mL tube and stored at -80°C, for a maximum of 2 weeks,
until analysis. Immune cells were prepared for flow cytometry by mixing an equal volume of PBS
with the blood sample, then centrifugation at 350 x g for 5 min. Contaminating erythrocytes in
the pellet were lysed by adding 1 mL of ammonium-chloride-potassium lysing buffer (150 mM
NH4Cl, 1 mM KHCO3, 0.1 mM Na2CO3, pH 7.3, Appendix A) for 5 min with gentle agitation, followed
by centrifugation 350 x g for 5 min. This process was repeated, after which the cell pellet was
resuspended in 500 µL of PBS and placed on ice.
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6.2.6 Bacterial enumeration
The liver and spleen were homogenised with a Precellys 24 Homogeniser (Bertin Technologies
SAS, Montigny-le-Bretonneux, France) using five cycles at 5,000 rpm twice for 20 s with 5 s break.
Homogenised liver, spleen or 1:10 lavage fluid were serially diluted with 0.7% NaCl solution in
96-well plates then spot plated in triplicate onto THY agar. Plates were grown overnight at 37°C
and bacteria enumerated by counting.

6.2.7 Flow cytometry
Data collection was performed using an Attune NxT (Invitrogen) flow cytometer with excitation
lasers; violet (405 nm), blue (488 nm), yellow (561 nm) and red (638 nm). Bandpass filters VL1
(440/50), VL2 (512/25), VL3 (603/48), VL4 (710/50), BL1 (530/30), YL1 (585/16), YL3
(695/40), YL4 (780/60) and RL2 (720/30) were used. Data were analysed and presented using
FlowJo software V10.6.1 (TreeStar Inc.). Compensation was performed by single antibody
staining of UltraComp eBeads (Thermo Fisher).

6.2.8 Flow cytometric analysis of murine immune cells
Lavage and blood cells, resuspended in 500 μL of PBS, were analysed by flow cytometry. Cells
were first centrifuged at 350 x g for 5 min and PBS decanted off. The cell pellet was then gently
resuspended in 1 mL Zombie Aqua Viability Kit (diluted 1:1000 in PBS, Biolegend) and incubated
for 15 min at RT protected from light. Samples underwent centrifugation at 350 x g for 5 min and
were resuspended in 10% (v/v) heat inactivated foetal bovine serum (FBS, Bovogen Biologicals)
in PBS. Samples underwent centrifugation at 350 x g for 5 min and liquid was decanted. A cell
staining master mix was made in Roswell Memorial Park Institute -1640 medium with 10% (v/v)
FBS, where fluorochrome conjugated antibodies r-phycoerythrin (PE)/Cyanine (Cy)5-CD11b,
fluorescein isothiocyanate (FITC)-CD16, PE/Cy7-CD31, brilliant violet (BV)421-CD45, BV711F4/80, BV605-Ly-6C and PE-Ly-6G and FLICA 660-YVAD-FMK fluorogenic molecule (FLICA 660
Caspase-1 assay kit, ImmunoChemistry Technologies) were added (Table 6.1). Each sample was
resuspended in 100 µL of master mix and incubated for 30 min protected from light, with gentle
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agitation at ten-minute intervals. Cells were washed by adding 1 mL 10% (v/v) FBS in PBS
followed by centrifugation at 350 x g for 5 min. Cells were resuspended in 300 µL of 10% (v/v)
FBS in PBS and samples were transferred to a 96-well plate. Cells were analysed using an Attune
NxT (Invitrogen, Carlsbad, CA, USA) flow cytometer.
Table 6.1: Fluorochrome conjugated antibodies and fluorescent dyes used in for in vivo
experiments in this thesis.
Conjugated antibody/Dye
Company Product #/Clone
Volume per sample (μL)
PE/Cy5 anti-mouse/human CD11b
BioLegend 101210/M1-70
1
FITC anti-mouse CD16

BioRad

MCA5998F/AT154-2

1

PE/Cy7 anti-mouse CD31

BioLegend

102417/390

1

BV421 anti-mouse CD45

BioLegend

103134/30-F11

0.5

BV711 anti-mouse F4/80

BioLegend

123147/BM8

1

BV605 anti-mouse Ly-6C

BioLegend

128035/HK1.4

0.5

PE anti-mouse Ly-6G

BioLegend

127607/1A8

0.5

FLICA 660-YVAD-FMK

ICT

ICT9122/-

0.33

Abbreviations: BV, brilliant violet; CD, cluster of differentiation; Cy, Cyanine; FITC, fluorescein
isothiocyanate; ICT, ImmunoChemisty Technologies; PE, r-phycoerythrin.

6.2.9 Murine serum cytokine determination
Serum cytokines were determined using the LEGENDplex™ mouse inflammation panel beadbased immunoassay (interleukin (IL)-1β, type I interferon (IFN)-β, IFN-γ, tumour necrosis factor
(TNF)-α, monocyte chemoattractant protein (MCP)-1, IL-6, IL-10, IL-12p70, IL-17A, IL-23, IL-27,
IL-33 and granulocyte-macrophage colony-stimulating factor (GM-CSF)) (BioLegend) and flow
cytometry as per the manufacturer’s instructions. In brief, samples and standards were
transferred to a v-bottom 96-well polyethylene plate and incubated with beads and detection
antibodies for 120 min at room temperature, with shaking (800 rpm) protected from light. PEconjugated streptavidin was then added and incubated for a further 30 min at RT, with shaking
(800 rpm) protected from light. Beads were washed twice with LEGENDplex™ wash buffer and
data collected using an Attune NxT (Invitrogen) flow cytometer. Beads were initially gated upon
forward scatter- area (FSC-A) and side scatter-area (SSC-A) (A and B populations). Cytokinespecific beads have a signature allophycocyanin (APC) fluorescence, with quantitative expression
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of each determined by the amount PE fluorescence, due to antibody binding, in comparison to a
set of cytokine standards. Data was analysed using the LEGENDplex™ software V8.0 (VigeneTech
Inc., Carlisle, MA, USA) to produce standard curves and interpolate samples (Appendix D).

6.2.10 Statistical analysis
Statistical analyses and graph creation were performed using Prism 6 (GraphPad Software Inc.,
San Diego, CA, USA). Where sample sizes were equal, data were analysed using two-way ANOVA
using Tukey HSD corrections. Two-way ANOVA ‘p’ values represent interaction (treatment*time)
or are specified as treatment or time (denoted by ‘p’). Where sample sizes were not equal (Figures
6.4, 6.6 and 6.8), nonparametric methods were applied. Under these circumstances data were
analysed by one-way ANOVA (Kruskal Wallis test, denoted by ‘kp’) with Dunn’s multiple
comparison or using Welch’s t-test (unpaired, denoted by ‘wp’). For all tests Gaussian distribution
was assumed, although tests of normality were not performed due to the small sample size.
Statistical test were used to compare treatment groups when they were comprised of three of
more mean values and post-hoc tests were only applied to significant ANOVA interactions.
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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6.3 Results
6.3.1 Intradermal GAS infection causes invasive infection in C57BL/6J mice
In order to investigate the immune cell response during the early stages of GAS infection, equal
numbers of male and female C57BL/6J mice were intradermally injected with 5448, 5448AP or
saline and euthanised at 6 or 24 h post-infection. Clinical observations of murine health, lesion
size and bacterial dissemination were recorded (Figure 6.1). Infection of mice with either GAS
strain significantly reduced mean body weight at 24 h compared to the uninfected (saline) control
(p<0.05, Figure 6.1A). Mice infected with both GAS strains developed lesions at 24 h, with 5448
inducing significantly larger lesions than 5448AP (Figure 6.1B), where injection sites were
imaged (Figure 6.1C). 5448 injection induced open lesions with exudate surrounded by redness
and 5448AP injection induced dry lesions, with purple and red discolouration of the surrounding
skin and swelling of the immediate area (Figure 6.1C) and hind limbs (not shown). To assess GAS
dissemination, the bacterial burden was measured at the site of infection (Figure 6.1D) and in the
spleen (Figure 6.1E) and liver (Figure 6.1F) by plating. The burden of GAS at all sites was similar
between strains at each time point, where an approximate log-fold increase was observed for
both strains between 6 and 24 h (Figures 6.1D-F). Of the clinical and bacterial observations made
in vivo during GAS infection, only lesion size differed between the two strains within 24 h.

6.3.2 Characterisation of murine immune cells using flow cytometry
Murine immune cells in the blood and lavage fluid following injection with 5448, 5448AP or saline
were assessed using flow cytometry at 6 and 24 h post-infection. A sequential flow cytometric
gating strategy characterised neutrophil (CD45+/CD11b+/Ly-6G+), iMO (CD45+/CD11b+/Ly6Chigh) and macrophage (CD45+/CD11b+/F4/80+) populations (Figure 6.2A). Cell populations
were assessed for inflammatory caspase activation (Figure 6.2B) and viability (Figure 6.2C). The
expression of CD markers on cell populations was only performed on viable cells (Figure 6.2C).
Immune cell populations with low cell counts have been outlined in Table 9.6 (Appendix G).
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Figure 6.1: Mice infected with emm1 GAS display signs of invasive disease 24 h post-infection. Male
and female 6-8 week old C57Bl/6J mice were injected with saline, 5448 or 5448AP and clinical disease
manifestations and bacterial loads assessed at 6 and 24 h. (A) Mouse body weight during infection,
represented as a percentage of pre-infection weight. (B) Area of lesion formation was calculated by
multiplying lesion length by lesion width, in mm. (C) Exemplar images of infection sites 24 h post-infection,
where images are representative of treatment groups. Bacterial concentrations were determined at (D) the
site of injection (in lavage fluid) and (E) in the spleen and (F) liver at 6 and 24 h following homogenization
of tissue, by serial dilution and plating on THY agar. Each data point represents the results from a single
mouse. Results are the means ± SD. Two-way ANOVA ‘p’ values represent interaction (treatment*time).
*p<0.05, **p<0.01 and ****p<0.0001 with black asterisks denoting significance from control and grey
asterisks between 5448 and 5448AP, or as indicated by a line.
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Figure 6.2: Flow cytometric sequential gating strategy for the identification of murine neutrophils,
inflammatory monocytes and macrophages. (A) Following injection with saline, 5448 or 5448AP,
immune cells were selected in blood (shown) and lavage fluid (not shown) as ‘singlets’ (FSC-A vs. FSC-H)
then ‘murine cells’ (FSC-A vs. SSC-A), before the assessment of CD45 (BV711) and CD11b (PE/Cy5).
CD45+/CD11b+ cells were further characterised as neutrophils (Ly-6G+), inflammatory monocytes (iMOs,
Ly-6Chigh) or macrophages (F4/80+). Immune cell populations were assessed for (B) inflammatory caspase1 activation using FLICA 660 (660-YVAD-FMK) and (C) viability using Zombie Aqua Fixable Viability Kit.
(A-C) Flow cytometric plots are representative of the gating strategy and display blood from a mouse
infected with 5448 at 6 h.
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6.3.3 Neutrophils respond to GAS infection and activate inflammatory caspases
The response of neutrophils (Ly-6G+) during 5448 and 5448AP GAS infection in mice was
investigated using flow cytometry. Infection of mice with either GAS strain resulted in an increase
in blood neutrophils compared to the saline injection (uninfected control) at 6 h only (p<0.01),
though the neutrophil response to 5448AP was significantly greater than 5448 (p<0.01, Figure
6.3A). Blood neutrophil populations returned to baseline after 24 h, indicating the mobilisation
of neutrophils during the early stage of infection (Figure 6.3A). Low blood neutrophil death was
observed, regardless of injection type or time (Figure 6.3B). GAS infection induced minor
increases to blood neutrophil inflammatory caspase activation, however statistical difference
from the saline control was not reached upon post-hoc analysis (Figure 6.3C, p>0.05). Infection
of mice with either GAS strain increased neutrophil populations at sites of injection (lavage fluid)
at both 6 and 24 h compared to the saline control (p<0.001), where the response to 5448AP
appeared sustained over 24 h (Figure 6.3D). Neutrophil death was increased in response to GAS
infection at 24 h, compared to saline injected mice (p<0.01, Figure 6.3E). Infection of mice with
5448AP, but not 5448, increased inflammatory caspase activation at 6 h compared to saline
(p<0.05), while both strains increased inflammatory caspase activation at 24 h compared to
saline (p<0.001, Figure 6.3D). Collectively, the neutrophil response to GAS involves the activation
of inflammatory caspases where an elevated response can be observed during 5448AP infection
of mice.

6.3.4 Characterisation of neutrophil CD11b, CD16 and CD31 expression
Viable neutrophils in the blood and lavage fluid were further characterised for CD11b, CD16 and
CD31 expression at 6 and 24 h by flow cytometry (Figure 6.4). Blood neutrophils from mice
injected with saline displayed consistent CD11b expression at 6 and 24 h, which was unchanged
by injection with either GAS strain (Figure 6.4A). The expression of CD16 on blood neutrophils
was similar between all treatments at 6 h and increased only in response to 5448 infection
between 6 and 24 h (wp=0.0446, Figure 6.4B). The expression of CD31 on blood neutrophils also
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displayed consistent expression between all treatments over the two time points (Figure 6.4C).
In contrast to blood samples, low neutrophil numbers and/or low cell viability at the site of
infection was observed (Figures 6.3D-E) and values with low cell counts were excluded from
analysis (outlined in Appendix G). Infection with either GAS strain increased lavage neutrophil
CD11b expression at 6 h compared to saline injection, where expression decreased by 24 h,
though differences were not statistically significant between treatments (Figure 6.4D, p=0.1782).
Neutrophils lavaged from the site of 5448 injection displayed increased CD16 expression
compared to saline injection (p<0.01), which by 24 h had significantly decreased (wp=0.0012,
Figure 6.4E). Neutrophils lavaged from the site of saline injection displayed variable CD31
expression at 6 h, with no significant differences in expression following infection with either GAS
strain at 6 h, or for 5448 between 6 and 24 h (Figure 6.4F). These data show that neutrophils
display consistent CD11b, CD16 and CD31 in the circulation during GAS infection, though
differences are measurable at the site of infection.
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Figure 6.3: Infection with GAS in vivo activates inflammatory caspases in murine neutrophils.
Following injection with saline, 5448 or 5448AP, cells were characterised by flow cytometry (Figure 6.2).
(A) Neutrophil populations (CD45+/CD11b+/Ly-6G+) in the (A-C) blood and (D-E) lavage fluid are shown as
the (A and D) percentage of CD45+ cells. Neutrophil populations were assessed for (B and E) viability using
Zombie Aqua Fixable Viability Kit and (C and F) inflammatory caspase activation using FLICA 660-YVADFMK. Each data point represents the results from a single mouse where n=8. Results are the means ± SD.
Two-way ANOVA ‘p’ values represent interaction (treatment*time) or are stated. *p<0.05, **p<0.01,
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***p<0.001 and ****p<0.0001, with black asterisks denoting significance from control and grey asterisks
between 5448 and 5448AP, or as indicated by a line.
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Figure 6.4: Neutrophil function during in vivo GAS infection can be tracked by cell-surface CD
expression. Following injection with saline, 5448 or 5448AP, cells were characterised by flow cytometry
(Figure 6.2). Neutrophil populations (CD45+/CD11b+/Ly-6G+) in the (A-C) blood and (D-F) lavage fluid
were assessed for the cell-surface expression of (A and D) CD11b-PE/Cy5, (B and E) CD16-FITC and (C and
F) CD31-PE/Cy7. Each data point represents the results from a single mouse where n=8 and mean
fluorescence intensity (MFI) is shown. Results are the means ± SD. One-way ANOVA (Kruskal Wallis test)
values represented as ‘kp’ and Welch’s t-test values represented as ‘wp’. **p<0.01, with black asterisks
denoting significance from control or as indicated by a line.

6.3.5 Monocytes respond to GAS infection and activate inflammatory caspases
The response of iMOs (Ly-6Chigh) during 5548 and 5448AP GAS infection in mice was investigated
using flow cytometry. Infection of mice with either GAS strain invoked a response from iMOs in
the blood, however only 5448AP significantly increased circulating populations at 6 h compared
to the saline control (p<0.01, Figure 6.5A). Low death was observed for blood iMO populations
following all treatments at both times (Figure 6.5B). Blood iMOs displayed moderate, but
consistent inflammatory caspase activation, with no significant differences determined between
any groups upon post-hoc analysis (Figure 6.5C, p>0.05). At the site of saline injection iMO
populations were observed in response to all treatments, however populations were sustained in
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response to 5448AP at 24 h (p<0.001, Figure 6.5D). Lavage iMO death was increased in response
to GAS infection at 24 h, compared to saline injected mice (p<0.05, Figure 6.5E). Inflammatory
caspase activation in iMOs was similar in all three groups at 6 h, however both GAS strains
increased inflammatory caspase activation in iMOs at 24 h compared to saline (p<0.05, Figure
6.5F). Collectively, in vivo GAS infection invokes recruitment of iMOs to the site of injection,
resulting in cell death and inflammatory caspase activation.
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Figure 6.5: Infection with GAS in vivo activates inflammatory caspases in murine inflammatory
monocytes. Following injection with saline, 5448 or 5448AP, cells were characterised by flow cytometry
(Figure 6.2). Inflammatory monocytes (iMOs, CD45+/CD11b+/Ly-6Chigh) in the (A-C) blood and (D-F) lavage
fluid are shown as the (A and D) percentage of CD45+ cells. IMO populations were assessed for (B and E)
viability using Zombie Aqua Fixable Viability Kit and (C and F) inflammatory caspase activation using FLICA
660 (660-YVAD-FMK). Each data point represents the results from a single mouse where n=8. Results are
the means ± SD. Two-way ANOVA ‘p’ values represent interaction (treatment*time) or are stated. *p<0.05,
**p<0.01, ***p<0.001 and ****p<0.0001, with black asterisks denoting significance from control or as
indicated by a line.

6.3.6 Characterisation of monocyte CD11b, CD16 and CD31 expression
Viable murine iMOs in the blood and at the site of injection were further characterised for CD11b,
CD16 and CD31 expression at 6 and 24 h by flow cytometry (Figure 6.6). Injection with either GAS
strain increased CD11b expression on blood iMOs at 6 (p<0.05) and 24 h (p<0.01) when
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compared to saline (Figure 6.6A). Similarly, injection with both GAS strains increased CD16
expression at 6 (p<0.05) and 24 h (p<0.05), where the response to 5448AP was increased but did
not reach statistical significance (p= 0.2377, Figure 6.6B). The expression of CD31 on blood iMOs
was similar between all groups at both 6 and 24 h (Figure 6.6C). Due to low iMO numbers and/or
low cell viability at the site of infection (Figures 6.3D-E) some data points were excluded from
analysis (outlined in Appendix G). The expression of CD11b on lavage iMOs was similarly high in
response to both GAS strains (Figure 6.6D). Increased expression of CD16 on lavage iMOs was
observed following 5448AP injection at 6 h only, though these differences were not statistically
significant (Figure 6.6E, wp=0.2185 and wp=0.7677). The expression of CD31 on lavage iMOs was
similar between all treatments (Figure 6.6F). Together, these data show that GAS infection
invokes largest changes to CD11b and CD16 on blood iMOs.

6.3.7 GAS infection does not invoke a strong response from murine macrophages
within 24 h
Finally, the response of macrophages (F4/80+) during 5448 and 5448AP GAS infection in mice
was investigated using flow cytometry. The percent of blood macrophages was unchanged
following all treatments (Figure 6.7A). High blood macrophage death was observed for all
treatments at both time points (Figure 6.7B). Blood macrophages displayed moderate and similar
amounts of inflammatory caspase activation following saline or GAS injection at both 6 and 24 h
(Figure 6.7C). Similar proportions of macrophages were present at the lavage site following
injection with saline or GAS (Figure 6.7D). High macrophage death was also observed at the
lavage site, with similar proportions due to all treatments at 24 h (Figure 6.7E). Lavage
Macrophages displayed increased inflammatory caspase activation only following 5448 injection
at 24 h, though a statistical difference was not determined between any treatments (Figure 6.7F,
p=0.0534). The response of macrophages to GAS infection in vivo is limited in this model, with no
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statistically significant evidence that GAS results in inflammatory caspase activation using the
time points in this study.

Figure 6.6: Inflammatory monocyte function during in vivo GAS infection can be tracked by cellsurface CD expression. Following injection with saline, 5448 or 5448AP, cells were characterised by flow
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cytometry (Figure 6.2). Inflammatory monocyte (iMO) populations (CD45+/CD11b+/Ly-6Chigh) in the (A-C)
blood and (D-F) lavage fluid were assessed for the cell-surface expression of (A and D) CD11b-PE/Cy5, (B
and E) CD16-FITC and (C and F) CD31-PE/Cy7. Each data point represents the results from a single mouse
where n=8 and mean fluorescence intensity (MFI) is shown. Results are the means ± SD. One-way ANOVA
(Kruskal Wallis test) values represented as ‘kp’ and Welch’s t-test values represented as ‘wp’. *p<0.05,
**p<0.01, ***p<0.001 and ****p<0.0001, with black asterisks denoting significance from control and grey
asterisks between 5448 and 5448AP, or as indicated by a line.

6.3.8 Characterisation of macrophage CD11b, CD16 and CD31 expression
Viable murine macrophages in the blood lavage fluid were further characterised for CD11b, CD16
and CD31 expression at 6 and 24 h by flow cytometry (Figure 6.8). Due to low macrophage
numbers and/or low cell viability (Figures 6.7A-B and D-E) some data points were excluded from
analysis (outlined in Appendix G). The expression of CD11b, CD16 and CD31 on blood
macrophages was similar following saline or GAS injection at both 6 and 24 h (Figure 6.8A-C).
Due to the limited number or complete absence of data points obtained for lavage macrophages,
no statistical tests were valid to compare groups for the expression of CD11b, CD16 or CD31
(Figures 6.8D-F). However, where data were available, the following observations can be made.
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The expression of CD11b on lavage macrophages was similar following injection with 5448 at 6
and 24 h and 5448AP at 6 h (Figure 6.8D). The expression of CD16 on lavage macrophages
following 5448 injection at 6 h was increased compared to 5448AP, where expression decreased
in response to 5448 by 24 h (Figure 6.8E). Finally, CD31 expression on lavage macrophages
following 5448 injection was greater than 5448AP at 6 h, where expression increased in response
to 5448 by 24 h (Figure 6.8F). The response of macrophages during GAS infection is well
established, however the current model is not useful for further characterisation of the
macrophage response within the first 24 h of infection.

Figure 6.7: GAS infection in vivo does not involve a strong macrophage response. Following injection
with saline, 5448 or 5448AP, cells were characterised by flow cytometry (Figure 6.2). Macrophage
populations (CD45+/CD11b+/F4/80+) in the (A-C) blood and (D-F) lavage fluid are shown as the (A and D)
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percentage of CD45+ cells. Macrophage populations were assessed for (B and E) viability using Zombie
Aqua Fixable Viability Kit and (C and F) inflammatory caspase activation using FLICA 660-YVAD-FMK. Each
data point represents the results from a single mouse where n=8. Results are the means ± SD. Two-way
ANOVA ‘p’ values represent interaction (treatment*time) or are stated. *p<0.05 and **p<0.01, with black
asterisks denoting significance from control or as indicated by a line.
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Figure 6.8: Macrophage function during in vivo GAS infection can be tracked by cell-surface CD
expression. Following injection with saline, 5448 or 5448AP, cells were characterised by flow cytometry
(Figure 6.2). Macrophage populations (CD45+/CD11b+/F4/80+) in the (A-C) blood and (D-F) lavage fluid
were assessed for the cell-surface expression of (A and D) CD11b-PE/Cy5, (B and E) CD16-FITC and (C and
F) CD31-PE/Cy7. Each data point represents the results from a single mouse where n=8 and mean
fluorescence intensity (MFI) is shown. Results are the means ± SD.

6.3.9 Increased inflammatory cytokines are released in response to 5448AP
Unregulated inflammation is a hallmark of invasive GAS disease. Hence, to assess inflammation,
serum cytokine concentrations at 6 and 24 h following injection with saline, 5448 or 5448AP were
determined using a 13-plex flow cytometric bead assay and flow cytometry (Figure 6.9). Two
bead populations A and B were selected by FSC-A and SSC-A (Figure 6.9A), where cytokine
concentrations were determined by PE and APC fluorescence (Figure 6.9B) and comparison to a
standard curve (Appendix D). With the exception of IL-6 and MCP-1, serum cytokines were
present in the majority of saline injected mice at 6 h with a rate order of IL-27 > IFN-β > IL-23 >
IFN-γ > IL-10 = TNF-α > IL-1β > GM-CSF > IL-17A > IL-1α > IL-12p70 (Figure 6.9C-O). The
presence of these cytokines in saline injected mice was similar at 24 h compared to 6 h (Figure
6.9C-O). Only IL-6 was increased by both 5448 and 5448AP infection at both time points
(p<0.0001, Figure 6.9H). Injection with both GAS strains also increased MCP-1 at 6 h (p<0.001)
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but this was significantly reduced at 24 h compared to 6 h (p<0.05, Figure 6.9N). Injection of 5448
did not significantly alter any of the remaining cytokines compared to saline (Figure 6.9C-G, I-M
and O). In contrast, injection of 5448AP significantly increased IFN-β (p<0.01, Figure 6.9D) at 6 h
and IFN-γ (p<0.0001, Figure 6.9E), IL-1α (p<0.01, Figure 6.9F), IL-1β (p<0.0001, Figure 6.9G), IL10 (p<0.0001, Figure 6.9I), IL-12p70 (p<0.001, Figure 6.9J), IL-17A (p<0.0001, Figure 6.9K) and
TNF-α (p<0.01, Figure 6.9O) at 24 h compared to saline. Significant increases were also
determined following 5448AP infection between 6 and 24 h for GM-CSF (p<0.0001, Figure 6.9C),
IFN-γ (p<0.0001, Figure 6.9E), IL-1β (p<0.0001, Figure 6.9G), IL-6 (p<0.0001, Figure 6.9H), IL-10
(p<0.0001, Figure 6.9I), IL-12p70 (p<0.001, Figure 6.9M), IL-17A (p<0.0001, Figure 6.9K), IL-23
(p<0.01, Figure 6.9L) and TNF-α (p<0.001, Figure 6.9O). Additionally, injection with 5448AP
significantly increased IFN-γ (p<0.0001, Figure 6.9E), IL-1β (p<0.0001, Figure 6.9G), IL-6
(p<0.0001, Figure 6.9H), IL-10 (p<0.001, Figure 6.9I), IL-12p70 (p<0.001, Figure 6.9J), IL-17A
(p<0.0001, Figure 6.9K) and TNF-α (p<0.0001, Figure 6.9O) at 24 h when compared to 5448.
Collectively both GAS strains induce some cytokine release, however 5448AP is generally
associated with higher concentrations of inflammatory cytokines than 5448. This increased
inflammatory response may contribute to the more severe disease pathology observed during
infection of mice with 5448AP.
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Figure 6.9: In vivo infection with 5448AP invokes greater release of inflammatory cytokines than
5448 infection. Following injection of mice with saline, 5448 or 5448AP inflammatory cytokines in serum
were determined using the LEGENDplex™ mouse inflammation cytometric bead assay and flow cytometry.
(A) Beads A and B were gated upon FSC-A vs. SSC-A and (B) fluorescence of PE vs. APC determined, where
(A-B) plots are representative and display results following 5448AP infection at 6 h. The concentration of
(C) GM-CSF, (D) IFN-β, (E) IFN-γ, (F) IL-1α, (G) IL-1β, (H) IL-6, (I) IL-10, (J) IL-12p70, (K) IL-17A, (L) IL-23,
(M) IL-27, (N) MCP-1 and (O) TNF-α was determined by comparison to a standard curve. Duplicate
measurements from each mouse are displayed, where n=8 mice were used for each treatment/time. Results
are the means ± SD. Two-way ANOVA ‘p’ values represent interaction (treatment*time) or are stated.
*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, with black asterisks denoting significance from control
and grey asterisks between 5448 and 5448AP, or as indicated by a line.
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6.4 Discussion
This chapter assessed the response of the innate immune cells (neutrophils, iMOs and
macrophages) and circulatory cytokines in response to GAS strains 5448 and 5448AP in a murine
model of invasive infection. Despite similar bacterial loads, 5448 induced larger lesions at the site
of injection then 5448AP. Neutrophils responded rapidly to GAS infection in vivo, but may remain
longer at the site of 5448AP injection than 5448. Neutrophils died in response to GAS and
activated inflammatory caspases, where additionally during 5448 infection, cell-surface CD16
expression decreases between 6 and 24 h. IMOs also made up a proportion of the inflammatory
response to GAS in vivo, with 5448AP instigating larger changes. Cell death with inflammatory
caspase activation was also evident for iMOs at the site of GAS infection. The expression of both
CD11b and CD16 on blood iMOs increased due to infection with either GAS strain. The response
of macrophages to these GAS strains however, could not be further described using this model
due to low cell viability. Both 5448 and 5448AP induced the release of inflammatory cytokines
during 24 h infection, however 5448AP was associated with higher concentrations in most cases,
indicating an increased inflammatory response.
Here, evidence is provided demonstrating that murine neutrophils and iMOs die in response to
emm1 GAS infection, where inflammatory caspase activation is evident. Caspase-1 is the most
notable inflammatory caspase, as it is primarily recognised for its role during the release of
inflammatory cytokine IL-1β (Man et al., 2017). The activation of inflammatory caspases was
similar in neutrophils and iMOs when comparing GAS strains 5448 and 5448AP. In contrast, the
release of IL-1β into the serum differed between these two strains, with increased IL-1β release
evident during 5448AP infection only. Due to the presence of a complete immune system, we
cannot attribute IL-1β release to neutrophils alone. Previously, caspase-1 activation and IL-1β
has only been reported for murine and human macrophages during GAS infection (Harder et al.,
2009, Lin et al., 2015, Timmer et al., 2009), yet the current study suggests that neutrophils and
iMOs may also contribute to a caspase-mediated inflammatory process. Increased release of IL-
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1β observed during 5448AP infection, may be a contributing factor in the development of invasive
GAS disease, as regulation of IL-1β can influence murine mortality (Hsu et al., 2011, Lin et al.,
2015). IL-1β and IFN-I have been identified as key homeostatic variables of inflammation during
infection of mice with GAS (Castiglia et al., 2016), where control is essential to resolve
inflammation.
Other factors should also be considered when comparing the inflammatory potential of the two
strains 5448 and 5448AP however. GAS virulence factor Streptococcus ADP-ribosyl transferase
(SpyA, spyA gene) can trigger IL-1β release from macrophages in vitro and in vivo (Lin et al., 2015).
The spyA gene has been found to be strongly upregulated in covS mutants, including 5448AP,
when compared to the functional covRS wild type (Maamary et al., 2010). The upregulation of
SpyA by 5448AP could also be a contributing factor increasing IL-1β release, if it acts similarly
upon neutrophils and iMOs, which future studies may wish to explore. Increased IL-1β can also
be an indicator of the severity of GAS infection (Norrby-Teglund et al., 2000). The increased
IL-1β observed during 5448AP infection may therefore be a result of upregulated virulence
factors, which in turn increase the severity of disease. The increased severity of disease during
5448AP infection, is further supported by the greater release of other inflammatory cytokines,
including, GM-CSF, IFN-ɣ, IL-1⍺, IL-10, IL-12p70, IL-17A and TNF-α along with greater release of
IL-6. Uncontrolled release of cytokines is termed a ‘cytokine storm’ and is associated with the
development of sepsis and increased mortality during invasive infections (Sriskandan and
Altmann, 2008).
The current study identifies differences in CD16 expression on murine neutrophils during GAS
infection. Significant differences were only observed during 5448 infection, where CD16
expression increased in the blood between 6 and 24 h and elevated CD16 was observed at 6 h but
decreased by 24 h in lavage fluid. Limited studies have explored this aspect of CD expression in
response to GAS infection. CD16 is commonly used as a maturation marker for neutrophils (Manz
and Boettcher, 2014) but plausibly the distinct increase and decrease at the site of infection could
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also be indicative of apoptotic death (Dransfield et al., 1994), however apoptotic neutrophil death
was not specifically investigated in this study. It was hypothesised that differences in neutrophil
CD11b would also be observed, as CD11bhigh neutrophils have been shown to be responsible for
the clearance of infection (Fine et al., 2019), but are also associated with the inflammatory
pathway that produces NETs (Cerutti et al., 2013). Similarly, it was hypothesised that CD31
expression would change in response to GAS infection, however this was not observed. It is
possible that like in humans, the down regulation of CD31 may also promote efferocytosis of
neutrophils (Brown et al., 2002), however as this occurs as a product of cell death, an earlier time
point with increased neutrophil viability may yield results that better reflect in vitro findings.
Although there are some distinct differences in gene profiles between humans and mice, it is also
accepted that they are broadly conserved (Ingersoll et al., 2010). It is possible that the presence
of a more complete and dynamic immune response in vivo or interspecies differences, may
underlie the differences between the results obtained using primary human neutrophils and
mouse models of infection in this thesis.
Along with the primary objective to investigate the response of neutrophils during GAS infection
in vivo, significant differences in CD11b and CD16 expression on iMOs were observed in the blood
only. IMOs infected with both GAS strains 5448 and 5448AP had increased CD11b expression,
where increased CD11b is indicative of activation and an inflammatory phenotype (Duan et al.,
2016). Though the response was comparable between strains, the percent of iMOs in the blood
was increased in response to 5448AP at 6 h. Similarly, iMOs infected with 5448 and 5448AP had
increased CD16 expression. Monocytes that exhibit CD16 expression are a subset of ‘nonclassical’ monocytes and are predominant monocyte subpopulation during systemic
inflammation in humans (Mukherjee et al., 2015). IMOs have not previously been investigated
during GAS infection but are significant cytokine producing cells (Loppnow et al., 2008). Thus,
these cells have the potential to significantly contribute to inflammation during GAS infection.
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Viability of iMOs in the blood is retained and future investigations should investigate their role
past 24 h during in vivo GAS infection.
Results relating to the role of macrophages during GAS infection using this model was not in line
with previous findings, which indicate macrophages play an essential role in the control of softtissue GAS infection in mice (Goldmann et al., 2004, Mishalian et al., 2011). Low macrophage
viability was observed, even following saline injection, meaning caution must be taken here when
drawing conclusions about the response of macrophages to GAS. The marker F4/80 was used to
characterise murine macrophages (Austyn and Gordon, 1981) and although additional markers
may not improve viability, they may assist with macrophage identification or classification and
be worth considering for future investigations. Potential candidates include (intracellular) CD68
(Rabinowitz and Gordon, 1991) and CD163 (Fabriek et al., 2005), while CD38 and early growth
response protein 2 can provide characterisation of classical (M1) and alternatively (M2) activated
macrophages, respectively (Jablonski et al., 2015).
A difference in bacterial dissemination was not observed between 5448 and 5448AP within 24 h
in this study, though previously it has been reported in a similar model at 48 h (Fiebig et al., 2015).
It was hypothesised that the covS mutant 5448AP would disseminate to the liver and spleen more
rapidly, while also having an increased load at the site of infection. This hypothesis was based on
the upregulation of the inflammatory response, as seen during 5448AP infection, facilitating
bacterial dissemination. GAS can survive and replicate intracellularly in macrophages (Barnett et
al., 2013, O’Neill et al., 2016), and hence may use macrophages and other immune cells to
disseminate and promote systemic infection. 5448AP however, is not readily phagocytosed by
neutrophils (Chapter 5), and recent work has identified that GAS trafficking occurs extracellularly
via the lymphatic system, in an intramuscular mouse model (Siggins et al., 2020). Lymph nodes
are generally used to filter bacteria, due to high concentrations of immune cells such as
neutrophils (Clement et al., 2018, Drinker et al., 1934). Disease progression through the
lymphatics has previously been described for metastatic neoplasms but has severe implications
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for the development of sepsis. A distinguishing feature of GAS strains that disseminate through
the lymphatic system is the high expression of hyaluronic acid capsule (Siggins et al., 2020). As a
result of covS mutation, 5448AP expresses significantly higher amounts of capsule compared with
5448 (Ravins et al., 2000, Sumby et al., 2006), which in turn may also mean that 5448AP is more
easily transported by the lymphatic system than 5448. Once within the lymph nodes, in vitro data
indicates neutrophils do not kill 5448AP, where a sustained bacterial presence would further
promote inflammation and bacterial dissemination. Therefore, characterisation of immune cells
within the lymphatic system may also provide further detail regarding GAS dissemination.
Invasive GAS disease progresses swiftly and the response of innate immune cells during the early
stages greatly dictates the outcome of infection. Imbalance or deregulation of the inflammatory
system can change recruitment of cells and cytokine release, thereby altering the progression of
disease. As such, understanding the host immune response to GAS may provide avenues to better
control infection. The work presented in this thesis shows that in a well-established mouse model
of invasive GAS infection, neutrophils and iMOs increase in the circulation at 6 h, migrating to
sites of infection where they die via a mechanism that is associated with inflammatory caspase
activation. During 5448AP infection, higher numbers of both neutrophils and iMOs are retained
at the site of infection after 24 h. Further, the release of multiple cytokines is increased during
infection with 5448AP and may contribute to exacerbation of infection. Whilst the recruitment of
immune cell populations during in vivo GAS infection has been described previously (Li et al.,
2014, Siggins et al., 2020, Tsatsaronis et al., 2015), more detailed phenotypic characterisation,
such as that presented here, may provide further insight into immune cell function. This is
especially important given the established heterogeneity of populations such as neutrophils that
directly respond to infection (Fine et al., 2019, Silvestre-Roig et al., 2016). This study addresses a
knowledge gap in the field, providing a more detailed description of C57BL/6J mouse neutrophils
and iMOs following injection with saline, 5448 or 5448AP. Future studies investigating innate
immune cells, including characterisation and cell death, should investigate times earlier than
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24 h. This model aims to complement in vitro work and provide further description to the complex
host-pathogen interaction that contributes to severe pathology and invasive GAS disease.
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Streptococcus pyogenes (Group A Streptococcus, Group A Streptococci, GAS) is responsible for a
significant health burden globally, manifesting as a diverse range of diseases (Carapetis et al.,
2005). Invasive infections, often characterised by unregulated inflammation and tissue
destruction, are difficult to treat and result in high mortality rates (up to 23%) within the first 7
days (Walker et al., 2014). Invasive infections may manifest commonly as necrotising fasciitis,
cellulitis and bacteraemia, where the development of sepsis or streptococcal toxic shock (STSS)
can further increase mortality up to 81% (Walker et al., 2014). A diverse range of GAS serotypes
are commonly isolated from invasive disease (Gherardi et al., 2018), however the M1T1 clone has
a particularly high association with invasive disease and has become globally disseminated (Aziz
and Kotb, 2008). Virulence factors that contribute to invasive disease have been extensively
researched, however there is an underrepresentation in the literature describing the host
response to such infections. Contemporary understanding of infection now leans towards the
idea that host immune cells can greatly influence the outcomes of disease, where pathways such
as cell death and signalling may have the potential to exacerbate infections and lead to
unregulated inflammation (Lawrence et al., 2020). Neutrophils are the front line of innate
immunity yet are well known for their ability to also cause damage to the host during an
unregulated response (Epstein and Weiss, 1989). Understanding of the neutrophil-response
during invasive GAS infection until now has been somewhat limited. This thesis aimed to optimise
a method for the isolation of neutrophil proteins, appropriate for the evaluation of caspase
activation by immunoblotting (Chapter 3). Further, this and other methods were employed to
characterise the human neutrophil response to emm98.1 and emm1 GAS in vitro (Chapters 4 and
5). Finally, neutrophils were characterised to determine their role during a murine model of
invasive emm1 GAS infection (Chapter 6). From the findings, a model is proposed where during
invasive GAS infection, an inflammatory neutrophil phenotype is favoured, where bacterial
persistence and hyperinflammation increase the severity of disease (Figure 7.1).
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Figure 7.1: Theoretical model of how infection with GAS promotes an inflammatory neutrophil
phenotype and contributes to the severity of disease. GAS isolates commonly used to model invasive
disease induce inflammatory neutrophil death but display limited evidence of the induction of antiinflammatory neutrophil death. During inflammatory neutrophil death, neutrophils release inflammatory
cytokines and internal contents (danger associated molecular patterns (DAMPs)), further promoting
neutrophil recruitment to the site of infection. GAS are resistant to neutrophil-mediated killing, and
neutrophil activation and antibacterial activity is reduced. Neutrophils do not undergo apoptosis, rather
have prolonged survival, during which time GAS further proliferate. Dampened signals of efferocytosis
results in neutrophil accumulation at the site of infection. Bacterial persistence is accompanied by the
continued release of inflammatory cytokines and promotes increased in the severity of disease.
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In a mouse model of chronic granulomatous, the importance of neutrophils during GAS infection
has previously been demonstrated (Nguyen et al., 2017). Furthermore, recent developments have
shown that the ability of these cells to fight infection is dictated by a subpopulation of ‘primed
neutrophils’ in both mice and humans, identified by elevated cluster of differentiation (CD)63,
CD66a and CD11b expression (Fine et al., 2019). Comparatively, less is known about neutrophils
compared to other immune cell types (Bardoel et al., 2014), partly due to their limited lifespan
once isolated from blood (Miyoshi-Akiyama et al., 2005). For this reason and due to their
abundance in circulation, neutrophils are an important research target. The effectiveness of
neutrophils as phagocytes stems from the abundance of enzymes and antimicrobial peptides
contained within their granules (Lim et al., 2017). These granular contents are released upon cell
lysis, with the ensuing release of proteases hindering the study of intracellular neutrophil
proteins. This thesis has optimised a reproducible method to prepare neutrophil protein lysates
that minimises protein degradation, allowing for the investigation of cell death proteins.
Additionally, neutrophil culture conditions have been optimised by other research groups, using
anoxic incubation conditions and supplementation with glucose to increase neutrophil viability
up to 20 h in vitro (Monceaux et al., 2016). Although this thesis did not require the application of
these methods, subsequent studies may now investigate remaining questions with techniques
such as DNA transfection and transfusion, allowing the field of neutrophil biology to further
progress.
The field of cell death has expanded significantly in recent years, particularly in regards to
understanding of inflammatory death pathways and their contribution to disease pathology
(Lawrence et al., 2020). Inflammatory neutrophil death was first reported in response to emm1
GAS (Kobayashi et al., 2003a), then again in response to emm98.1 GAS (Tsatsaronis et al., 2015),
however both instances were described as necrotic death. The work presented in thesis now
demonstrates that neutrophil death occurs in the presence of inflammatory caspase activation,
during infection with both emm1 and emm98.1 GAS in humans and in response to emm1 GAS in
mice. In the context of invasive infection, this finding is important to understanding downstream

UOW

159

Characterising the neutrophil response to Group A Streptococcus
inflammation, such as the release of interleukin (IL)-1β, which results from the induction of
inflammatory death pathways. Although gasdermin D (GSDMD) is considered as a hallmark of
pyroptosis in many cell types, it was not investigated in this study (Karmakar et al., 2020).
Notably, inflammatory caspase activation in response to emm1 GAS did not directly correlate to
amounts of IL-1β release from human neutrophils or in mice, unlike what was seen in response
to emm98.1 GAS. In vitro, emm1 GAS invoked nearly double the release of IL-1β from human
neutrophils when compared to emm98.1 GAS, with the highest release in response to covS mutant
5448AP. This may indicate that emm1 GAS have an alternative caspase-independent mechanism
of IL-1β activation compared to emm98.1 GAS, with a possibility it may be regulated by the control
of virulence regulator system (covRS). Infection of neutrophils with other bacterial pathogens
such as Staphylococcus aureus, has demonstrated that IL-1β release can occur in a proteasedependant manner, in the absence of IL-18 (Kremserova and Nauseef, 2019). During infection of
neutrophils with emm1 GAS negligible release of IL-18 was also observed. Future studies should
seek to explore the mechanism of IL-1β release further, as it may be another factor contributing
to emm1 invasive disease pathology. Additionally, the role of GSDMD during GAS-mediated
inflammatory neutrophil death should also be explored, as pyroptotic markers differ between
macrophages and neutrophils and hallmarks of one cell type may not be indicative for the other
(Karmakar et al., 2020).
It has been well established that mutation within the covRS confers increased virulence and
resistance to neutrophil mediated killing in both emm1 and non-emm1 GAS (Maamary et al., 2010,
Walker et al., 2007), where multiple virulence factors are differentially regulated as a result of
covRS mutation (Kilsgård et al., 2016, Sumby et al., 2006). Two of the strains used in this study
contain covS mutations (NS88.2 and 5448AP), however otherwise these strains are genetically
diverse from one another (Davies et al., 2019, Fiebig et al., 2015, Tsatsaronis et al., 2013). Despite
these differences, similarities in the neutrophil response to NS88.2 and 5448AP were observed.
Neutrophil death occurs in the presence of inflammatory caspase activation during infection with
all strains, but absence of apoptosis during infection with covS mutants NS88.2 and 5448AP. Both
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CD16 and CD31 are retained by neutrophils during infection with NS88.2 and 5448AP, though CD
expression for 5448AP was not reflected in vivo. Additionally, NS88.2 and 5448AP demonstrate
increased proliferation, rather than killing, in the presence of viable human neutrophils. It is
hypothesised that for covS mutants, multiple strains may invoke an ‘invasive phenotype’ that
disrupts the homeostatic balance required for infection control. The identification of a common
neutrophil response phenotype between genetically diverse strains has implications for the
development of therapeutics that target infection in areas where GAS disease is endemic, as there
is often significant serotype/emm-type diversity in these regions (Steer et al., 2009b). Although
reports of GAS harbouring covS mutations in these regions are limited, future investigation may
focus on determining the extent to which a broader set of GAS serotypes associated with invasive
infections also induce this neutrophil phenotype.
Limited treatment options and swift progression make invasive GAS infection a devastating
disease and despite numerous efforts, vaccines that cover all GAS serotypes are still under
development (Davies et al., 2019). Thus, a more comprehensive understanding of the immune
response during invasive infection and the identification of early biomarkers may assist in
broadening therapeutic options and decreasing mortality. The characterisation of cells using
expression of CD markers can allow for the identification of important cell subtypes (Fine et al.,
2019) and interpretation of cell function during conditions such as inflammation (Lakschevitz et
al., 2016). CD11b and CD64 expression on neutrophils have both been identified as potential
biomarkers of severe inflammation (Barth et al., 2001, Qiu et al., 2019), though this thesis did not
confirm these findings during emm1 or emm98.1 GAS infection of neutrophils in vitro. The use of
CD molecules as biomarkers poses significant problems however, as over 370 are known.
Therefore, analysing the expression of only one or two markers may not be informative across a
diversely heterogenetic population in a clinical setting. Tools such as high throughput flow
cytometry may be more useful for a broader analysis of CD expression in a clinical setting
(Lakschevitz et al., 2016). Using such techniques, future studies should aim to establish a
standardised set of cell characterisation markers along with a panel of CD markers that may be
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used to determined neutrophil function and potentially have distinguishing features when
assessed during a diseased state. If this is done across many diseases with similar inflammatory
phenotypes, the data may serve useful in meta-analyses to better describe and understand the
human inflammatory response to infection.
Time point selection for analysis of immune cell and inflammatory responses in animal models
greatly influence conclusions. A sub-aim of this study was to better inform future investigations
through the identification of optimal time points for the study of human and mouse neutrophils
during GAS infection. The data in Chapters 4 and 5 indicate the optimal opportunities to assess
neutrophil viability, reactive oxygen species production and cell-surface CD expression (namely
CD11b, CD16, CD31 and CD66b) in vitro occurs within a 60 min incubation with GAS. During this
time caspases can also be detected, however cleavage products are best assessed after 180 min
incubation with GAS. Similarly, the release of cytokines from GAS infected neutrophils
predominantly occurs from 60 min and optimally after 180 min for most cytokines analysed here.
Neutrophils are known to respond rapidly to infection (Serhan et al., 2007), and in vivo data
presented confirms that neutrophil viability at the site of infection is low by 24 h. Therefore, when
investigating neutrophil function (such as via measurement of CD expression), neutrophils may
need to be assessed prior to this time point if viability is an important factor. The limited
correlation of CD expression findings between the human in vitro and mouse in vivo work could
be a result of timing. Additionally, it cannot be excluded that differences may also be due to
species-specific factors and the presence of a more complete immune response in vivo. One
significant challenge in the development of this project was the selection of time points. The
majority of published studies with neutrophils present data from a single, often a 30 minute time
point. Here, it was shown that the use of multiple time points can be highly informative and may
be more representative of the true complexity of clinical GAS infection. This information can also
assist other researchers asking similar questions, with the possibility to save resources and time
along with aiding application of the ‘3R’s’ (Replacement, reduction and refinement of animal use)
to in vivo research (National Health and Medical Research Council, 2019). Due to the exploratory
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nature of the animal work in this thesis, findings and correlations to in vitro data may have also
been limited by the number of biological replicates. Future experiments with additional
observations and optimised timing may allow better correlation between neutrophil CD
expression during in vitro and in vivo GAS infection.
The resurgence of GAS disease in recent decades (Efstratiou, 2000) and high rates of mortality
due to invasive infections (Walker et al., 2014) necessitate research into GAS infection. The early
immune response to GAS, predominantly mediated by neutrophils, plays an important role in host
defence but also can contribute to the severity of invasive disease, by means of influencing the
resolution of inflammation. This thesis describes the host-pathogen interaction that occurs
between diverse GAS isolates associated with invasive disease and human neutrophils, providing
insights into inflammatory neutrophil death, cellular signalling and cytokine release. The data
here shows that GAS modulation of the neutrophil inflammatory response may contribute to the
development of invasive disease pathology. This builds knowledge within a developing area of
infection research and adds to the understanding of GAS disease severity.
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9 Appendices
9.1 Appendix A: Buffers and solution
Unless otherwise noted, solutions were made to volume using deionised H2O.
5 x Polyacrylamide agarose gel electrophoresis (PAGE) loading buffer
Tris-hydrochloride (pH 6.8, Astral Scientific)
Glycerol (Merck)
Bromophenol blue (Sigma-Aldrich)
Sodium dodecyl sulphate (Sigma-Aldrich)
2-mercaptoethanol (Sigma-Aldrich)

225 mM
50% (v/v)
0.05% (w/v)
5% (w/v)
5% (v/v)

Ammonium-chloride-potassium lysing buffer (pH 7.3)
NH4Cl (Sigma-Aldrich)
KHCO3 (Sigma-Aldrich)
Na2CO3(Sigma-Aldrich)

150 mM
1 mM
0.1 mM

Annexin-V assay buffer
4-(2-hydroxyethyl)piperazine-1-thanesulfonic acid (pH 7.4, Sigma-Aldrich)
NaCl (Sigma-Aldrich)
CaCl2 (Ajax Finechem)

10 mM
140 mM
2.5 mM

Coomassie Brilliant Blue rapid stain
Coomassie Blue R-250 (MP Biomedicals)
Methanol (RCI Labscan)
Glacial acetic acid (RCI Labscan)

2 g/L
400 ml/L
100 ml/L

Destain solution
Methanol (RCI Labscan)
Glacial acetic acid (Ajax Finechem)

400 ml/L
100 ml/L

Hank’s balanced salt solution (HBSS, pH 7.3 - 7.4)
Hank’s balanced salt (Corning)
NaHCO3 (Univar Solutions)

9.41 g/L
0.35 g/L

Lysogeny broth (LB)
NaCl (Sigma-Aldrich)
Tryptone (Merck)
Yeast extract (Sigma-Aldrich)

10 g/L
10 g/L
5 g/L

Phosphate buffered saline (PBS, pH 7.3 – 7.4))
NaCl (Sigma-Aldrich)
KCl (Sigma-Aldrich)
Na2HPO4 (Amresco)
KH2PO4 (Amresco)

127 mM
2.7 mM
7.9 mM
1.5 mM

Polyacrylamide agarose gel electrophoresis (PAGE) running buffer
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Tris-hydrochloride (Astral scientific)
Glycine (Amresco)
Sodium dodecyl sulphate (Sigma-Aldrich)

25 mM
200 mM
0.1% (w/v)

Tris-buffered saline containing tween-20 (TBST, pH 7.3-7.4)
KCl (Sigma-Aldrich)
NaCl (Sigma-Aldrich)
Tris (hydroxymethyl) methylamine (Amresco)
Tween 20 (Sigma-Aldrich)

2.7 mM
138 mM
50 mM
0.1% (v/v)

Western transfer buffer
Tris-hydrochloride (Astral Scientific)
Glycine (Amresco)
Methanol (RCI Labscan)

25 mM
0.19 M
20% (v/v)
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9.2 Appendix B: Bacterial concentrations at mid-log phase

Figure 9.1: Colony forming units (CFU) per mL of Group A Streptococcus at mid-logarithmic phase.
The bacterial concentration of NS88.2rep, NS88.2 5448 and 5448AP was determined at mid-logarithmic
phases (OD600 = 0.4) following two washes of the bacterial pellet with PBS. Bacteria were serially diluted
and spot plated onto THY agar, then incubated overnight at 37°C. GAS were enumerated by counting.
NS88.2rep and NS88.2 had concentrations of 1 x 108 ± 2.4 x 107 CFU/mL and 4 x 107 ± 1.6 x 107 CFU/mL
respectively (n = 8). 5448 and 5448AP had concentrations of 1 x 108 ± 3.0 x 107 CFU/mL and 1 x 108 ± 2.0
x 107 CFU/mL respectively (n = 10). The above values were used to calculate multiplicity of infection (MOI).
Result are the pooled means ± SD from triplicate measurements.
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9.3 Appendix C: Calculation of protein concentrations of neutrophil lysates
using the DC Protein Assay
0 .4

0 .4

2

R = 0 .9 8 9 5

2

0 .3

0 .2

0 .1

S lo p e
Y - in t e r c e p t
X - in te r c e p t

0 .0
0

500

1000

0.0001505 ± 6.335e-006
0.01547 ± 0.006392
-102.8
1500

2000

2500

B S A c o n c e n tr a tio n ( u g /m L )

A b s o r b a n c e (A 7 5 0 )

A b s o r b a n c e (A 7 5 0 )

R = 0 .9 9 7 2

0 .3

0 .2

B0
B1
B2
B3

0 .1

0.002226
0.0002053
-3.388e-008
3.265e-012

0 .0
0

500

1000

1500

2000

2500

B S A c o n c e n tr a tio n ( u g /m L )

Table 9.1: Comparison of bovine serum albumin (BSA) standard curve models for the determination
of protein concentration in neutrophil lysates. A dilution series of BSA (0, 62.5, 125, 250, 500, 750, 1000,
1500 and 200 µg/mL) was made in corresponding neutrophil lysis buffer ( see Chapter 2) and protein
concentrations of neutrophil lysates were determined using the DC Protein Assay (Bio-Rad) by
determination of absorbance at 750 nm (A750) (Lowry et al., 1951). Linear and cubic models were compared
and the cubic fit was applied for interpretation of unknown values (neutrophil lysate protein
concentration). Exemplary curves are shown.
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9.4 Appendix D: Calculation of cytokine concentrations
Table 9.2: Standard curve construction for the determination of cytokine concentrations using the
LEGENDplex™ (BioLegend) bead-based flow cytometric assay.
Values were measured from a lyophilised cytokine standard diluted in series and calculated using the
LEGENDplex™ software V8.0 (VigeneTech Inc.) as per the manufacturer’s instructions. Values for the IL-1β
cytokine standard are shown from one experiment and are representative of the process for all cytokines.
Sample
name
C0.1
C0.2
C1.1
C1.2
C2.1
C2.2
C3.1
C3.2
C4.1
C4.2
C5.1
C5.2
C6.1
C6.2
C7.1
C7.2

Expected
concentration
(pg/ml)
0.00
0.00
2.44
2.44
9.77
9.77
39.06
39.06
156.25
156.25
625.00
625.00
2500.00
2500
10000.00
10000.00

MFI

53.10
52.20
58.50
71.10
83.70
110.70
198.90
207.90
1022.00
1130.00
7358.00
7538.00
32057.00
30974.00
69845.00
70097.00

Concentration
(pg/ml)
<0.36
<0.36
1.08
3.89
7.03
13.90
34.47
36.39
154.86
166.83
638.35
650.08
2491.51
2388.71
9992.33
10094.59

Average
MFI
52.65

Average
concentration
(pg/ml)
<0.36

CV
(%)

Recovery
(%)

1.21

-

64.80

2.41

13.75

98.80

97.20

10.47

19.64

107.25

203.40

35.43

3.13

90.71

1076.00

160.90

7.09

102.98

7448.00

644.22

1.7

103.08

31515.00

2439.74

2.43

97.59

69971.00

10043.29

0.25

100.43

Table 9.3: Standard curve for the calculation of cytokine (IL-1β) concentration using the
LEGENDplex™ (BioLegend) bead-based flow cytometric assay and the LEGENDplex™ software V8.0.
Data from table 9.2 were used to create a standard curve for the comparison of unknown cytokine
concentrations. Data for IL-1β are shown from one experiment and is representative of the process for all
cytokines.
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9.5 Appendix E: Screening for the release of inflammatory cytokines
N S 8 8 .2 re p

150

100

50

0
180

0 .7

0 .6

0 .5

0 .4

360

60

T im e ( m in )

30
20
10
0

2
1
0
60

1 .0
0 .5
0 .0

180

0 .8
0 .6
0 .4
0 .2
0 .0

300
200
100
0
-1 0 0
60

0 .9 4
0 .9 2
0 .9 0
0 .8 8
0 .8 6
60

0 .6
0 .4
0 .2
0 .0

8

6

4

2

0
60

2

360

1 .0
0 .8
0 .6
0 .4
0 .2
0 .0
1

2

1 .0
0 .8
0 .6
0 .4
0 .2
0 .0
1

T im e ( m in )

IL - 3 3 c o n c e n tr a tio n ( p g /m L )

T im e ( m in )

180

360

T im e ( m in )

IL - 2 3 c o n c e n tr a tio n ( p g /m L )

IL - 1 8 c o n c e n tr a tio n ( p g /m L )

0 .8

180

T im e ( m in )

T im e ( m in )

1 .0

360

400

360

0 .9 6

2

180

500

T im e ( m in )

IL - 6 c o n c e n tr a tio n ( p g /m L )

IL - 1 0 c o n c e n tr a tio n ( p g /m L )

1 .5

T im e ( m in )

3

T im e ( m in )

IL - 1 7 A c o n c e n tr a tio n ( p g /m L )

2 .0

60

4

360

1 .0

1

2 .5

360

5

T im e ( m in )

1

180

IL - 8 c o n c e n tr a tio n ( p g /m L )

M C P - 1 c o n c e n tr a tio n (p g /m L )

T N F - a c o n c e n tr a tio n ( p g /m L )

40

180

5448AP

T im e ( m in )

50

60

5448

IL -1 2 p 7 0 c o n c e n tr a tio n ( p g /m L )

60

N S 8 8 .2

IF N - g c o n c e n tr a tio n ( p g /m L )

IF N - a 2 c o n c e n tr a tio n (p g /m L )

IL - 1 b c o n c e n tr a tio n ( p g /m L )

PMN

2

T im e ( m in )

1 .0
0 .8
0 .6
0 .4
0 .2
0 .0
1

2

T im e ( m in )

Table 9.4: The release of cytokines from human neutrophils during GAS infection was measured
using the LEGENDplex™ human inflammation cytometric bead assay and flow cytometry over 360
min. Beads were gated as previously described (Figure 4.6). Screening of 13 inflammatory cytokines was
performed where all data are shown (n=2 donors). IL-1β, TNF-α, IL-8 and IL-18 were selected for further
investigation.
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9.6 Appendix F: Anti-human antibody titration
CD11b
Unstained

1 µL

Neutrophils

FSC-H

SSC-A

Singlets

3 µL

5 µL

FSC-A

FSC-A

CD16

FITC fluorescence

CD31

CD47

Unstained

Unstained

Unstained

1 µL

1 µL

1 µL

3 µL

3 µL

3 µL

5 µL

5 µL

5 µL

FITC fluorescence

PE/Cy7 fluorescence

CD64

PE fluorescence

CD66b
Unstained

Unstained

1 µL

1 µL

3 µL

3 µL

5 µL

5 µL

PE fluorescence

PerCP/Cy5.5 fluorescence

Table 9.5: Titration of antibodies used during flow cytometry of human neutrophils. Purified human
neutrophils were incubated in the absence of antibody (unstained) or with 1, 3 or 5 µL of antibody.
Neutrophils were gated upon singlets then viable neutrophils and assessed for their respective
fluorescence by flow cytometry. Data were used to select an appropriate volume for cell staining.
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9.7 Appendix G: Counts of murine immune cells following flow cytometric characterisation
Table 9.6: Event counts of immune cells characterised by flow cytometry. Gating and description of immune cells is described in Chapter 6. Values <90 are shown
in red and were excluded from live cell analysis due to high variability.
Time
(h)

Sample

Mouse ID

6

Blood

Saline 48M.fcs

6

Blood

6

CD45+
(total)

CD45+ (live)

Neutrophils
(total)

Neutrophils
(live)

iMOs (total)

iMOs (live)

Macrophages
(total)

Macrophages
(live)

166473

149346

597

537

639

563

29

14

Saline 38F.fcs

216014

178483

1980

1923

1225

1142

207

90

Blood

Saline 2M.fcs

15037

9049

54

51

46

40

54

41

6

Blood

Saline 29F.fcs

116207

77297

2042

1910

1715

1085

1604

149

6

Blood

Saline 26M.fcs

148368

118403

683

655

516

483

55

33

6

Blood

Saline 25M.fcs

232991

197067

3431

2858

1853

1242

640

274

6

Blood

Saline 14F.fcs

135662

112375

1109

1079

733

704

27

11

6

Blood

Saline 13F.fcs

102538

75427

764

718

382

347

172

79

6

Blood

5448 16F.fcs

76480

61306

3369

3324

710

671

309

159

6

Blood

5448 20M.fcs

80592

48562

6737

4232

2925

1749

530

202

6

Blood

5448 27F.fcs

149356

113083

4979

3933

3041

1954

280

81

6

Blood

5448 28M.fcs

28095

19473

1369

1318

1425

1374

21

10

6

Blood

5448 35F.fcs

65173

48915

4080

3903

1798

1628

1823

867

6

Blood

5448 40F.fcs

82116

63979

2198

2087

1882

1757

264

117
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Time
(h)

Sample

CD45+ (live)

Neutrophils
(total)

Neutrophils
(live)

iMOs (total)

iMOs (live)

Macrophages
(total)

Macrophages
(live)

6

Blood

5448 43M.fcs

44746

35779

2958

2620

809

618

913

396

6

Blood

5448 4M.fcs

30742

24360

1701

1576

914

836

244

178

6

Blood

AP 18F.fcs

68418

57097

10449

10275

1119

994

2270

452

6

Blood

AP 24M.fcs

57922

36898

7633

6888

2589

2158

452

210

6

Blood

AP 30M.fcs

41715

34792

2412

2232

1532

1362

35

10

6

Blood

AP 34F.fcs

85535

60360

3287

2591

1143

714

1980

190

6

Blood

AP 37F.fcs

66128

55938

5383

5143

1869

1723

1198

362

6

Blood

AP 42F.fcs

94055

80381

15167

15019

11900

11299

363

89

6

Blood

AP 44M.fcs

46098

37977

2499

2190

720

569

90

30

6

Blood

AP 6M.fcs

49960

40802

4033

3814

1612

1481

826

364

24

Blood

Saline 8M.fcs

210264

168167

1019

971

891

861

35

17

24

Blood

Saline 49M.fcs

190604

163175

2931

2618

1254

1044

556

180

24

Blood

Saline 44F.fcs

201880

167056

1988

1879

1587

1491

6043

625

24

Blood

Saline 42F.fcs

230163

188222

1329

1175

1044

810

49

16

24

Blood

Saline 33F.fcs

100172

92200

593

566

576

561

149

121

24

Blood

Saline 32M.fcs

186113

161457

1516

1435

776

736

208

88

24

Blood

Saline 26M.fcs

92495

84801

1529

1445

400

367

69

59
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Time
(h)

Sample

Mouse ID

24

Blood

Saline 20F.fcs

24

Blood

24

CD45+
(total)

CD45+ (live)

Neutrophils
(total)

Neutrophils
(live)

iMOs (total)

iMOs (live)

Macrophages
(total)

Macrophages
(live)

215590

173214

1198

1118

839

772

410

65

5448 10M.fcs

61108

50329

340

282

407

348

87

31

Blood

5448 22F.fcs

43614

32489

446

385

538

497

2346

625

24

Blood

5448 22M.fcs

19541

14658

127

113

109

91

119

68

24

Blood

5448 30F.fcs

65439

57181

1135

1119

1649

1552

1581

1352

24

Blood

5448 34M.fcs

52697

40626

871

712

2246

2112

362

62

24

Blood

5448 39F.fcs

39149

23715

477

412

638

497

912

204

24

Blood

5448 46F.fcs

43036

28670

375

299

467

329

1533

220

24

Blood

5448 46M.fcs

28648

20321

183

144

238

146

79

16

24

Blood

AP 12M.fcs

45202

33111

531

491

731

656

343

146

24

Blood

AP 23M.fcs

504

331

6

4

0

0

2

1

24

Blood

AP 24F.fcs

37780

27885

501

400

466

401

1816

713

24

Blood

AP 32F.fcs

7096

5006

140

125

224

218

211

65

24

Blood

AP 36M.fcs

62105

45924

282

264

1019

950

91

34

24

Blood

AP 41F.fcs

42053

27782

383

318

823

622

269

42

24

Blood

AP 47M.fcs

28490

19622

242

212

281

197

59

16

24

Blood

AP 48F.fcs

72680

55586

407

379

1354

1271

962

149
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Time
(h)

Sample

CD45+ (live)

Neutrophils
(total)

Neutrophils
(live)

iMOs (total)

iMOs (live)

Macrophages
(total)

Macrophages
(live)

6

Lavage

Saline 48M.fcs

3196

1537

131

124

36

24

49

11

6

Lavage

Saline 38F.fcs

2462

1279

597

152

407

154

56

12

6

Lavage

Saline 2M.fcs

1507

888

122

101

61

34

78

4

6

Lavage

Saline 29F.fcs

1722

889

88

79

69

30

86

34

6

Lavage

Saline 26M.fcs

1420

995

50

36

38

24

27

6

6

Lavage

Saline 25M.fcs

1348

581

12

4

46

18

76

23

6

Lavage

Saline 14F.fcs

1128

609

17

7

53

7

115

10

6

Lavage

Saline 13F.fcs

2330

980

18

5

15

4

47

5

6

Lavage

5448 16F.fcs

11647

8553

8094

6257

2692

1955

144

60

6

Lavage

5448 20M.fcs

4789

1882

2405

1032

742

251

110

38

6

Lavage

5448 27F.fcs

1403

626

30

10

62

24

83

30

6

Lavage

5448 28M.fcs

7551

5688

4327

3561

2189

1731

70

26

6

Lavage

5448 35F.fcs

12867

5601

7460

3459

2730

1333

200

79

6

Lavage

5448 40F.fcs

12083

5805

7293

3862

3974

2286

152

90

6

Lavage

5448 43M.fcs

9017

4591

4680

3194

2154

1436

171

97

6

Lavage

5448 4M.fcs

39760

28009

34691

25244

8363

5626

386

201

6

Lavage

AP 18F.fcs

12673

3614

9475

2129

2739

394

228

36
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Time
(h)

Sample

Mouse ID

6

Lavage

AP 24M.fcs

6

Lavage

6

CD45+
(total)

CD45+ (live)

Neutrophils
(total)

Neutrophils
(live)

iMOs (total)

iMOs (live)

Macrophages
(total)

Macrophages
(live)

2890

796

877

129

219

40

92

29

AP 30M.fcs

41779

17195

35223

14030

12775

5526

309

186

Lavage

AP 34F.fcs

1919

632

280

49

130

19

87

15

6

Lavage

AP 37F.fcs

6473

2702

2724

1404

753

377

85

24

6

Lavage

AP 42F.fcs

92981

59129

83333

54042

37365

26005

1069

746

6

Lavage

AP 44M.fcs

17473

9915

13409

8260

2159

1111

156

72

6

Lavage

AP 6M.fcs

8344

3923

5448

2745

843

333

140

28

24

Lavage

Saline 8M.fcs

1204

940

7

5

17

6

50

11

24

Lavage

Saline 49M.fcs

4843

1186

72

31

50

6

63

7

24

Lavage

Saline 44F.fcs

1086

582

24

11

13

3

36

11

24

Lavage

Saline 42F.fcs

4872

1216

26

8

51

11

70

11

24

Lavage

Saline 33F.fcs

0

0

0

0

0

0

0

0

24

Lavage

Saline 32M.fcs

888

575

6

5

7

3

37

13

24

Lavage

Saline 26M.fcs

1155

596

75

42

9

4

48

26

24

Lavage

Saline 20F.fcs

1086

817

11

2

17

5

46

10

24

Lavage

5448 10M.fcs

92300

5477

39319

591

8897

102

279

21

24

Lavage

5448 22F.fcs

82617

2377

34064

259

8249

29

127

9
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UOW

Characterising the neutrophil response to Group A Streptococcus
Time
(h)

Sample

CD45+ (live)

Neutrophils
(total)

Neutrophils
(live)

iMOs (total)

iMOs (live)

Macrophages
(total)

Macrophages
(live)

24

Lavage

5448 22M.fcs

229978

33397

115683

7596

8862

261

481

104

24

Lavage

5448 30F.fcs

3687

869

1074

138

364

26

58

23

24

Lavage

5448 34M.fcs

209180

59005

83350

12104

16071

2405

1813

497

24

Lavage

5448 39F.fcs

30441

1326

5543

172

6792

130

181

16

24

Lavage

5448 46F.fcs

124504

7204

67420

2111

16579

599

794

39

24

Lavage

5448 46M.fcs

161018

2596

93722

1031

30774

130

612

75

24

Lavage

AP 12M.fcs

10673

800

7111

24

2505

5

93

7

24

Lavage

AP 23M.fcs

36982

473

33727

51

5520

3

152

24

24

Lavage

AP 24F.fcs

29268

1192

23047

98

7698

23

78

11

24

Lavage

AP 32F.fcs

4289

843

1982

9

389

3

76

25

24

Lavage

AP 36M.fcs

26026

571

20214

31

6992

2

92

19

24

Lavage

AP 41F.fcs

10282

933

5474

7

3935

2

131

8

24

Lavage

AP 47M.fcs

16149

736

11912

13

8494

3

125

5

24

Lavage

AP 48F.fcs

5508

637

2853

16

709

4

45

7

J.G.W

Mouse ID

CD45+
(total)
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